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Q U I L L  O N  S C A L P E L  This section
provides a medium through which Canadian 
surgeons can declare themselves, briefly and in­
formally, on the day-to-day affairs of surgery.
PRESENT STATUS OF OTOLARYNGOLOGY
Those who are not well informed often con­
sider otolaryngology as a specialty concerned 
primarily with such mundane problems as 
nose bleeds, tonsillectomies, sinus and ear 
infections and the prescribing of antihista­
mines for the treatment of postnasal dis­
charge. While this type of work continues as 
part of the general practice of the otolaryn­
gologist there is no uniform definition today 
as to what identifies an otolaryngologist or 
what comprises the scope of his activities. As 
the second oldest recognized surgical spe­
cialty in North America, after ophthalmo­
logy, otolaryngology serves as a good ex­
ample of a discipline whose interests and 
capabilities are overlapped by many other 
specialties.
Otolaryngology is a medical and surgical 
specialty that embraces otorhinolaryngology, 
allergy, head and neck cancer surgery, plas­
tic reconstructive and maxillofacial surgery 
and bronchoesophagology. In order to prac­
tise the specialty a physician must have ade­
quate knowledge of the medical and surgical 
problems related to the ear, nose, paranasal 
sinuses, buccal cavity and appendages, pha­
rynx, larynx, bronchi, neck, chest and eso­
phagus, including the related nervous system. 
The physician must have adequate knowl­
edge of microbiology, biochemistry, em­
bryology, pathology, pharmacology and 
physyology as applied to the specialty.
A young physician who is qualified in 
otolaryngology today has had at least 3 
years of training in the specialty in addition 
to 1 year in general surgery. Following this 
many may subspecialize and take addi­
tional training in an area in which they have 
a particular interest, and limit their practice 
to otology, rhinology, plastic and reconstruc­
tive surgery, head and neck surgery, or some
other aspect of otolaryngology. These young 
well-trained otolaryngologists might well be 
regarded as “head and neck specialists”, and 
there is a move currently gaining momentum 
among these young people to make such a 
change in designation.
The practice of otolaryngology for many 
has become sophisticated and refined. The 
use of the operating microscope has not only 
completely upgraded surgical techniques in 
the ear, particularly in reconstructive middle 
ear and neuro-otologic surgery, but also in 
the larynx, the nose and the paranasal si­
nuses. We now appreciate the role of allergy 
in rhinology and conservative surgery in 
laryngeal carcinoma. In addition we have 
contributed to improvements in reconstruc­
tive surgery of the nasal pyramid. These are 
but a few examples of the ever-changing 
practice of otolaryngology.
Noise pollution has emerged as a major 
problem in our society today. The applica­
tion of government regulations to industry 
has resulted in an ever-increasing demand 
for expertise in this field. Many otolaryngo­
logists are keenly interested and are deeply 
involved in seeking solutions to various as­
pects of the problem.
The relationship of otolaryngology to 
overlapping specialties in the university mi­
lieu can result in substantial patient benefit, 
but in certain geographical areas this over­
lapping has led to a conflict of interests. 
This is understandable, for in order to excel 
one must strive for perfection; such a goal 
on the part of several people can lead to con­
flicts. These conflicts can be resolved by 
deciding on what is best for the patient; this 
is the only basis for a solution.
While it is constructive to have a degree 
of healthy competition between overlapping
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specialties it is also necessary to foster co­
operation. As an example, audiology and 
vestibular units, while properly under the 
aegis of otolaryngology, are of great value 
to other specialties such as ophthalmology, 
neurology, neurosurgery and medicine.
In the nonuniversity milieu the relation­
ship of otolaryngology to the other special­
ties depends on the ability, availability and 
progressiveness of the individual otolaryn­
gologist. If an otolaryngologist is well trained
and capable he will be recognized by the 
physicians and surgeons in his community. 
If he is available he will be sought after for 
consultations. If he is progressive and keeps 
up with the developments within his special­
ty he will be a credit to otolaryngology.
J. D. Baxter, md, frcs[c]
Professor and chairman,
Department of otolaryngology,
McGill University,
Montreal, PQ.
*
CARDIAC SURGERY: THE NEW CHALLENGE
Over the past 25 years there has been amaz­
ing progress in the specialty of cardiac sur­
gery. Although there had been earlier spora­
dic efforts, it was experience gained in World 
War II that led people to believe that surgery 
on the heart was feasible. Gross, Crafoord 
and Blalock proved that abnormalities rela­
ted to the heart could be corrected or im­
proved with extracardiac procedures, and 
Harkins, Bailey and Murray demonstrated 
the feasibility of closed-heart operations. 
Bigelow showed us that the heart could, with 
the use of hypothermia, be opened for short 
periods of time. With the persevering efforts 
of men such as Gibbons and Lillehei, open- 
heart surgery became a reality.
Investigative procedures developed by 
cardiologists, and improved anesthesia, 
made it possible for a number of talented 
surgeons to develop procedures for the cor­
rection of cardiac abnormalities that could 
now be identified in vivo. Coincident with 
these many new developments was the 
marked improvement in intensive care; car­
diac surgery has become a way of life.
Initially, activities were directed to what 
might be looked on as the gross problems re­
lated to cardiac surgery. As these have been 
solved, more attention has been devoted to 
the finer details of improving prostheses and
learning about the physiology of individual 
myocardial cells rather than the myocardium 
as a whole. Coincident with this is the need 
to assess the results: Is the mortality rate as 
low as it can be? Does cardiac surgery pro­
mote a better way of life? Has the life span 
been prolonged and if so, is it rewarding? 
What is the place of rehabilitation?
In many ways great progress has been 
made, but much remains to be done. Most 
congenital defects can be corrected, but can 
they be prevented? Infections are being at­
tacked; the ravages of rheumatic fever are 
now preventable. Degenerative problems can 
be greatly improved, but we have made little 
progress in the understanding and prevention 
of arteriosclerosis.
In this issue of the Journal (pages 101 
to 146) the results of the work done by 
some of our investigators are presented. We 
commend them for their efforts; we urge 
them to continue. We hope that their work 
will encourage others to take up the chal­
lenge of investigation.
Donald R. Wilson, md, frcs[c]
Professor and chairman,
Department of surgery,
University of Toronto,
Toronto, Ont.
■ i
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SELF-ASSESSMENT
SESAP II QUESTION
350. A temporary or permanent cardiac pacemaker is LEAST likely to be required for a 
patient who
(A) has Stokes-Adams attacks
(B) has congestive heart failure with complete heart block
(C) has atrial fibrillation and slow ventricular rate
(D) has sinus bradycardia with angina pectoris
(E) requires cholecystectomy and develops asymptomatic complete heart block 
For this incomplete statement select the one completion that is best from the five given. 
For the critique of Item 350 see page 177 of this issue.
(Reproduced by permission of the American College of Surgeons from SE SA P  II  Syllabus: 
Surgical Education and Self-assessment Program No. 2.)
DAVIS & GECK SURGICAL ESSAY AWARD FOR RESIDENTS
Davis & Geek annually awards $1000.00 to the surgical resident submitting the 
best paper on a surgical topic to the Canadian Journal of Surgery. This award is in­
tended to promote scientific and literary excellence among Canadian surgeons in 
training.
The conditions of entry for the 1977 award are the following: —
1. Candidates shall be currently engaged in a recognized surgical residency program 
leading to eligibility for the Fellowship of the Royal College of Physicians and 
Surgeons of Canada in one of the surgical specialties (cardiovascular and thoracic 
surgery, general surgery, neurosurgery, obstetrics and gynecology, ophthalmology, 
otolaryngology, orthopedic surgery, plastic surgery and urology).
2. The material to be submitted shall be in the form of a manuscript relating to
work in which a surgical resident is or has been the prime or major investigator. 
Prior oral presentation at a Royal College meeting or a Surgical Forum meeting 
will not be a disqualification, but prior publication as a formal paper in a 
journal will. The paper should relate to any field of surgical interest. The manu­
script must conform to the style requirements of the Journal and must not
exceed 3000 words of text and six tables and/or six figures. Coauthors are
permitted on the understanding that the candidate shall be the first author and 
that only the first author shall be eligible for the award.
3. Entries must be received in the office of the Journal no later than June 30, 1977. 
Each entry must be submitted to E. M. Cooperman, MD, FRCPfC], at the 
office of the Canadian Journal of Surgery, PO Box 8650, Ottawa, Ont. 
K1G 0G8, with a letter stating that the paper is being submitted as an entry 
for the Davis & Geek Surgical Essay Award.
4. All papers submitted shall be the property of the Canadian Journal of Surgery 
unless returned to the author without publication.
All papers submitted will be judged by an independent committee comprising at 
least one member of the editorial board of the Journal, one fellow of the Royal College
of Physicians and Surgeons of Canada, and one representative of The Canadian Medical
Association, together with other fellows invited to serve at the discretion of the three 
permanent members of the committee. For the purpose of judging, the candidates will 
be anonymous. The judges’ decision shall be final.
The name of the successful candidate and the title of the paper will be announced 
in the November 1977 issue of the Journal.
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LEFT ATRIAL THROMBOSIS COMPLICATING MITRAL STENOSIS: 
RESULTS OF SURGICAL TREATMENT*
CONRAD PELLETIER, MD, FRCS[C],t SAAD BIZRI, MD, ROBERT COSSETTE, MD, 
FRCS[C], LEON DONTIGNY, MD, FRCS[C] and ROLAND LEVY MD, FRCS[C]
In 343 patients treated surgically for mitral valve 
disease, there was thrombosis of the left atrium 
in 40. Massive atrial thrombosis was present in 
32 of them, yet the diagnosis was suspected or 
established preoperatively in only 12, because 
of insufficient clinical signs. A transventricular 
mitral commissurotomy was performed in 32 pa­
tients and mitral valve replacement in the re­
maining 8. Surgical mortality was 23% in the 
patients with atrial thrombosis compared with 
7% in the thrombus-free patients: 66% of the 
deaths were due to cerebral embolism. Systemic 
embolism occurred in 17% of the patients who 
had a closed approach initially and in 27% fol- 
- lowing a planned open procedure. Among the 
survivors, 65% were asymptomatic or markedly 
improved: the average follow-up was 42 months. 
Atrial thrombosis increases the surgical risk 
because of the high incidence of operative em­
bolism, a complication that is not avoided by the 
use of open procedures, but that could be pre­
vented by earlier surgical treatment of mitral 
stenosis, before atrial thrombi develop.
Parmi 343 patients operes pour une atteinte val- 
vulaire mitrale, 40 avaient une thrombose de 
I'oreillette gauche au moment de I'intervention. 
Dans 32 des cas, il y avait une thrombose auricu- 
laire massive, mais le diagnostic n’a pu etre 
suspecte ou etabli avant I'operation que dans 12 
a cause de I'insuffisance des signes cliniques. 
Trente-deux patients ont subi une commissuroto- 
mie mitrale trans-ventriculaire et les huit autres 
un remplacement valvulaire mitral. Chez les pa­
tients ayant une thrombose auriculaire, la morta- 
lite operatoire fut de 23%, comparativement a 
7% en I'absence de caillots. L'embolie cerebrale 
fut la cause des 66% des deces. Avec l'approche 
chirurgicale initiate a coeur ferine, I'incidence 
d'embolie systemique fut de 17%; elle fut de 
27% chez les patients operes d'emblee a coeur
*From the division of cardiovascular and thora­
cic surgery, department of surgery, Maisonneuve 
and Sacre-Coeur Hospitals, University of Mont­
real, Montreal, PQ.
Presented at the annual meeting of the Canadian 
Cardiovascular Society, Edmonton, Alta., Oct. 18- 
23, 1976.
tScholar, Medical Research Council of Canada.
Reprint requests to: Dr. Conrad Pelletier, Cardio­
vascular and thoracic surgery, Sacre-Coeur Hospi­
tal, 5400 Blvd Gouin W. Montreal, PQ H4J lC5.
ouvert. Soixante-cinq pour-cent des survivants 
restent asymptomatiques ou ameliores apres une 
evolution post-operatoire moyenne de 42 mois. 
La thrombose auriculaire augmente le risque 
operatoire a cause de I’incidence elevee d'em- 
bolies, complication que n'elimine pas ('utilisa­
tion d'une intervention a coeur ouvert, mais 
qu'un traitement chirurgical precoce de la ste- 
nose mitrale pourrait aider a prevenir.
T hrombosis of the left atrium remains a 
major threat to patients with mitral valve 
stenosis. This complication has been reported 
in 5 to 26% of patients with mitral stenosis 
treated surgically.1, 2 With the advent of 
cardiopulmonary bypass, the incidence of 
operative embolism in these patients has 
been decreased but not eliminated.2 Knowl­
edge of the presence of thrombi before sur­
gery would greatly facilitate the manage­
ment of this condition. Unfortunately, the 
diagnosis is seldom made preoperatively, be­
cause of the lack of typical signs. In addi­
tion, there is no direct relationship between 
preoperative systemic embolism and the 
presence of left atrial clots at the time of 
surgery.2- 4 This has been one of the argu­
ments in support of the routine use of the 
open approach to mitral stenosis.3 Since 
closed mitral commissurotomy is still cur­
rently used by our group, it was of interest 
to analyze our results in regard to this prob­
lem. In the present report, we have reviewed 
our experience with 40 patients in whom 
left atrial thrombi were found at surgery.
Patients and M ethods
From Jan. 1, 1967 to Dec. 31, 1973, 
343 patients with mitral valve disease 
were treated surgically. Forty (12%) of 
these patients were found to have thrombi in 
the left atrium associated with mitral steno­
sis. A closed mitral commissurotomy was 
performed in 32 patients and mitral valve 
replacement in the remaining 8. Table I 
illustrates the respective incidence of atrial 
thrombosis with each procedure. There were 
26 women and 14 men. Among the patients 
with atrial thrombi, 78% were older than 45
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TABLE I.—Incidence of Left Atrial T hrom­
bosis in M itral Valve Surgery
No. of No. with left 
cases atrial thrombosis
Procedures______________ (and % )  (and %)
Closed mitral
commissurotomy . 250 (73) 32 (13)
Mitral valve
replacement.........  93 (27) 8 ( 9)
Total.........................  343 (100) 40 (12)
years and the average age was 52 (range, 
35 to 66 yr). Preoperatively, the functional 
incapacity, based on the New York Heart 
Association (NYHA) classification, was the 
following: 1 patient in functional class II 
(slight limitation of activity), 25 in class III 
(marked limitation of activity) and 14 in 
class IV (confined to bed or chair). Twenty- 
five patients had signs of, or had been treated 
for, chronic heart failure and 10 patients 
complained of typical anginal pain. Ten pa­
tients had sustained systemic embolism prior 
to their admission: cerebral vessels were in­
volved in seven patients, renal vessels in 
three and femoral arteries in two. Atrial fi­
brillation was present in all patients, except 
one, before operation. Four patients had 
undergone a previous closed mitral commis­
surotomy.
R o e n t g e n o g r a m s  and C ardiac 
C a t h e t e r iz a t io n
The left atrium was usually found to be 
slightly to moderately enlarged on cardiac 
roentgenograms. There was marked atrial 
dilatation in only four patients. Slight calci­
fication of the mitral valve was seen in 21 
patients, whereas there were densely calci­
fied leaflets in only 6. Calcifications of the 
left atrial walls were present in two patients 
(Fig. 1).
The diagnosis of left atrial thrombosis was 
established or suspected preoperatively in 
only 12 patients. Left atrial angiography was 
performed in six patients and was positive 
in only three (Fig. 1).
Cardiac catheterization was carried out in 
39 patients preoperatively. Most had a low 
cardiac output with a cardiac index averag­
ing 2.2 //m inm 2 in 36 patients (range, 1.0 
to 3.5 //m inm 2). The pressure gradient 
across the mitral valve averaged 18 mm Hg 
at rest (28 patients); in 12 patients the 
gradient was 20 mm Hg or greater. The mi­
tral surface area was less than 1.0 cm2 in 19 
patients, between 1.0 and 1.5 cm2 in 6 and 
greater than 1.5 cm2 in 2. Pulmonary hyper­
tension was present in 25 patients (63%), 
with systolic pressures between 50 and 75 
mm Hg in 20, and above 75 mm Hg in the 
remaining 5. No significant degree of mitral 
regurgitation was found in these patients. 
There was an associated valvulopathy in 
seven patients (aortic valve in six, tricuspid 
valve in one).
O p e r a t iv e  T e c h n iq u es  and F in dings
In 29 patients the operative approach was 
through a left anterior thoracotomy (planned 
closed procedure). In 14 of these patients, a 
transventricular mitral commissurotomy was 
done without cardiopulmonary bypass; the
Fig. 1.—Cineangiogram of patient with left atrial thrombosis. A: before injection, calcifications 
are seen in wall of left atrium (arrows). B: large filling defect (arrows) in left atrium due to massive 
thrombus.
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TABLE I I — Surgical Procedures in 40 P atients 
with Left Atrial T hrombosis
Surgical procedures No. of cases
Left atrial thrombectomy.................... 39
Closed mitral commissurotomy.........  32
Mitral valve replacement....................  8
Associated procedures:
Aortic valve replacement................
Tricuspid valve replacement..........  1
Femoral embolectomy.....................
Pulmonary embolectomy................  1
atrial thrombi were either evacuated through 
the atrial appendage incision (11 patients) at 
the beginning of the procedure, or, when 
firmly adherent to the appendage, excluded 
at the end of the procedure (3 patients) by 
ligation at the base of the appendage. In 15 
patients, cardiopulmonary bypass was in­
stituted through cannulation of the femoral 
vessels following the discovery of atrial 
thrombi on digital exploration. Fibrillation 
was induced and the clots were removed; 
subsequently a transventricular commissuro­
tomy was performed after defibrillation. 
Prosthetic replacement of the mitral valve 
was carried out in two patients because of 
severe regurgitation resulting from mitral di­
latation.
In the remaining 11 patients a median 
sternotomy was used and cardiopulmonary 
bypass was instituted in the usual manner 
before exploration of the left atrium (open 
procedure). This approach was chosen either 
because a valve replacement was contem­
plated (seven patients), usually for heavily 
calcified valves, or because a preoperative 
diagnosis of left atrial thrombosis had been 
made (four patients). Following fibrillation, 
the left atrium was opened and the thrombi 
extruded. In one case a completely endothe- 
lialized mural thrombus was firmly adherent 
to the posterior wall and could not be re­
moved. Table II details the various surgical 
procedures performed in this study.
In 32 patients massive thrombosis of the 
left atrial cavity was found. The thrombi 
were predominantly adherent to the poste­
rior wall with a varying degree of pulmonary 
vein obstruction. In eight patients, throm­
bosis was limited to the atrial appendage. 
Severe mitral stenosis was found in all but 
one patient with massive thrombosis of the 
left atrium and minimal valve stenosis.
R esu lt s
Surgical Mortality and Complications
The respective surgical mortality in pa­
tients with and without thrombosis of the 
left atrium is shown in Table III. In the 40 
patients with atrial thrombi, there were 9 
operative deaths (23%) compared with an 
operative mortality of 7% in the thrombus- 
free group. Three of the nine deaths were 
not related to the presence of atrial throm­
bi. Two patients died of acute left ventricular 
failure at the termination of cardiopulmo­
nary bypass; in both, technical difficulties 
followed mitral valve replacement. One pa­
tient, who sustained massive pulmonary em­
bolism preoperatively, died during operation. 
Six patients died 1 to 30 days after surgery 
from cerebral embolism (Table IV). Severe 
neurologic deficits were present before oper­
ation in three of these patients owing to re­
cent cerebral emboli: in one there were signs 
of a new embolic episode immediately fol­
lowing operation, while in the other two pre­
existing deficits extended. In the remaining 
three patients, cerebral embolism occurred 
during operation, and two of these patients 
also had coronary and femoral emboli. 
In two other patients neurologic deficits at-
TABLE III.— Influence of Left Atrial T hrombosis on Surgical M ortality in
M itral Valve Surgery
Procedures
Total no. of 
cases
Surgical mortality 
\and% )
Patients with left atrial thrombosis: .................................. ..........  40
............... 32
9 (23)
5(16)
Mitral valve replacement.................................................. ..............  8* 4 (50)
Patients without left atrial throm bosis:............................
Mitral commissurotomy...................................................
Mitral valve replacement..................................................
..................... 303
..................... 218
.....................  85*
22 ( 7)
9 ( 4) 
13 (15)
* Including patients with multiple surgical procedures.
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TA B LE  I V — Surgical Complications and Causes of Death in Patients with 
Left Atrial T hrombosis
Complications_____ Surgical deaths Survivors Total
Cerebral em bolism ...............................................................  0* 2 8
Closed approach................................................................. 3 2 5
Open approach...................................................................  3 q 3
Acute heart failure.................................................................  2 0 2
Pulmonary embolism............................................................. 1 0 1
*Two patients had associated emboli (coronary, femoral).
tributed to cerebral embolism developed 
after operation; subsequently the deficits re­
solved (Table IV). In all, 8 patients suffered 
systemic embolism that could be related to 
surgery — 5 (17%) of the 29 patients who 
underwent a planned closed procedure 
and 3 (27%) among the 11 patients who 
underwent an open procedure. Massive 
atrial thrombosis was present in all but one 
patient who survived following a cerebrovas­
cular accident; in this patient a small throm­
bus in the atrial appendage had been evacu­
ated through the atriotomy before dilation 
of the mitral valve.
Late Follow -Up Data
Follow-up of the 31 survivors ranged 
from 6 to 103 months (average, 42 mo) (Ta­
ble V). Twenty patients (65%), including 16 
who underwent commissurotomy and 4 who 
had valve replacement, remained asympto­
matic or were markedly improved (NYHA 
classes I and II). Eight patients remained un­
changed or deteriorated progressively follow­
ing initial mitral commissurotomy (Fig. 2); 
seven of them (26% of those who survived 
the initial commissurotomy) were advised 
to undergo mitral valve replacement — 
six complied, 12 to 94 months (average, 41 
mo) after initial surgery. No atrial thrombi 
were found at reoperation in these patients. 
Three patients had the following associated 
procedures: aortic valve replacement, aorto­
coronary bypass, and aortocoronary bypass
TABLE V.— Long-Term F ollow-Up Data of 31 
Patients Surviving Initial Surgery
Follow-up No. of patients
Total cases...........................................  31
Asymptomatic or improved...............  20
Reoperation needed (valve
replacement)...................................  7
Late death............................................ 4
Late systemic embolism.....................  1
Long-term anticoagulation................ 15
with resection of ventricular aneurysm and 
aortic commissurotomy.
Anticoagulants were not administered 
routinely after operation. In 15 patients, in­
cluding 5 with a valvular prosthesis, long­
term anticoagulation therapy was prescribed. 
One patient suffered a myocardial infarc­
tion 2 weeks after operation; this was at­
tributed to coronary embolism. He subse­
quently received anticoagulants. There were 
no other instances of systemic embolism 
during follow-up. Two patients receiving 
anticoagulants suffered a cerebral hemor­
rhage 5 and 20 months after operation, re­
spectively; one made a full recovery and the
*  RE OP
Fig. 2.-N ew  York Heart Association (NYHA) 
functional classification in 31 patients who sur­
vived initial surgical procedure; preoperative and 
last visit or at reoperation. (CMC =  closed mitral 
commissurotomy, MVR =  mitral valve replace­
ment.) *Six patients underwent reoperation (REOP) 
for mitral valve replacement during follow-up.
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other died. There were three additional late 
deaths — one 7 months after operation from 
respiratory insufficiency, and the others 18 
and 94 months after operation from heart 
failure (total late mortality, 13%). One of 
these patients died of congestive heart fail­
ure following reoperation for mitral valve 
replacement and aortocoronary bypass.
D iscussion
Left atrial thrombosis was present in 12% 
of our patients operated upon for mitral 
valve disease. Most had massive thrombosis, 
yet the diagnosis was seldom made preoper- 
atively (30%). The difficulty of establishing 
such a diagnosis before surgery is well recog­
nized.^- (i The various factors usually asso­
ciated with atrial thrombosis have been re­
viewed by Ullal and colleagues.1' However, 
none of these is diagnostic. In our group of 
patients, most were older than 45 years and 
had a clinical history of chronic congestive 
heart failure; in addition, all but one were in 
a state of atrial fibrillation. The radiographic 
size of the left atrium and the degree of val­
vular calcification bore no relationship to 
atrial thrombosis; calcified atrial walls were 
an exceptional finding. In most instances the 
patients had severe mitral stenosis. Like 
others,fi we found an unusually high inci­
dence of angina, suggesting associated 
ischemic disease of the myocardium. How­
ever, in this series coronary artery angio­
graphy was not done and other factors, such 
as low cardiac output, pulmonary hyperten­
sion and coronary embolism, could have con­
tributed to the angina. Systemic embolism 
before surgery, though not uncommon, is not 
invariably associated with the finding of 
atrial clot at operation.2- 4 Only 10 of our 
patients had a previous history of embolism.
The surgical mortality was substantially 
higher when left atrial thrombosis was pre­
sent than when it was not (23% v. 7%). 
Two thirds of the patients died from syste­
mic embolism, and 50% of them had severe 
neurologic deficits before operation. It has 
been claimed that the incidence of embolism 
could be reduced consistently by routine use 
of open mitral commissurotomy.3 Postoper­
ative embolic complications of 2 to 8% and 
operative mortality of 2% or less were re­
ported with this procedure.2 However,
such results have not been obtained uni­
formly. An operative mortality of 25 and 
30% and an incidence of postoperative em­
bolism of 10 and 12% were reported by Ullal 
and colleagues6 and by Peterson and asso­
ciates,7 respectively, in patients who had 
either a mitral valve replacement or an open 
commissurotomy. These figures are similar 
to our results. Systemic embolism directly 
related to surgery occurred in six (15% ) of 
our patients; four patients (10%) died of a 
cerebral embolism suffered during operation 
while in two others (5%) a prior stroke was 
extended. Among our patients, the incidence 
of embolic accidents was higher (27% ) in 
the patients who underwent an open proce­
dure than in those for whom a closed proce­
dure was initially chosen (17%). Therefore 
it is uncertain that the systematic use of open 
procedures would contribute substantially to 
the prevention of this major complication. 
On the other hand, only eight of our patients 
required valve replacement. In six of them, 
prosthetic replacement was planned because 
of heavily calcified valvular leaflets. In only 
two patients was the mitral valve replaced 
after a closed commissurotomy had failed. 
From published reports, it is often difficult 
to recognize the relative incidence of valve 
replacement required because of the failure 
of an open commissurotomy. In the group 
of patients reported by Roe and colleagues,2 
44% had a valve replacement. Finnegan and 
colleagues8 noted a more than twofold in­
crease in valve replacement after they aban­
doned closed mitral commissurotomy. With 
otherss- 11 we believe that when commissuro­
tomy is performed in the closed beating 
heart there is a lower incidence of secondary 
regurgitation and of valvular replacement.
The long-term results of this study have 
also been satisfactory; 65% of the survivors 
were restored to functional NYHA classes 
I or II for an average follow-up period of 
3 Vi years. Within the same period of time, 
7 (26%) of the patients who initially had a 
closed commissurotomy required reopera­
tion. This compares favourably with the re­
sults of Ellis and associates8 in a long-term 
follow-up study of 1000 cases of closed com­
missurotomy. As pointed out by Hanlon and 
associates,1" even though the open approach 
to mitral commissurotomy may offer certain 
theoretical advantages, the long-term results
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have not yet established the superiority of 
this technique.
A high incidence of late recurrent em­
bolism or atrial thrombosis has been re­
ported.6- 7 This has not been our experience 
even though anticoagulant therapy was not 
used routinely after operation. Only one pa­
tient had a possible late embolic episode and 
no atrial thrombi were found in the six pa­
tients who underwent reoperation. Our cur­
rent policy is to prescribe anticoagulants for 
all patients with a valvular prosthesis and 
when rough endocardial surface remains 
after excision of a large atrial thrombosis.
When thrombi are present in the left atrial 
cavity, cardiopulmonary bypass is manda­
tory in order to achieve complete excision. 
We now use the approach of Gott and his 
colleagues!> in patients who are at high risk 
for such a complication. A sternal-splitting 
incision is made and the patient placed on 
partial cardiopulmonary bypass. With the 
heart beating, a digital exploration is per­
formed and a transventricular closed com­
missurotomy is done if the atrium is free of 
clot. When thrombi are present the atrium 
is opened to evacuate the thrombi, and a 
transventricular commissurotomy performed 
after atrial closure and defibrillation.
This technique offers both the advantages 
of closed commissurotomy and the security 
of readily available total bypass in case 
thrombi are found. In patients with low risk 
of atrial thrombosis, we perform closed com­
missurotomy through a left anterior thoraco­
tomy. To improve preoperative disclosure of 
atrial thrombosis, left atrial cineangiograms 
are used more frequently, and we are now 
assessing the value of echocardiography in 
the diagnosis of this condition. Whatever the 
surgical technique used, atrial thrombosis 
remains a major and potentially lethal com­
plication of mitral stenosis, and efforts
should be directed towards its prevention. 
This goal could be achieved by earlier sur­
gical treatment of patients with proven mi­
tral stenosis; because only a small risk is 
involved with closed commissurotomy the 
surgeon may adopt a more aggressive atti­
tude towards the minimally disabled patient.
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EFFECT OF UNILATERAL PULMONARY ARTERY OCCLUSION ON 
THE ARTERIAL OXYGEN PRESSURE OF CHILDREN UNDERGOING 
PULMONARY SYSTEMIC ARTERY SHUNT PROCEDURES*
D. A. MURPHY, MD, G. L. DUNN, MD, D. A. GILL1S, MD, A. R. C. DOBELL, MD
and A. S. W ENNING, MD
Of 20 children undergoing thoracotomy who had 
blood-gas analysis at various intervals during 
their operative procedure, 18 had congenital 
heart disease causing cyanosis. The venous ad­
mixture was apparent on compressing the lung 
to expose the mediastinal structures and was di­
minished upon clamping the pulmonary artery to 
the exposed lung. This observation may be of 
clinical value in raising the arterial oxygen pres­
sure when sudden deterioration occurs during 
performance of a systemic pulmonary shunt in 
cyanotic children.
Parmi 20 enfants qui ont subit une thoracotomie 
et chez qui on realisa des analyses des gaz san- 
guins a divers intervalles durant leur intervention 
chirurgicale, 18 souffraient d’anomalies cardia- 
ques congenitales causant de la cyanose. Le me­
lange veineux etait apparent apres compression 
du poumon de fagon a exposer les structures 
mediastinales et il etait diminue par clampage 
de I'artere pulmonaire menant au poumon expo­
se. Cette observation peut avoir un interet Clini­
que lorsqu'il faut augmenter la pression arte- 
rielle d’oxygene, en presence d'une deterioration 
subite pendant la realisation d'une derivation 
pulmonaire generale chez les enfants cyanoti- 
ques.
In the creation of a systemic to pulmonary 
artery shunt, it is necessary temporarily to 
occlude one of the pulmonary arteries. Cya­
notic children, even with low arterial oxygen 
pressure (Pao2), usually tolerate this proce­
dure well. Since a portion of one lung is com­
pressed during the surgical procedure, we 
considered it possible that occlusion of the 
pulmonary artery to the collapsed segment
*From the departments of surgery and anesthe­
siology, Dalhousie University, Halifax, NS and 
McGill University, Montreal, PQ.
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by decreasing the venous admixture, would 
result in an increase in Pao2. To test this 
hypothesis, arterial blood gases were meas­
ured in 20 children at various stages during 
the surgical procedure.
M a t e r ia l s  a n d  M e t h o d s
Over a period of 4 years, 18 children with 
congenital heart disease causing cyanosis 
and 2 children with atrial septal defects at 
the Izaak Walton Killam Hospital for Chil­
dren and the Montreal Children’s Hospital, 
underwent arterial blood-gas analysis se­
quentially during their operative procedure. 
The two patients with atrial septal defects 
underwent closure of these defects through 
a right thoracotomy, and the pulmonary 
artery was temporarily occluded during the 
preliminary steps before initiating cardiopul­
monary bypass. The cyanotic children all un­
derwent systemic to pulmonary artery shunts. 
Not all children undergoing shunts at these 
centres were included in the study since 
emergency situations, tiny infants and surg­
ical or hemodynamic changes during the 
operative procedure precluded complete stu­
dies and prevented their inclusion in the 
series.
Duplicate blood samples were taken with 
heparinized plastic syringes from Teflon 
needles inserted percutaneously or through 
exposed radial, temporal or posterior tibial 
arteries. The syringe plunger was rinsed with 
full-strength heparin and the excess dis­
charged from the syringe, except for the 
small amount left in the nozzle tip. Before 
the duplicate sample was taken, 1 ml of 
blood was withdrawn from the arterial line 
and discarded. Air was expressed from the 
syringe, which was corked and placed on 
ice; blood gases were measured within 30 
minutes on a Radiometer Mark 2 physio­
logical blood gas analyzer (Radiometer Co., 
Copenhagen).
Anesthetic techniques and doses of anes­
thetic agents used varied with the anesthetist 
and the particular case. However, in all
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cases, anesthesia was maintained with D-tu- 
bocurarine and either morphine or keta­
mine, and the patients were ventilated with 
100% oxygen throughout the procedure.
In patients weighing less than 20 kg, ven­
tilation was achieved with a Bird Mark VII 
respirator coupled to the patient via a Bird 
Mark IV patient assister, which was attached 
to the expiratory limb of a standard Rees T- 
piece. The accurate measurement of tidal 
and minute volumes is extremely difficult in 
small infants and neonates so ventilation was 
initiated at a fixed rate of 20/min and the 
tidal volume was set empirically.
The following lists the blood sampling se­
quence :
1. Patient supine after induction on inter­
mittent positive pressure ventilation
2. Patient in anterolateral thoracotomy 
position:
A—chest open but lung not retracted 
B— lung compressed longer than 5 min 
C— pulmonary artery occluded, 1 min 
D— pulmonary artery occluded, 5 min 
E— pulmonary artery released, 5 min 
F—pulmonary artery released, 30 min 
G— pulmonary artery clamped for shunt, 
1 min
H— pulmonary artery clamped for shunt, 
5 min.
At no time was the normal sequence of
surgery, or the patient’s safety jeopardized. 
The pulmonary artery occlusion was carried 
out as the systemic vessel was being pre­
pared (steps C to F), and the remaining steps 
occurred during the anastomosis.
R esults
The average, duplicate, sample values for 
all patients are listed in Table I. In order to 
compare patients, the percentage changes in 
Pao2 between each maneuver were calcu­
lated; the differences are summarized in Ta­
ble II.
The Pao2 decreased 17% (P <  0.01) when 
the lung was collapsed to expose the me­
diastinal structure (A to B). The pulmonary 
artery was dissected from its bed, encircled 
and subsequently occluded. This maneuver 
resulted in a 7% increase in Pao2 at 1 min­
ute (P < 0.025) and a 9% increase by 5 
minutes (P < 0.025). However, upon release 
of the pulmonary artery for 5 to 30 minutes 
there was no substantial change in the Pao2 
from the 9% increase (B to E or B to F). 
Although further clamping of the pulmonary 
artery to complete the anastomosis resulted 
in a 2 to 3% increase over the original pre­
clamping value (B to C, B to H), there was 
actually a 9 to 7% decrease in Pao2 com­
pared with the values just prior to reclamping 
the pulmonary artery.
TABLE I.—Average Arterial Oxygen Pressure of Duplicate Samples Taken During Study of 
20 Children with Congenital H eart D isease Causing Cyanosis
Samples
Heart defects A B C D E F G H
Tetralogy.................................... 55 42.5 47.5 47 53 _ _ _
ASD............................................. 452.5 370 165 182.5 357.5 — — _
TA ............................................... 39 31 26 32 27 30 _ _
ASD.............................................. 560 445 427.5 420 — 420 — _
Tetralogy...................................... 54 37.5 47 51 50 — — 50
TGA, PA ...................................... 17 22 25 21.5 21.5 — —
Tetralogy...................................... 84 42 55.5 58 58 61 54 _
DC. SV, PS................................. 52 53.5 58.5 60.5 56 — 52.5 53.5
PS, VSD, TGA........................... 45 40.5 42.5 41.5 40 43 42 41
Atrioventricular canal, PS........ 63 39.5 38.5 45.5 40 43 41 41.5
TGA, PS, D C ............................. 73 70 67.5 66 65 — —
T A ................................................. 50 48.5 68 67 66 66 49 57.5
PA, VSD...................................... 80 39 48.5 52 49.5 52.5 40.5 45
Tetralogy...................................... 425 223 335 326.5 280 234 250.5 287.5
TA ................................................. 48 50 54 55.5 — — — 52
PA................................................ 71 73 77.5 68 69.5 42.5 42 39
Tetralogy..................................... 69 61.2 67 65.5 69 — 68 71
PA................................................ 63 57 53 56 63 60 46 39
TGA, TA, PAB.......................... — 62 60 56.5 61 63.5 53
Tetralogy..................................... 52 42.5 42 44 43 51.5 52.5 47
ASD = atrial septal defect; TA = tricuspid atresia; TGA = transposition of the great arteries; PA = 
pulmonary atresia; DC = dextrocardia; SV = single ventricle; PS = pulmonary stenosis; VSD = ventri­
cular septal defect; PAB = pulmonary artery banding.
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In other words, initially there was a small 
(7 to 9%), but significant (P < 0.025), in­
crease in Pao2 upon clamping the pulmon­
ary artery. The Pao2 did not return to its 
previous preclamping level when the pul­
monary flow was supposedly re-established. 
After approximately 30 minutes, the syste­
mic artery was dissected free and the formal 
anastomosis begun. It then was necessary 
to clamp the pulmonary artery again; this 
resulted in a surprising decrease (9 to 7% , 
P < 0.025, 0.05) in the measured Pao2.
D iscussion
The Pao2 decreased by an average of 
17% (P <  0.01) when the chest was opened 
and a portion of one lung was collapsed to 
expose the relevant hilar structures. This is 
in keeping with experimental1 and clinical 
studies2"4 demonstrating venous admixture 
to the left side of the heart with lung col­
lapsed.
The small, but significant, increase in the 
systemic Pao2 observed on clamping the 
pulmonary artery to the partially collapsed 
lung is not a new observation;5 however, it
is important that it occurs in cyanotic chil­
dren with major intracardiac shunting. This 
observation can be put to clinical advantage 
when a child deteriorates during the perform­
ance of such a shunt. Most surgeons favour 
an open pulmonary artery until the last mo­
ment; they consider that some ventilation is 
better than none in patients with such a cri­
tically low Pao2. We did not study children 
with an unoccluded pulmonary artery whose 
exposed lung continued to be partially ven­
tilated; it is therefore not known whether 
the Pao2 would also increase 7 to 9% with­
out pulmonary artery clamping. It is unlike­
ly that this would occur, since most clinical 
observations in adults indicate a decrease in 
the Pao2 in this situation.
It is surprising that upon releasing the pul­
monary artery after the first clamping, the 
Pao2 did not decrease to its preclamping 
value. If the collapsed lung continued to 
supply venous blood to the left atrium after 
re-establishing blood flow to the lung, a de­
crease in Pao2 would be expected. In ex­
perimental acute atelectasis in the open­
chested animal, there is an initial decrease 
in pulmonary vascular resistance.1- 6> 7 An
TABLE II.—Summary of P ercentage D ifferences in  Pao2 (mm H g)
Sampling sequence Mean (± )
Standard 
deviation (a)
Significance
(P)
A Chest open but lung not retracted..................
B Lung compressed > 5 m in ..............................
............  -  0.17 0.21 < 0.01
B
C PA occluded 1 min............................................ ............  +  0.07 0.22 <  0.025
B
D PA occluded 5 min............................................. ............  +  0.09 0.22 < 0.025
B
E PA released 5 min.............................................. ............  -  0.10 0.16 < 0.01
B
F PA released 30 min............................................ ............  +  0.10 0.24 < 0.025
B
G PA clamped 1 min. Shunt................................. ............  0.02 0.19 < 0.05
B
H PA clamped 5 min. Shunt................................. ............  +  0.03 0.23 < 0.05
E PA released 5 min..............................................
F PA released 30 min............................................
............  -  0.01 ±  0.13 < 0.05
E
G PA clamped 1 min. Shunt................................ ............  -  0.09 0.17 <  0.025
E
H PA clamped 5 min.............................................. ............  -  0.07 0.18 < 0.05
PA = pulmonary artery.
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increase in pulmonary flow is followed quick­
ly by a progressive increase in vascular re­
sistance and approximately 15% reduction 
in pulmonary flow. In the intact animal, the 
shunt flow decreased by approximately 30% 
in 3 hours of collapse A In chronic atelecta­
sis, a marked reduction in blood flow occurs; 
this has been attributed to the organic 
changes in the lung rather than to the reflex 
vasoconstriction observed in acute atelecta­
sis. Organic changes can occur as early as 6 
hours,9 but were not observed at all by Hin- 
shaw and Emerson1" in an earlier, but simi­
lar, study. It is possible that after release of 
the pulmonary artery following the initial 
occlusion, the blood flow to the atelectatic 
segment is not restored because, in spite of 
an open pulmonary artery, these reflexes 
persist. This theory could be studied by 
measuring flows with an electromagnetic 
flow probe to the relevant lobe before and 
after pulmonary artery occlusion.
Approximately 30 minutes elapsed be­
tween the initial pulmonary artery occlu­
sion and the beginning of the formal shunt 
procedure. During this time, ventilation had 
not been adjusted. When the clamps were 
reapplied, a significant decrease in Pao2 
occurred. Several explanations for this are 
possible. Changes in cardiac output or in in­
tracardiac shunting could occur. These could 
alter the mixed venous Pao2 and clearly in­
fluence the measured Pao2. To study this 
one would have simultaneously to measure 
the mixed venous Pao2 with the arterial 
Pao2 to ensure that no changes in arterio­
venous oxygen difference were occurring. It 
is possible that a change in arteriovenous 
oxygen could occur as an isolated event, but 
it is unlikely that such a change would be a 
consistent finding since each patient in our 
study had a variable intracardiac anatomy. 
A more likely explanation is that in the in­
terval of 30 minutes to 1 hour of fixed-vol­
ume respiration, patchy atelectasis occurred 
in the dependent lung. This would have 
brought about a notable decrease in the 
Pao2 if the pulmonary artery to the sur­
gically exposed lung was occluded.11' 14 
This certainly was apparent in the first atrial 
septal defect study (Table I), in which a 
marked decrease in Pao2 occurred when the 
pulmonary artery to the partially collapsed
lung was occluded; the pressure immediately 
increased when pulmonary flow to the ex­
posed lung was re-established.
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PREDICTIVE VALUE OF MYOCARDIAL PERFUSION IMAGING 
FOR AORTOCORONARY BYPASS SURGERY*
WILLIAM J. KOSTUK, MD, FRCPfC] and MICHAEL J. CHAMBERLAIN, MD, FRCP[C]
Evaluation of patients for aortocoronary bypass 
(A C B ) surgery is dependent on the findings at 
cardiac catheterization. Left ventricular angio­
graphy cannot distinguish between reversible 
and irreversible myocardial dysfunction. In 82 
patients macroaggregates of human serum al­
bumin, labelled with iodine-131, were injected 
before operation into the right coronary artery 
and technetium-99m labelled microspheres were 
injected into the left coronary artery. Two weeks 
after operation similar technetium-99m and 
iodine-131 injections were made into the native 
vessels and grafted vessels, respectively. Myo­
cardial distribution of the 20 pi. particles was 
visualized with a rectilinear scanner. Sixty-seven 
patients had normal myocardial perfusion scans 
preoperatively even though wall motion was ab­
normal in 34. There was substantial improvement 
in the left ventricular function of these 34 pa­
tients; the mean ejection fraction increased from 
56 to 65%. Fifteen patients had abnormal myo­
cardial perfusion scans; improvement in left 
ventricular function in this group occurred only 
if the bypass graft was made to an area with 
normal regional perfusion preoperatively. It is 
certain that an adequate capillary bed is present 
if the myocardial scan is normal, regardless of 
the degree of critical stenosis in either coronary 
artery. The patient with a completely occluded 
coronary artery and normal myocardial scan is a 
good candidate for ACB and will show improved 
left ventricular contraction if the ACB is patent.
L’evaluation d'un patient en prevision d'un pon­
tage aortocoronarien (PAC) depend des resultats 
du catheterisme cardiaque. L’angiographie du 
ventricule gauche ne peut distinguer entre une 
insuffisance myocardiaque reversible et une in- 
suffisance irreversible. Chez 82 patients, des 
macro-aggregats de serum albumine humaine 
marquee a l'iode-131 ont ete injectes, avant I'ope- 
ration, dans I'artere coronaire droite, et des mi­
crospheres marquees au technetium-99m ont ete 
injectees dans I'artere coronaire qauche. Deux 
semaines apres I'intervention des injections si 
milaires de technetium-99m et d'iode-131 ont ete 
faites, respectivement dans les vaisseaux natu-
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rels et dans les vaisseaux greffes. La distribu­
tion myocardiaque des particules de 20 u a ete 
mise en evidence a I'aide d'un scintigraphe recti- 
ligne. Soixante sept patients ont presente des 
scintigraphies de perfusion myocardiaque nor- 
males avant I'operation, bien que le mouvement 
de la paroi ait ete anormal chez 34 d'entre-eux. 
II y a eu une amelioration sensible du fonctionne- 
ment du ventricule gauche chez ces 34 patients; 
la fraction moyenne dejection a augmente de 56 
a 65%. Quinze patients avaient une scintigraphie 
de perfusion myocardiaque anormale; dans ce 
groupe ('amelioration de la fonction ventricu 
laire gauche n’est survenue que lorsque le pon­
tage a ete fait vers une region qui etait normale- 
ment perfusee avant I'operation. II est certain 
qu'un lit capillaire adequat est present, lorsque 
la scintigraphie du myocarde est normale, quel- 
que soit le degre de stenose critique de cha- 
cune des arteres coronaires. Le patient ayant 
une artere coronaire completement obliteree 
mais presentant une scintigraphie du myocarde 
normale, devient alors un bon candidat au PAC 
et il beneficiera d'une amelioration de la contrac­
tility du ventricule gauche si le PAC est fonc- 
tionnel.
Aortocoronary bypass (ACB) surgery is 
being performed with increasing frequency 
to relieve symptoms of coronary atheroscle­
rosis.11’ Preoperative evaluation is depen­
dent not only on the coronary anatomy, as 
defined by selective coronary angiography, 
but also on left ventricular contraction as 
seen during left ventriculography. Unfor­
tunately, the ventricular angiogram does not 
differentiate contraction abnormalities due 
to ischemia and those due to scarring. 
Such differentiation is essential if aortocoro­
nary bypass surgery is contemplated: :!‘,i 
delivery of additional blood to a region of 
ischemia should be of benefit, whereas in­
creased blood flow to scarred myocardium is 
of no value and is a risk to the patient.
Evaluation of regional myocardial perfu­
sion with labelled macroaggregated albumin 
(MAA) particles is a promising technique 
that can differentiate abnormalities due to 
ischemia and to scarring.7 111 During the 
past 3 years, we have evaluated this method 
in patients undergoing diagnostic coronary 
angiography.101 - The present report deals
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with our experience in 82 patients who un­
derwent ACB. These patients were studied 
before and after operation.
The purpose of the study was to answer 
the following question: with labelled MAA 
myocardial perfusion imaging, is it possible 
to predict preoperatively which patients with 
an abnormality of left ventricular contrac­
tion will show improvement in left ventri­
cular function after successful ACB?
P a t ie n t s  a n d  M etho ds
The study comprised 82 patients with 
chronic stable angina pectoris. Selective co­
ronary angiography and left ventriculography 
were performed (with the patient’s consent) 
with the patient at rest; little or no premed­
ication was used. Timed power injections of 
40 to 45 ml of Renografin 76 (meglumine 
diatrizoate and sodium diatrizoate) were 
used for chamber angiography, and manual 
injections of 6 to 10 ml of contrast medium 
were used for selective coronary arterio­
graphy. All angiography was recorded on 35- 
mm cine film at 60 frames/s. Postoperative 
evaluation carried out a median of 14 days 
after operation (range, 10 d to 3 mo), con­
sisted of left ventricular angiography and 
selective injection of the bypass grafts and 
coronary arteries.
Following selective angiography, labelled 
particles of human serum MAA were in­
jected into each of the coronary arteries and 
each of the ACB grafts. In the preoperative 
study, particles of MAA labelled with iodine- 
131 (131I) were injected into the right coro­
nary artery, while particles labelled with 
technetium-99m (i,n”Tc) were placed into 
the left coronary artery. In the postoperative 
study, the " mTc-labelled MAA was injected 
into the native vessels and the 131I-labelled 
MAA into the bypass grafts. The particles 
are 20 to 30 ^  in diameter and have a bio­
logic half-life of 3 to 5 hours. The dose 
range for 0:'mTc was 200 to 300 pCi con­
sisting of 20 000 to 30 000 particles; 100 
/aCi of 131I was used with a similar number 
of particles.
Following completion of the invasive car­
diac procedure, the patients were transferred 
to the department of nuclear medicine for 
myocardial imaging. Myocardial scans were 
obtained in both a 45° left anterior oblique 
and an anterior view with a rectilinear scan­
ner. The scanner is connected to a computer 
that permits a colour-coded pictorial display 
and allows differentiation of radioactivity 
in the appropriate count range. Use of the 
dual isotope technique is particularly help­
ful because separate preoperative evaluation 
of both right and left coronary artery perfu­
sion can be obtained. In addition this tech­
nique allows differentiation postoperatively 
of perfusion through the native arteries and 
through the ACB grafts.
Left ventricular volumes and the ejection 
fraction (EF) were calculated from end- 
diastolic and end-systolic silhouettes in the 
right anterior oblique projection and the 
single-plane area length method.13 Each 
ventriculogram was analyzed by Herman’s 
method14 for the presence of regional ab­
normalities of wall motion. All premature 
contractions and immediately successive 
beats were excluded from analysis. The 
myocardial perfusion images were read with­
out knowledge of the laboratory data. The 
normal image was defined as the uniform 
perfusion of the arterial bed injected. The 
abnormal image was a clearly discernible 
region of diminished or absent activity. Tech­
nically unsuitable images were excluded.
R e s u l t s
Of the 82 patients in this study, 67 had 
an overall normal myocardial perfusion scan,
L E F T  V E N TR IC U L A R  C O N T R A C T IO N
Fig. 1.—Patient population with normal myocar­
dial scintiscans grouped into preoperative normal 
or abnormal left ventricular contraction. Height 
of bar represents mean ejection fraction (EF) ±  
standard error of mean. Number in clear bar in­
dicates number of patients in each group. N S =  
not significant.
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while in 15 patients perfusion defects were 
present and the labelled albumin-particle 
scan was abnormal.
Patients with normal myocardial perfu­
sion scans can be divided into two groups 
based on the left ventricular contraction —  
normal left ventricular contraction (group 
1) and abnormalities of wall motion in the 
form of hypokinesis, akinesis or dyskinesis 
(group 2) (Fig. 1). The 33 patients in group
1 showed no change in EF after operation; 
the value remained at 75%. Preoperatively 
the 34 patients in group 2 had a mean EF of 
56%. Postoperatively, there was a substan­
tial improvement in left ventricular contrac­
tion; the mean EF increased to 65% (Figs.
2 and 3).
The results of EF in the 15 patients in 
whom there was a perfusion defect on the 
myocardial scan are shown in Fig. 4. The 
patient groups indicate whether the regional 
myocardial perfusion to which a bypass graft 
was inserted was normal or abnormal. In 
the eight patients who had a normal region­
al perfusion, preoperative EF was 52%; this
increased to 58% after operation. Although 
the trend was towards improvement, it was 
not statistically significant. In the seven pa­
tients who had a bypass graft to a region 
associated with a perfusion defect, there was 
no change in the left ventricular EF; the 
mean value remained at 45%. Figs. 5 to 7 
illustrate the findings in a patient in whom 
a bypass graft had not altered the myocardial 
perfusion. Indeed, the operation was asso­
ciated with a deterioration of left ventricular 
function.
The overall postoperative change in left 
ventricular function in the patients who had 
abnormal left ventricular contraction pre­
operatively is shown in Fig. 8. Of the pa­
tients who had normal myocardial perfusion 
scans in spite of abnormalities of left ventri­
cular contraction, 62% showed an improve­
ment in left ventricular function; 29% re­
mained unchanged, while only 9% showed a 
deterioration. On the other hand, of patients 
in whom there was a perfusion defect, only 
33% showed an improvement and 27% ex­
hibited a deterioration.
Fig. 2.—Normal preoperative myocardial perfusion scan with labelled macroaggregated albumin 
(M AA). Regional myocardial perfusion supplied by right coronary artery (A) and left coronary artery 
(B) of patient with abnormal left ventricular contraction in form of inferior-wall akinesis (EF, 59%). 
Right coronary artery perfusion is abnormal owing to proximal occlusion of this vessel; however, left 
coronary artery supplies inferior wall through collateral vessels. Combined view of A and B is shown 
in C. In this and all subsequent scans, left anterior oblique view is at top and anterior view at bottom.
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Fig. 3.—Postoperative myocardial perfusion scan of patient in Fig. 2. A is perfusion of right and 
left coronary artery showing large perfusion defect in inferior wall and area of ventricular septum. B is 
perfusion supplied by aortocoronary bypass (ACB) grafts to right, left anterior descending and left cir­
cumflex coronary arteries. C represents combined overall normal perfusion through coronary arteries 
and ACB grafts. Left ventricular contraction returned to normal (EF, 69%).
D iscussion
There are many reports in the literature 
dealing with the selection of patients for 
ACB surgery. Most investigators agree that 
the critical factors in predicting a success­
ful bypass include the diameter of the artery 
beyond the obstruction, the size and quality 
of distal run-off and the presence or absence 
of collateral vessels. However, the effect of
ACB on ventricular performance remains 
controversial.1518
The purpose of this study was to test the 
hypothesis that if, in spite of critical coro­
nary artery stenosis or obstruction, myocar­
dial perfusion, as assessed by the labelled 
albumin-particle technique, was normal, 
then left ventricular contraction if abnormal, 
should improve with ACB surgery. We have 
shown that ventricular performance as meas-
NO R M A L A B N O R M A L
R E G I O N A L  M Y O C A R D I A L  P E R F U S IO N
Fig. 4.—Patient group with abnormal myocardial 
perfusion scintiscans. These are subdivided into 
two groups on basis of whether regional myocar­
dial perfusion into which bypass graft was placed 
was normal or abnormal.
Fig. 5.—Abnormal myocardial perfusion of right 
coronary artery (A) and left coronary artery (B). 
There is increase in proximal activity for right 
coronary artery in keeping with mid-occlusion of 
this vessel. B shows large perfusion defect in ante­
rior wall.
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Fig. 6.—Preoperative (A, B) and postoperative (C, D) left ventricular angiograms of patient whose 
myocardial scintiscan is shown in Fig. 5. A and C represent end diastole, and B and D represent end 
systole. Anterolateral and apical akinesis present preoperatively is unchanged and perhaps worse in post­
operative study. In addition, inferior-wall akinesis is present.
*
<
Fig. 7.—Postoperative myocardial perfusion scan of patient in Figs. 5 and 6. A is perfusion through 
left coronary artery and B that through graft to left anterior descending coronary artery. C (combined 
view of A and B) shows no change in perfusion to anterior wall in spite of patent ACB.
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L E F T  VE N TR IC U LA R  CONTRACTION
Fig. 8.—Postoperative change in left ventricular 
contraction on basis of normal or abnormal pre­
operative test using MAA myocardial scintiscan. 
Numbers refer to patients in each group.
ured by EF and wall-motion abnormalities 
does improve in some patients. Although 
this finding is not new, we have shown, with 
use of the labelled albumin particles, that it 
is possible to predict preoperatively which 
patient is most likely to show improvement.
Regional myocardial perfusion as assessed 
by the labelled albumin-particle technique 
provides an evaluation of the patency of 
small vessels of the myocardial vascular bed. 
The distribution of the biodegradable par­
ticles reflects the distribution of blood flow 
to each region containing these particles and 
can be detected by external radionuclide 
imaging. Regional obstruction of blood flow 
is associated with a corresponding area of 
diminishing concentration of radioactivity in 
the perfusion image. By this technique, if 
the myocardial perfusion image is normal, 
regardless of the degree of critical stenosis in 
the coronary artery and in spite of abnor­
malities in left ventricular contraction, the 
patient has an adequate capillary bed and 
should be a good candidate for ACB. Con­
versely, if myocardial perfusion is absent 
or markedly impaired, it is unlikely that the 
patient will show an improvement in left 
ventricular function after ACB surgery.
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INFLUENCE OF LEFT VENTRICULAR FUNCTION AND OTHER PARAMETERS ON EARLY AND LATE MORTALITY FOLLOWING CORONARY BYPASS SURGERY*
BERNARD R. CHAITMAN, MD, FRCP[C], MARTIAL G. BOURASSA, MD, ALAIN  HEITZ, MD and LUCIEN CAMPEAU, M D, FRCP[C]
Left ventricular performance, coronary anatomy 
and postoperative clinical parameters of 66 con­
trol patients (group I) randomly selected from 
797 survivors of coronary bypass surgery were 
compared with those of 45 patients who died 
within 30 days of operation (group II) and 53 pa­
tients who died late (average, 22 ±  2 mo) 
(group III).
Average preoperative left ventricular end-di­
astolic pressure, ejection fraction and mean cir­
cumferential fibre shortening rate were signifi­
cantly better in group I than in group III patients. 
These same parameters were not significantly 
different when group I was compared to group 
II. Abnormal wall motion was significantly less 
frequent in patients from group I than in patients 
from groups II and III. Tripie-vessel disease was 
present preoperatively in 40 (61%) controls com­
pared with 37 (82%) early deaths (P =  0.021) and 
35 (66%) late deaths (NS). The number of grafts 
placed per patient was not significantly different 
in the three groups. Perioperative myocardial in­
farction (Ml) and low cardiac output syndrome 
were the commonest causes of early death. Late 
complications such as Ml and heart failure oc­
curred in 4 (6% ) v. 15 (32%) (P =  0.0006) and 4 
(6 % ) v. 27 (57%) (P<0.0001) group I v. group III 
patients, respectively.
Surgical expertise, preoperative ventricular 
performance and triple-vessel disease are impor­
tant determinants of early mortality following 
bypass surgery and preoperative left ventricular 
performance is one of the most important deter­
minants of late mortality.
Les indices de la fonction ventriculaire gauche, 
les donnees de la coronarographie et certains pa- 
rametres cliniques post-operatoires de 66 pa­
tients (groupe I) choisis au hasard a partir de 
797 patients, sont confrontes a ceux observes 
chez 45 patients decedes en dedans de 30 jours 
apres chirurgie (groupe II) et 53 patients dece-
*From the Montreal Heart Institute, and the de­partment of medicine, University of Montreal, 
Montreal, PQ.
Supported in part by a grant from the lean-Louis Levesque Foundation.
Presented at the annual meeting o f the Canadian Cardiovascular Society, Edmonton, Alta., Oct. 18- 
23, 1976.
Reprint requests to: Dr. Bernard R. Chaitman, Montreal Heart Institute, 5000 Belanger St. E, 
Montreal, PQ H IT  1C8.
des tardivement (moyenne 22 ±  2 mois) (groupe 
III), tous ayant subi des pontages aortocorona- 
riens. La pression telediastolique gauche pre­
operatoire, la fraction d'ejection et la vitesse 
moyenne de raccourcissement des fibres myo- 
cardiaques sont statistiquement meilleurs dans 
le groupe I par rapport au groupe III. Les me- 
mes parametres ne sont pas statistiquement 
differents en comparant les patients du grou­
pe I par rapport au groupe II. Des anomalies 
de la dynamique ventriculaire sont moins fre- 
quemment observees dans le groupe I par rap­
port au groupe II et III. En preoperatoire, une 
atteinte des trois troncs coronariens a ete ob- 
servee chez 40 patients (61% ) du groupe I, chez 
37 (82%) du groupe II (P=0.021) et 35 (66%) du 
groupe III (NS), le nombre de greffons par 
patient a ete similaire en moyenne, soit pour les 
trois groupes. La survenue d'infarctus du myo- 
carde en periode perioperatoire est la cause la 
plus frequente des deces precoces. Un infarctus 
du myocarde, comme complication tardive, a ete 
observe chez 4 patients (6 % ) du groupe I, et 15 
patients (32%) du groupe III (P =  0.0006); par 
ailleurs, I’insuffisance cardiaque pour les memes 
groupes etait presente chez 4 patients du groupe 
I (6 % ) en regard de 27 patients du groupe III 
(57%) (P <  0.0001).
A la suite de pontage aortocoronarien, les fac- 
teurs relies a la mortalite precoce sont I’exper- 
tise chirurgicale, la fonction ventriculaire pre­
operatoire et la presence d’une atteinte des trois 
troncs coronariens. Le facteur le plus discrimi­
nant quant a la mortalite tardive a la suite de 
cette chirurgie, est la fonction ventriculaire gau­
che preoperatoire.
T h e  effect of coronary artery bypass on lon­
gevity and preservation of myocardial func­
tion is unknown. The data presently available 
are controversial,1-6 and in several reports 
this may be related to the small numbers of 
patients studied. With adequate numbers for 
meaningful statistical analysis it should be 
possible to have more definite information 
to provide a guide in the selection of patients 
for surgery. In this report, we have compared 
objective assessment of left ventricular func­
tion, coronary anatomy and postoperative 
follow-up parameters in 45 patients who died 
early and 53 patients who died late from 
797 survivors.
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M aterial and M ethods
Patient Material
One thousand consecutive patients under­
went aortocoronary bypass surgery at the 
Montreal Heart Institute between Sept. 1, 
1969 and Aug. 31, 1974. Almost all patients 
had class III to IV angina pectoris (Cana­
dian Cardiovascular Society [CCS] classifi­
cation)7 and coronary artery stenoses equal 
to or greater than 70%. One hundred and 
five patients had associated cardiac proce­
dures (valve commissurotomy or replace­
ment, wall resection) and are excluded from 
this report. Three groups of patients were 
evaluated (Fig. 1). The control group (group 
I) comprised 66 patients (59 men and 7 
women; mean age, 50 ±  1.0 yr), alive in 
January 1975 who were randomly selected 
from 797 survivors. Nonsurvivors included 
45 patients (36 men and 9 women; mean age, 
52 ±  1.1 yr) who died within 30 days of 
surgery (group II) and 53 patients (47 men 
and 6 women; mean age, 51 ±  0.9 yr) who 
died between 1 month and 5 years after 
operation (group III). Late deaths were di­
vided into cardiac-related (40 patients, 
group Ilia) and noncardiac-related (13 pa­
tients, group Illb) deaths. Forty patients 
(18, 5 and 17 patients in groups I, II and III 
respectively), operated on before 1972, had 
associated internal mammary implants. This 
procedure was abandoned at our hospital 
after 1972.
Preoperative Evaluation
Selective coronary arteriography was per-
Fig, 1.—Total number of patients in each group 
per year of operation. First, second and third col­
umn in each year represent number of patients in 
groups I, II and III, respectively. Interrupted lines 
in columns (1969-72) show number of patients 
with internal mammary implant. Table in upper 
right corner lists total number of patients in each 
group. ACBG =  aortocoronary bypass graft, IM1 
=  internal mammary implant.
formed by a percutaneous transfemoral ap­
proach as described previously.8 Left ventri­
cular pressures were measured and left ven­
triculography was always done before coro­
nary arteriography. The left ventricular end- 
diastolic pressure (LVEDP) was taken coin­
cident with the peak of the R wave on the 
electrocardiogram. Left ventricular cinean- 
giograms were filmed in the right anterior 
oblique position at 60 frames/s. The left 
ventricular silhouettes were traced in end 
diastole and in end systole by one experi­
enced observer. Ventriculograms with fre­
quent extrasystoles, inadequate opacification 
or improper centring of the image were ex­
cluded from analysis. The diaphragm was 
traced and when external markers were un­
available,!> the ribs or spine were traced to 
provide an extracardiac reference system.10 
Left ventricular wall motion was assessed by 
visual inspection of the tracings and of the 
left ventricular cineangiogram. Anterior in­
ferior and apical segments of the left ventricle 
were evaluated. For statistical purposes, 
moderate to severe hypokinesis, akinesis and 
dyskinesis were considered as abnormal wall 
motion, and mild hypokinesis was considered 
as normal wall motion. Ejection fraction 
(EF) was calculated using a digital computer. 
Left ventricular EF could be calculated pre­
opera tively in 53 patients of group I, 28 pa­
tients of group II and 38 patients of group 
III. In 22 patients of group I and 10 of group 
III the EF was calculated both before and 
after operation; the latter calculation was 
made at an average interval for the two 
groups of 21.9 ±  2.9 and 17.6 ±  2.9 months, 
respectively, following coronary revascular­
ization. In all these patients left ventriculo­
graphy was performed more than 2 months 
postoperatively. Mean circumferential fibre 
shortening rate (VCF) was determined from 
the Karliner formula11 where, except in the 
presence of mitral regurgitation, 50 ms is 
subtracted to account for the pre-ejection 
period. Cinecoronary arteriograms were in­
terpreted by at least one of three experienced 
cardiovascular radiologists. Each vessel was 
filmed in four to six views.12 Stenosis was 
recorded as severe when atherosclerotic nar­
rowing was equal to or greater than 50% 
of the intraluminal diameter. When the left 
main coronary artery was involved, it was 
considered to represent double-vessel in-
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volvement. The operative technique used in 
preparation of the saphenous vein and tech­
nical factors relating to aortocoronary anas­
tomosis have been described previously.13
Postoperative Studies
Clinical and angiographic parameters 
were recorded postoperatively. Functional 
disability caused by angina was coded ac­
cording to the CCS classification,7 which was 
adapted from the New York Heart Associa­
tion classification. In the CCS classification, 
class I patients have angina during strenu­
ous exertion but not during ordinary phys­
ical activity; class II limitation occurs with 
ordinary activity such as walking or climb­
ing stairs rapidly; class III patients have 
marked limitation of ordinary physical acti­
vity such as walking one to two blocks on 
the level and climbing one flight of stairs in 
normal conditions and at a normal pace; 
class IV patients cannot carry on any physical 
activity without discomfort. Perioperative 
myocardial infarction (MI) was diagnosed 
when the 12-lead electrocardiogram (ECG) 
taken within 48 hours of operation revealed 
new Q waves greater than 0.04 seconds in 
more than one lead. In many patients who 
died early, autopsy findings suggested peri­
operative MI. Postoperative late infarction 
was recorded when a classic clinical history 
was accompanied by increased cardiac en­
zymes and electrocardiographic changes, or 
when fresh infarction was documented at au­
topsy. Most patients with symptoms of con­
gestive heart failure had at least one hospital­
ization accompanied by classic radiologic 
features of left ventricular failure.
Coronary anatomy and graft status were 
re-evaluated in 50 patients in group I and 
41 patients in group III at an average in­
terval of 14.5 ±  1.9 and 8.7 ± 1.9 months 
after operation, respectively. When the graft 
appeared occluded, selective injections were 
usually made into the remaining stump, or a 
bolus injection was made in the ascending 
aorta showing the remaining stump or irreg­
ularities of the aortic wall at the graft origin. 
Progression of disease in the native coronary 
anatomy was considered to have occurred 
when a new lesion was present in a nonby- 
passed artery or distal to a bypassed vessel, 
or when a preoperative lesion progressed 
to subtotal or complete occlusion. For sta­
tistical purposes, grafts with more than 50% 
stenosis were considered to constitute an in­
adequate result and were added to the oc­
cluded graft category.
Autopsies were performed on 37 of the 
45 patients in group II. A late clinical follow­
up was possible for all control patients and 
47 of the patients in group III at least 6 
months before death. The cause of death 
was determined from the Quebec Bureau of 
Vital Statistics for all patients, including the 
six patients who died late in whom a clin­
ical follow-up was not possible. Forty of 
the 53 late deaths were attributable to car­
diac causes.
Statistical Analysis
Analysis of the parameters in group I were 
compared statistically with those in groups 
II and III, using Dunnett’s test and the har­
monic mean.14 Analysis of nonparametric 
results was performed using a Fisher’s exact 
test.1 '> Patients in group Ilia  were compared 
with those in group 111b using an unpaired 
Student’s t-test, or Fisher’s exact test in the 
case of nonparametric comparisons.
R esults
Preoperative Left Ventricular Function
Patients who died early (group II) and 
late (group III) following coronary bypass 
surgery had a more severe degree of left 
ventricular impairment. Abnormal inferior 
and apical-wall motion occurred in 9 (15%) 
and 13 (21%) of group I patients v. 14 
(39%) and 17 (47%) of group II patients 
(Fig. 2). Mean LVEDP was 11 ±  0.6 (mean 
±  1 SEM) mm Hg in group I and 13 ±  1.4 
mm Hg in group II. Mean EF was 0.49 ±  
0.01 in group I and 0.45 ±  0.02 in group II. 
Mean VCF was 0.76 ±  0.03 circumferences 
per second (circ/s) in group I and 0.75 —  
0.07 circ/s in group II (Fig. 3).
When patients who died late (group III) 
were compared with patients in the control 
group (group I), preoperative abnormalities 
of wall motion were much more frequent in 
group III. Abnormal motion of the anterior 
wall was present in 15 (25%) patients in 
group I and 23 (46%) patients in group 
HI (P =  0.027); defects of apical-wall motion 
were observed in 13 (21%) patients in 
group I and in 29 (58%) patients in group
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III (P =  0.0002); inferior wall-motion de­
fects were seen in 9 (15%) group I patients 
and in 26 (52%) group I lf  patients (P < 
0.0001) (Fig. 2). Mean LVEDP was 11 ± 
0.6 mm Hg in group I and 16.2 — 1.3 mm 
Hg in group III (P < 0.001). Mean EF was 
0.49 — 0.01 in group I and 0.41 ±  0.02 in 
group III (P < 0.001). Mean VCF was 0.76 
±  0.03 circ/s in group I and 0.53 ±  0.04 
circ/s in group III (P <  0.001) (Fig. 3).
The difference in preoperative left ven­
tricular performance was also significant 
when the cardiac causes (group Ilia) of late 
death were compared with the noncardiac 
causes (group Illb). LVEDP was 17.4 ±  
1.7 and 11.9 ±  1.6 mm Hg; EF was 0.38 ±  
0.02 and 0.50 ±  0.03 (P<0.01) and mean
Fig. 2.—Significance of abnormal preoperative 
left ventricular contraction as determinant of early 
and late mortality following coronary bypass sur­
gery. Abnormalities of wall motion were signifi­
cantly more frequent in inferior and apical left 
ventricular segments of group II patients than in 
group I controls. Contraction abnormalities of an­
terior (P =  0.0271), inferior (P <  0.0001) and 
apical (P =  0.0002) ventricular segments were 
more common in group III patients than in those 
in group I. Among group III patients, wall-motion 
abnormalities of inferior segment (P =  0.0236) 
were more frequent in those who died of cardiac 
than of noncardiac causes.
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Fig. 3.—Importance of preoperative left ventri­
cular function as determinant of late mortality. 
Indices of left ventricular performance were not 
significantly different in group II patients from 
controls. Among group III patients, left ventricular 
end-diastolic pressure (LVEDP) was greater (P <  
0.001), and ejection fraction (EF) (P <  0.001) 
and mean circumferential fibre shortening rate 
(VCF) (P <  0.001) were substantially lower than 
in group I patients. EF (P <  0.01) and VCF (P <  
0.05) were significantly lower in group Ilia than 
in group Illb.
VCF was 0.48 ± 0.04 and 0.66 ± 0.08 
circ/s (P < 0.05), respectively (Fig. 3).
If patients having aortocoronary bypass 
grafts alone were considered, the differences 
were again significant. LVEDP was 11.8 — 
0.7 mm Hg in group I and 16.6 ±  1.7 mm 
Hg in group III (P < 0.005). The EF was 
0.49 ±  0.02 in group I and 0.42 ±  0.03 in 
group III (P < 0.02) and the mean VCF was 
0.74 ± 0.04 circ/s and 0.56 ± 0.05 circ/s 
(P <0.01), respectively.
Postoperative Changes in Ventricular
Function
Of the 22 patients in group I studied 21.9 
±  2.9 months after coronary revasculariza­
tion, the average EF remained unchanged 
from 0.51 ±  0.02 to 0.48 ±  0.04. Of the 10 
patients in group III studied 17.7 ±  2.9 
months postoperatively, the EF of 0.41 ± 
0.06 v. 0.41 ±  0.08 also remained the same 
(Fig. 4).
The average follow-up in group III was 
22 ±  2 months compared with 30 ±  2 
months in group I (P < 0.25). When the sur­
vival time of group Ilia  patients was averaged 
with respect to the EF an important trend 
became obvious (Table I); longevity was 
directly related to the preoperative EF: of the 
seven patients with an EF less than 0.30, the 
survival time was 14.9 ±  3.6 months after 
operation compared with 30.8 ±  5.3 months 
for six patients having an EF greater than 
0.50 (P < 0.05). The influence of poor left 
ventricular function on late survival is evi-
Late dea th  (n =  10)
Mean fo llo w -u p  21.9 t  2.9 mo Mean fo llow -up 17.6 t  2.9 mo
Fig. 4.—Surgical intervention does not lessen left 
ventricular function in patients who die late after 
coronary bypass surgery (group III). Left ventri­
cular performance assessed by EF (mean ±  1 SEM) 
did not change appreciably after operation in 
groups I or III. Patient in group III whose EF de­
creased from 0.50 to 0.31 after operation suffered 
a myocardial infarction (MI) 2 months postoper­
atively.
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TABLE I.—L ate D e a t h : Assessm ent of E jec tio n  F raction  in  G ro u p  III a
Ejection fraction
Objective
survival,
mo
No. of 
patients
Subjective
survival,
mo
No. of 
patients
0.30 14.9 ±  3.6 7 13.8 ±  2.5 14
0.31 -  0.49 23.2 ±  3.8 14 23.2 ±  3.8* 14
0.50 30.8 ±  5.3* 6 34.1 ±  5.2f 9
*P <  0.05. 
fP  <  6.001.
dent. Markedly dilated left ventricles fre­
quently could not be traced, so a subjective 
appraisal of the EF was made. When a visual 
appraisal of left ventricular function was 
made, 14 patients with a predicted EF of less 
than 0.30 lived for 13.8 ±  2.5 months com­
pared with 9 patients with normal ventri­
cular contraction who survived 34.1 ±  5.2 
months postoperatively (P < 0.001).
Preoperative Coronary Anatomy
Triple-vessel disease was present in 37 
(82%) patients in group II compared with 
40 (61%) of those in group I (P < 0.0207). 
Left main coronary artery disease occurred 
in 11 (24%) patients in group II compared 
with 7 (11%) in group I (P =  0.0676). If 
patients having coronary bypass grafts alone 
were considered, 32 (80%) in group II 
compared with 28 (58%) in group I had 
triple-vessel disease (P =  0.0391).
The number of patients with triple-vessel 
disease preoperatively was not significantly 
different in group III from those in group I 
(35 [66% ] v. 40 [61%]). Among patients in 
group Ilia, 28 (74%) had triple-vessel dis­
ease compared with 7 (54%) patients in 
group Illb.
Coronary Anatomy and Graft Follow-Up
The number of grafts placed was not signi­
ficantly different in groups I, II, or III (1.89 
±  0.10, 2.00 ±  0.12 and 1.72 ±  0.10, re- 
pectively). Nor was it significant when pa­
tients having bypass grafts alone were con­
sidered (2.13 ±  0.12, 2.05 ±  0.13 1.83 ±
0. 13, respectively). Graft status was known 
at autopsy in 31 patients in group II. Fifty- 
six of 62 grafts (90%) were patent and free 
of significant stenoses. When patients in 
group III were compared with those in group
1, the number with at least one excellent 
bypass graft and the number with progres­
sion of native disease were not significantly
different (29 [71 %] v. 44 [88%] and 14 
[34%] v. 13 [26% ], respectively).
When patients having bypass grafts alone 
were considered, 18 (69%) of those in group 
III compared with 31 (94%) of those in 
group I had at least one graft patent, and 8 
(30%) patients in group III v. 7 (21%) 
patients in group I had progression of their 
native disease. The follow-up period in this 
subgroup of patients was a mean of 5.8 
months (range, 0.5 to 51 mo) for group III 
and 12.4 months (range, 0.5 to 57 mo) for 
group I.
Postoperative Clinical Parameters 
Severe postoperative angina occurred in 
19 (29%) group I patients compared
Functional class Perioperative infarction
Fig. 5.—Residual or recurrent angina pectoris 
occurred in 24 (51%) group III patients v. 19 
(29%) group I patients (P =  0.0193). Incidence 
of perioperative MI was similar in both groups. 
Frequency of late MI (P =  0.0006) and congestive 
heart failure (P =  0.0001) was greater in group 
III than in group I.
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with 24 (51%) group III patients (Fig. 
5). When those having bypass grafts alone 
are considered, this difference became more 
marked (11 [23 %] and 19 [61%], respec­
tively). In group I, eight (44%) patients 
with associated internal mammary implants 
had residual or recurrent angina compared 
with five (31%) patients in group II.
Perioperative MI occurred in six (9%) 
control patients and four (8%) patients 
who died late. Four (6%) patients in 
group I had a postoperative MI compared 
with 15 (32%) patients in group III. MI 
was a terminal event in all 15 group III 
patients; MI was confirmed at autopsy in 9 
of these patients.
There were 4 (6%) patients in group I 
with congestive heart failure postoperatively 
and 27 (57%) patients in group III 
(P < 0.0001). Of the four patients in group 
I two had failure before operation and in 
two this complication developed de novo 
postoperatively; one had a perioperative 
MI and in the other heart failure occurred 
subsequent to MI after the operative period.
Of the 27 patients in group III who suf­
fered congestive heart failure, 18 had evi­
dence of this complication preoperatively 
and in 9 it developed postoperatively; 2 of 
the 9 patients had a perioperative MI, and 
heart failure developed in 4 subsequent to 
MI after the operative period. There was no 
obvious explanation for the heart failure that 
developed in the remaining three patients.
Of the 27 patients in group III with post­
operative congestive heart failure, 25 died 
of cardiac causes.
Causes of Early and Late Mortality
Intraoperative MI and low-output syn­
drome postoperatively accounted for 35 
(78%) of the 45 early deaths (Table II). Of 
these 45 patients, 18 died within the first 24 
hours. The average time of death was 4 ±  1 
days after operation. Autopsies were per­
formed on 37 of the 45 patients. Cardiac 
causes accounted for 40 (76%) of the 53 
late deaths (Table III). Fourteen patients 
died of MI, and in nine MI was confirmed at 
autopsy. The distribution of causes of late 
death in the remaining 40 patients was ap­
proximately equal. Autopsies were either 
not performed or the results were unavail­
able for 12 of the 13 sudden deaths.
D iscussion
Statistical identification of risk factors that 
relate to operative and late death following 
coronary bypass surgery is often limited be­
cause of the small numbers of patients stu­
died. In many series, a quantitative evalua­
tion of left ventricular performance frequent­
ly is not done.1- 6- 10 in this report we have 
studied the preoperative ventricular function 
of 45 patients who died early (group II) and 
53 who died late (group III) after coronary 
bypass surgery; these patients have been 
compared with a cohort of 66 patients ran­
domly selected from 797 survivors.
Many authors have reported an increased 
operative mortality in patients with severe 
left ventricular dysfunction3-3- 17-19 and 
triple-vessel disease.-- 4 In our series of early 
deaths, abnormal motion of the left ventri­
cular wall and triple-vessel disease were sta­
tistically more frequent than in the control 
group. Other parameters such as decreased 
EF and increased LVEDP were not signifi­
cantly different from the controls. All ventri­
culograms in this series were filmed in the 
six-inch mode and the ventricular outlines 
of markedly dilated ventricles could not be 
traced. This may account for notable im­
pairment of left ventricular contraction ass­
essed by wall-motion abnormalities but not 
by EF. The commonest cause of early death
TABLE II.—Causes of Early M ortality (< 30  
D ays), Group II* (n = 45)
Cause ACBG ACBG +  IM I  Total
Arrhythmia..............  2 0 2
Low output..............  15 4 19
Myocardial
infarction.............. 16 0 16
Bleeding.................... 6 1 7
Embolism.................  1 0 1
Total.........................  40 5 45
*ACGB = aortocoronary bypass graft, IMI =
internal mammary implant.
TABLE III.—Causes of Late M ortality, Group
III (n =53)
Cause ACBG ACBG +  IM I Total
Sudden death . . . . 7 6 13
Myocardial
infarction..........
9 5 14
Congestive failure 10 3 13
Noncardiac.......... 10 3 13
T otal..................... 36 17 53
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was perioperative MI and low-output syn­
drome. Other reports have also listed intra­
operative MI as the commonest cause of 
operative mortality in coronary bypass sur­
gery.3' 20 In this study the number of grafts 
placed per patient was the same in the pa­
tients with early deaths as in the control 
group of patients, and graft patency at au­
topsy was 90%. It is not clear when MI 
occurs during a coronary bypass operation. 
The high percentage of patent grafts found at 
autopsy in group II indicates that perioper­
ative MI is not prevented by having perme­
able grafts. Operative mortality in coronary 
bypass surgery has been shown to decrease 
in different centres as the experience of the 
surgical team increases. 20 The decrease 
in operative mortality may be explained by 
better patient selection or by greater tech­
nical expertise exhibited by various surgical 
teams. We would conclude that there are 
several causes of operative mortality, and 
depressed ventricular function is one. Peri­
operative technical factors, for example, may 
play a major role; we did not assess this fac­
tor in our study except for documenting the 
occurrence of perioperative MI.
Poor preoperative left ventricular per­
formance was the most important parameter 
relating to late mortality. Preoperative EF 
and mean VCF were significantly decreased 
and abnormal left-ventricular-wall motion 
and LVEDP were significantly increased in 
patients in group III. Other preoperative pa­
rameters, such as the number of stenotic 
vessels and the number of grafts placed per 
patient, were similar in groups I and III. 
The incidence of perioperative MI was simi­
lar in group I (9%) and in group III (8%) 
to that reported in the literature.21 Thus, 
among the preoperative parameters evalu­
ated in this study, poor left ventricular func­
tion was the most important determinant of 
late mortality. When group III was subdi­
vided into patients dying of cardiac and non­
cardiac causes, ventricular performance in 
the patients with cardiac-related deaths was 
significantly diminished. The importance of 
preoperative left ventricular performance as 
a determinant of late mortality has been con­
firmed in other studies as well.5' u- 22-24
Several authors have reported that left 
ventricular function is not appreciably 
changed 6 months to 1 year after coronary
bypass surgery providing there has been no 
intervening MI.23'28
No data are available on postoperative left 
ventricular performance in patients who 
have died late after coronary bypass surgery. 
We were able to re-evaluate left ventricular 
EF in a small number of the patients in 
groups I and III. There was no significant 
difference in EF after operation in either 
group. Thus, in evaluating the significance 
of left ventricular function on late mortality, 
preoperative ventricular performance ap­
pears to be the important factor, caused by 
the surgical intervention itself.
The postoperative course of the patients in 
group III was characterized by a greater in­
cidence of residual or recurrent angina pec­
toris and MI than in group I patients. This 
could not be related to the number of pa­
tients who had occluded grafts at postoper­
ative angiography or progression of disease 
in the native circulation, or both; the inci­
dence was similar in both groups. However, 
coronary and graft arteriography were per­
formed an average of 6 months later in group 
I patients and the results represent cumula­
tive graft patency and not consecutive serial 
data (late angiographic follow-up was limited 
to 2 weeks in 51% of group III patients v. 
24% of group I patients).
Postoperative congestive heart failure was 
significantly more common in group III 
than in group I. This was related to the pre­
operative clinical status. We know this be­
cause heart failure persisted in 18 patients 
in group III who had congestive heart fail­
ure before operation. Our results show that 
late survival following coronary bypass sur­
gery is strongly influenced by the preoper­
ative status of the left ventricle and does not 
appear to be improved in patients with poor 
left ventricular function. Moreover, patients 
in group III had more frequent residual an­
gina and a greater incidence of MI after by­
pass surgery than did the patients iir group 
I. These data suggest that surgery for relief 
of angina and prevention of MI in patients 
with significantly impaired left ventricular 
function may not always be successful. Cer­
tainly, one should not rely too much on these 
secondary benefits when recommending sur­
gery to such patients.
Preoperative left ventricular performance 
is the most important factor relating to late
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mortality following bypass surgery. Other 
factors such as late progression of disease in 
the native circulation and long-term viability 
of grafts may also be important, but require 
further study. Coronary atherosclerosis is a 
progressive disease. Surgical palliation of 
symptoms is an admirable goal in suitable 
patients with good or slightly impaired left 
ventricular function who are incapacitated 
despite medical therapy. Whether coronary 
artery bypass will influence longevity, or pre­
serve myocardial function, will not be 
known until the long-term results of prospec­
tive randomized studies to evaluate medical 
and surgical therapy are reported.
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The Effect of
Trasytol
in
 ^ Hyperfibrinolytic 
V Hemorrhages
FBA Pharmaceuticals Ltd.
Distributed by:
Boehringer Ingelheim  (C anada) Ltd.
Trasylol, in its role as an 
antifibrinolytic agent, inhibits 
both plasmin and the 
plasminogen activator.
Synthetic antifibrinolytic 
agents inhibit only the 
plasminogen activator.
Trasylol is indicated for primary and generalized, secondary 
hyperfibrinolytic hemorrhages with and w ithout the shock 
syndrome. Secondary hyperfibrinolysis fo llow ing 
intravascular clotting may require heparin and/o r 
fibrinogen replacement in addition to Trasylol. 
With Trasylol, the antifibrinolytic agent with 
simultaneous anti-coagulant (anti-throm boplastic) 
effect, there will not be a dangerous shift 
in the equilibrium between 
the clotting and the lysis system 
in favour of coagulation. 
Synthetic antifibrino lytics 
are contraindicated if there is 
evidence of active intravascular 
coagulation. Trasylol is indicated 
in all cases of hyperfibrinolysis, 
whether a differential diagnosis 
has been made or not.
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Trasylol
•  increases the chances 
of survival in acute 
pancreatitis
•  prevents the enzymatic 
release of toxic 
polypeptides and kin ins
•  stops hyperfibrinolytic 
hemorrhage
Indications and Dosage
Hyperfibrinolytic Hemorrhage 
These c o n d itio n s  o ccu r in surgery , 
including open heart surgery, prostatic 
surgery and patho log ica l obste trica l 
bleeding conditions, such as in abruptio 
placentae.
Initial dosage: 200,000 — 500,000 K.I.U. 
of which 200,000 K.I.U. should be given 
by intravenous injection (a t a rate not to 
exceed 5 ml per minute), the rest if neces­
sary by slow infusion. Adm in istra tion 
should be continued up to 1,000,000 
K.I.U. per day until the hemorrhage has 
been arrested.
Pancreatitis
Initial dosage: 100,000 — 200,000 K.I.U. 
to be followed by 100,000 K.I.U. every 
six hours for a period of 4-5 days. The 
drug is administered either by intraven­
ous in jection (at a rate not to exceed 5 
ml per minute) or by slowlnfusion. 
Warnings and Precautions 
Trasylol is a polypeptide and thus may 
act as an antigen. Although adverse reac­
tions due to hypersensitivity have been 
described infrequently, this possibility 
should always be kept in mind. In patients 
w ith a h is to ry of hypersensitiv ity, the 
usual precautions for the prevention and 
arrest of a lle rg ic  reactions should be 
observed prior to the adm inistration of 
Trasylol.
Availability
Trasylol (aprotinin) is available in 10 ml 
am puls co n ta in ing  100,000 K.I.U . in 
boxes of 5 ampuls.
Trasylol® Product Monograph is available 
on request.
The object of
Trasylol:
Control of proteolytic enzymes.
FBA Pharmaceuticals Ltd.
Distributed by:
Boehringer Ingelheim (Canada) Ltd.
2121 Trans Canada Highway, Dorval, P.Q. H9P1J3
GLIMPSES OF SURGICAL HISTORY: 
N FOR NEEDLES
DAVID A. E. SHEPHARD
NEEDLES are among the most ancient of 
surgical instruments, but man the hunter used 
needles long before man the surgeon used 
special tools. Man early developed implements 
as extensions of his fingers, and the need for 
the hunter to probe wounds and remove 
foreign bodies certainly led to the invention 
of needles of one type or another. Domestic 
chores were facilitated by needles and thread, 
and needles similar to the flat, eyed surgical 
needles of today have been found alongside 
obviously domestic tools in ancient archeologic 
sites. Needles used to make nets and to stitch 
together the hides making a tent were soon 
adapted by early surgeons in their work of 
healing.
Wounds required suturing; cysts, abscesses 
and piles needed evacuating; and extraneous 
objects in the integument and eye had to be 
removed. The Hindus, the Greeks, the Romans 
and the Arabians perfected the surgical needle 
for a variety of purposes; Albucasis’ treatise 
on surgical instruments, in particular, illus­
trated the usage of needles and their applica­
tion to delicate work such as treatment of 
cataract. These ancient needles, however, were 
all solid; none was hollow.
The relatively late development of the 
hollow needle is perhaps surprising, for the 
need to extract blood from piles, for example, 
was recognized by the Hindus, who also 
developed hypodermic medication -  albeit by 
scarifying the skin with a knife or razor and 
rubbing in ointment manually -  and Wren, 
the English architect, used quills in injecting 
opium in 1656. Primitive syringes, too, were 
known to Albucasis among others. The hypo­
dermic needle and syringe were not invented 
until the mid-19th century; credit being given 
for their contributions to Lafargue (1836) and 
Taylor and Washington (1839), and especially 
Wood (1843), Rynd (1845) and Pravaz 
(1851). Man the hunter and then man the 
surgeon was now man the 19th-century tech­
nologist, the initiator of so many remarkable 
advances in surgery and other fields of human endeavour.
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PERCUTANEOUS INSERTION OF A PERMANENT TRANSVENOUS 
PACEMAKER ELECTRODE THROUGH THE SUBCLAVIAN VEIN*
ARTHUR FRIESEN, MD, GEORGE J. KLEIN, MD, FRCP[C], WILLIAM J. KOSTUK, 
MD, FRCP[C] and SURAJ P. AHUJA, MD, FRCP[C]
Insertion of transvenous permanent pacemaker 
leads through the subclavian vein is relatively 
safe and simple. This procedure was performed 
in 29 patients. The only serious complication was 
dislocation of the lead in eight patients. With this 
technique the endocardial lead can be positioned 
quite readily in the right ventricle. Use of the 
technique should be considered whenever the 
cephalic vein cannot be located readily or is too 
small to permit placement of an endocardial 
lead.
L'insertion par la veine sous-claviere des deri­
vations d'un stimulateur cardiaque transveineux 
permanent, est reiativement sure et simple. Cette 
procedure a ete realisee chez 29 patients. La 
seule complication serieuse rencontree, a ete la 
dislocation de la derivation chez 8 patients. Par 
cette technique, la derivation endocardiaque peut 
etre placee assez facilement dans le ventricule 
droit. Le recours a cette technique devait etre 
envisage chaque fois que la veine cephalique ne 
peut etre facilement localisee, ou qu'elle est trop 
petite pour permettre la mise en place d'une de­
rivation endocardiaque.
Endocardial pacing was first reported in 
the early 1950s by Callaghan and Bigelow1 
who used endocardial atrial electrodes in 
animal experiments. Right ventricular endo­
cardial pacing was first reported in 1959 by 
Furman and Robinson.- Transvenous per­
manent endocardial pacing is now the pre­
ferred method.3 One of the technical diffi­
culties in positioning transvenous endocar­
dial leads has been the accessibility of suit­
able venous channels. The most commonly 
used vessels are the cephalic vein, found in 
the deltopectoral groove,4 and the internal 
and external jugular veins,5 but each may 
be difficult to find or cannulate, or both. 
The subclavian vein has been used,0- 7 occa­
sionally. In this report we describe the tech­
nique and results of permanent lead place­
ment through the subclavian vein.
*From the cardiac investigation unit, University 
Hospital, London, Ont.
Presented at the annual meeting of the Canadian 
Cardiovascular Society, Edmonton, Alta., Oct. 
18-23, 1976.
Reprint requests to: Dr. William J. Kostuk, Car­
diac investigation unit, University Hospital, 339 
Windermere Rd., London, Ont. N6A 5A5.
Patients and Methods
Patients
Between Nov. 1, 1975 and Oct. 31, 1976, 
leads for permanent pacing were implanted 
through the subclavian vein in 29 patients 
(16 men and 13 women; average age, 70,1 
yr). Their disorders are listed in Table I.
The endocardial lead was a unipolar Med­
tronic lead, model 6909-58 (Medtronic Inc., 
Minneapolis, MN), while the pulse genera­
tors implanted were Medtronic models 5951 
and 5961.
Surgical Technique
Under local anesthesia and with aseptic 
technique, a small 3-mm incision is made 
about 1 cm below the clavicle and 2 cm la­
teral to the mid-clavicular line, similar to the 
method of Loskot, Michaljanic and Klusil.8 
The subclavian vein is located by directing an 
18 or 20 gauge needle through the incision, 
immediately under the clavicle towards the 
suprasternal notch; this prevents laceration 
of the vein or damage to adjacent structures. 
Once the vein is located, the needle is with­
drawn and a 14 gauge needle introduced 
in a similar fashion. A 35-cm spring guide 
is introduced through the needle and the 
needle withdrawn. A 15-cm Teflon dilator 
and a 10-cm no. 9 French Desilets-Hoffman 
radiopaque sheath are introduced over the 
spring guide into the subclavian vein. With 
the patient holding his breath, the guide and 
dilator are withdrawn and the pacemaker 
lead rapidly introduced through the sheath. 
Once the lead has been advanced into the 
superior vena cava, the sheath is withdrawn, 
cut longitudinally with a pointed scalpel and 
removed. The proximal end of the lead is 
then tunnelled subcutaneously to the pulse 
generator pocket. The endocardial lead is 
positioned in the right ventricular cavity; 
when the pacing and sensing thresholds are 
adequate the lead is sutured to the underly­
ing tissue with three to four silk sutures. The 
lead is then attached to the pulse generator, 
which is placed in the pulse-generator pocket,
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and both are sutured to the underlying tissue.
Alternatively, the subclavian vein has been 
punctured from within the pocket incision in 
a similar fashion; this simplifies the tech­
nique because the lead does not require tun­
nelling into the pocket.
R esu lts
We have found the insertion of a perma­
nent transvenous pacemaker lead through 
the subclavian vein both simple and safe. 
The major complication was dislocation of 
the endocardial lead; repositioning was re­
quired in eight patients (Table I). Three of 
the lead displacements occurred within 10 
days of placement; two patients had enlarged 
right ventricular chambers and subsequently 
required epicardial leads. Five lead displace­
ments occurred late — 3 weeks to 7 months 
after implantation. In all cases, lead reposi­
tioning was readily performed without diffi­
culty. In one patient the lead was inadver­
tently damaged during repositioning. The
damaged lead was cut and a no. 9 French 
Desilets-Hoffman sheath was passed over the 
damaged lead into the subclavian vein. The 
old lead was then withdrawn and replaced 
by a new lead through the sheath without 
need for additional puncture. Another pa­
tient, who was a ‘twiddler”,9 displaced her 
endocardial lead back into the pocket. No 
hematoma or bleeding was noted. A new 
lead was inserted without difficulty through 
a fresh subclavian puncture via the original 
pocket incision.
In one patient, a small asymptomatic 
pneumothorax was noted on a routine follow­
up chest radiograph. This required no the­
rapy and cleared spontaneously.
On two occasions, we were unable to 
puncture the subclavian vein. The first fail­
ure occurred in an elderly, cachectic woman 
in whom the subclavian artery was punc­
tured; the needle was withdrawn and no 
bleeding was noted. This incident occurred 
early in our experience and prompted us to 
abandon further attempts in that patient to
TABLE I.—D iagnosis for and Complications of Subclavian Vein  Endocardial Lead Placement 
in 29 P atients from November 1975 to October 1976
Patient no. Age and sex Diagnosis Complications
1 81 M T achycardia-bradycardia ____
2 60 F T achycardia-bradycardia Repositioning at 6 wk
3 66 M Complete heart block —
4 79 F Complete heart block _
5 67 M Complete heart block Repositioning a t 3 mo 
(x 2) — epicardial
6 76 M Stokes-Adams attacks _
7 78 M Stokes-Adams attacks Repositioning a t 7 mo
8 59 F T achycardia-bradycardia Repositioning a t 10 d
9 52 F T achycardia-bradycardia Repositioning at 1 d — 
epicardial
10 60 M Complete heart block —
11 83 F Sinus arrest, RBBB,* LAHf “Twiddler” — 3 wk
12 77 F Complete heart block _
13 84 F Complete heart block _
14 42 M Stokes-Adams attacks ____
15 82 F Complete heart block Repositioning a t 3 wk, 3 mo
16 62 M T achycardia-bradycardia Repositioning a t 6 d
17 74 M Complete heart block Asymptomatic pneumothorax, 
repositioning
18 72 M Stokes-Adams attacks ____
19 51 F Severe bradycardia ____
20 84 M Complete heart block ____
21 73 F Sick sinus syndrome _
22 74 M Sick sinus syndrome —
23 82 F Complete heart block ____
24 82 M Complete heart block _
25 71 M T achycardia-bradycardia ____
26 80 F Complete heart block ____
27 68 M Trifascicular block ____
28 55 F T achycardia-bradycardia _
29 58 M Complete heart block —
*RBBB = right bundle branch block. 
fLAH = left anterior hemiblock.
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find the subclavian vein. The second failure 
was in a confused, agitated man in whom 
localization of the subclavian vein was not 
possible because of continuous shoulder 
movements.
No other complications, such as myocar­
dial perforation, air embolization, skin ero­
sion, lead fracture or infection, occurred.
Discussion
The external jugular4- ll’"1- and cepha- 
lic4- «• 11-1:4 veins have been the most fre­
quently selected sites for insertion of perma­
nent pacemaker leads. Each site has its draw­
backs. The cephalic vein may be difficult to 
find or too small to cannulate, or both. The 
external jugular vein, though easier to find, 
may be associated with a greater number of 
lead fractures as a result of the sharp bend 
of the lead on entry into the vein.14 More­
over, use of the jugular vein requires tun­
nelling of the lead either under or over the 
clavicle in order to reach the site of the pulse 
generator; this may make repositioning diffi­
cult.
The subclavian vein, on the other hand, 
is readily found and easily cannulated. Its 
close proximity to the infraclavicular pulse- 
generator pocket removes the need for sub­
cutaneous burrowing if the vein is punctured 
from within the pocket.
The lead may be passed into the subcla­
vian vein either percutaneously or through 
the generator incision. Once the vein has 
been cannulated, the lead is usually placed 
into the right ventricle within minutes. This 
is advantageous in the elderly debilitated pa­
tient who frequently is unable to lie still for 
long periods of time. The procedure is safe 
in the hands of an individual with experi­
ence in cannulating the subclavian vein. 
Furthermore, the same site may be used more 
than once, obviating the need to search for 
vessels.
Subclavian vein puncture has been asso­
ciated with a number of potential problems: 
pneumothorax, air embolism, arterial cannu- 
lation and laceration, hematoma formation 
and difficulty in finding the vessel. These 
complications, however, are infrequent in 
experienced hands. Use of a small-bore nee­
dle to locate the vein initially reduces the 
risk of complication.
Asymptomatic pneumothorax occurred in
one of our patients; it resolved without the­
rapy. This problem is most likely to occur 
during the search for the vein, and may be 
avoided by sliding the needle immediately 
below the clavicle toward the suprasternal 
notch. Uncooperative patients and patients 
with severe pulmonary disease may be at 
greater risk for this complication.
Air embolism did not occur in our series; 
it may be avoided by careful instructions to 
the patient to exhale or hold his breath while 
the spring guide or endocardial lead is in­
serted into the subclavian vein.
In two patients the subclavian vein could 
not be found. The first patient was an elder­
ly cachectic woman in whom there appeared 
to be insufficient space between the clavicle 
and ribs to reach the subclavian vein. At this 
time, the subclavian artery was punctured 
and the needle immediately withdrawn. The 
patient had no symptoms and no detectable 
hematoma developed. The second failure 
occurred in an agitated and confused man 
who was unable to control breath holding 
and excessive shoulder movements. In this 
setting, the risk of lung puncture, air em­
bolism or vessel laceration may be high.
A major concern in the present series was 
the high incidence of lead dislocations. The 
lead is inserted through the muscle and 
connective tissue layers into the subclavian 
vein, through a region of relatively loose 
tissue with none of the snug walls to “hold” 
the lead as the cephalic vein might have. 
This explains the higher incidence of dis­
placement due to lead movements at the 
site of insertion. Indeed, it may have played 
a role in the early displacements. In an at­
tempt to correct this problem we secure the 
lead to the underlying tissue with three to 
four separate silk sutures. Since this refine­
ment was added there have been very few 
displacements.
This method of insertion of permanent 
pacemaker leads should be considered when­
ever the cephalic vein cannot be readily lo­
cated or is too small to permit placement of 
a permanent endocardial lead.
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MYOCARDIAL INFARCTION FOLLOWING CORONARY ARTERY 
BYPASS: FACTORS INFLUENCING ITS OCCURRENCE*
P. BEDARD, MD, FRCS[C], H. MARCINEK, MD, B. MORTON, MD, FRCP[C],
F. SMITH, MD, FRCP[C], Y. AKYUREKLI, MD, FRCS[C], M. BRAIS, MD, FRCS[C]
and W. J. KEON, MD, FRCS[C]
The authors have undertaken a prospective study 
on postoperative myocardial infarction (PM I) 
following coronary artery bypass (CAB) grafting. 
PM I was diagnosed from electrocardiographic 
findings by the criteria of the American Heart 
Association. From Aug. 1, 1975 to Feb. 27, 1976, 
198 patients (177 men, 21 women) underwent 
CAB. Their ages ranged from 31 to 71 years 
(mean, 49 yr). Of these patients, 18 (9 % )  su s ­
tained a PMI.
A  number of factors were analyzed to deter­
mine their influence on the occurrence rate of 
PMI. Preoperative factors such as the New York 
Heart Association classification, measurement 
of left ventricular function and evaluation of 
the severity of coronary artery disease were not 
helpful in predicting a predisposition to PMI.
Endarterectomy was the only operative inter­
vention associated with a higher incidence of
*From the University of Ottawa cardiac unit, 
Ottawa Civic Hospital, Ottawa, Ont.
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1053 Carling Aye., Ottawa, Ont. K1Y 4E9.
PM I (18%). Other factors such as the interval of 
cardiac anoxia and cardiopulmonary bypass and 
the number of vesse ls grafted did not seem  to be 
associated with PMI. Low blood flow ( < 4 0  ml/ 
min) through the graft could be correlated with 
the area of infarction in only 5 of 18 patients.
Am ong the operated patients, postoperative 
ventricular arrhythmia was much more common 
in patients with PMI. The hospital mortality in 
this group was 1 1%  (two patients).
Les auteurs ont entrepris une etude prospective 
des infarctus postoperatoires du myocarde (IPM ) 
consecutifs a un pontage aortocoronarien (PAC). 
LTPM a ete diagnostique selon les criteres de 
I'American Heart Association, a partir des traces 
electrocardiographiques. Du m ois d'aout 1, 1975 
a fevrier 27, 1976, 198 patients (177 hom mes et 
21 femmes) ont regu un PAC. Leur age variait de 
31 a 71 ans (49 ans, en moyenne). De ces pa­
tients 18 (9% ) ont subit un IPM.
Un certain nombre de facteurs a ete analyse 
afin de determiner leur influence sur la frequen­
ce des IPM. Certains facteurs preoperatoires tels 
que la mesure de la fonction ventriculaire gau­
che, la New York Heart A ssoc iation  classifica­
tion, et 1'evaluation de la gravite de la maladie 
coronarienne, n 'ont ete d 'aucun secours pour 
predire les pre-dispositions a ITPM.
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L'endarterectomie a ete la seule intervention 
chirtfrgicale associee a une plus haute frequence 
d’lPM. D'autres facteurs, tels que I'intervalle 
d'anoxie cardiaque et de derivation cardiopulmo- 
naire et le nombre de vaisseaux greffes, n'ont 
pas semble influencer la frequence de I'lPM. Un 
faible debit du greffon (40 ml/min) peut avoir 
eu une correlation avec la surface de I'infarctus 
chez seulement 5 des 18 patients.
Parmi les patients operes, I’arythmie ventri- 
culaire postoperatoire a ete beaucoup plus fre- 
quente au sein du groupe IPM. La mortality chez 
les patients hospitalises de ce groupe a ete de 
11% (deux sujets).
T h is  study was undertaken on a prospective 
basis to establish the factors that may influ­
ence the incidence of postoperative myocar­
dial infarction (PMI) after coronary artery 
bypass (CAB) surgery. The incidence and 
severity of myocardial injury following CAB 
surgery becomes an important consideration 
in evaluating its effect on the relief of angina, 
the incidence of subsequent myocardial in­
farction and the improvement in survival.1'3 
The purpose of the study was to discover 
the clinical, laboratory and radiographic 
factors in the patient before, during and 
after operation that might help to predict a 
susceptibility to PMI.
M e t h o d
From Aug. 1, 1975 to Feb. 27, 1976, 198 
consecutive patients receiving CAB grafts 
were followed at the University of Ottawa 
cardiac unit. There were 177 men and 21 
women; their ages ranged from 31 to 71 
years (mean, 49 yr). Coronary angiography 
and cardiac ventriculography were per­
formed on all patients before operation. 
However, postoperatively, coronary angio­
graphy was not performed as a routine. All 
patients had standard 12-lead electrocardio­
grams taken before operation, at 2 hours 
after and again at 1, 2, 3 and 10 days after 
operation. Myocardial infarction was diag­
nosed from the electrocardiographic find­
ings, and the criteria for such a diagnosis 
were based on the American Heart Associa­
tion4 recommendations, depending for the 
most part on the appearance of new Q 
waves.4' 7 Cardiopulmonary bypass was car­
ried out using a disposable oxygenator with 
hemodilution, normothermia and a high- 
flow technique. Normothermic cardiac arrest 
was used for the distal anastomosis.
Statistical analysis was obtained by com­
paring the noninfarct and infarct groups on 
the basis of preoperative, intraoperative and 
postoperative factors. / -  values were ob­
tained for independent variables for both 
groups. Yates correction was applied and P 
values were then arrived at. Only values be­
low 0.05 were considered significant.
R e s u l t s
Of the 198 patients studied, 18 (9%) sus­
tained a PMI, giving two study groups: 180 
patients without PMI (group 1) and 18 pa­
tients with PMI (group 2).
Preoperative Status
Clinical assessment included age, indica­
tion for surgery (Table I) and classification 
according to the New York Heart Associa­
tion (NYHA). The average age of both 
groups was the same (49 yr). Similar propor­
tions of both groups were operated on for 
stable angina. Unstable angina was the in­
dication for operation in 18 patients; 1 suf­
fered a PMI. Four patients with an unstable 
myocardial infarction were operated upon; 
two had evidence of an extending infarction 
postoperatively. The average NYHA classi­
fication for both groups was class III — an­
gina with mild exertion.
The preoperative hemodynamic data 
were evaluated and both left ventricular 
end-diastolic pressure (LVEDP) (10.8 mm 
Hg) and aortic mean pressure (100 v. 96 mm 
Hg) were similar in both groups. Preoper­
ative coronary angiographic data are anal­
yzed in Table II. On average, the degree of 
stenosis of the vessels operated upon was 75 
to 95% in both groups. Left main vessel dis­
ease occurred in three (1.6%) patients in 
group 1 and two (11%) patients in group 2. 
Comparable figures were obtained in the pre­
sence of triple-, double- and single-vessel
TABLE I.—Preoperative Clinical Data
Group 1 Group 2
Indications for Number ' Number
operation (and %) (and %)
Stable angina........................ 160 (89) 15 (84)
Unstable angina...................  17 (9.5) 1 ( 5)
Congestive heart failure. . .  1 (0.5) —
Acute myocardial infarction 2 (1.0) 2 (11)
T ota l.......................................  180 18
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TA BLE II .—Analysis of Preoperative Coron-
ary Arteriography
Group 1 Group 2
Extent of disease
Number 
(and %)
Number 
(and %)
Left main coronary a rte ry ..
T riple-vessel.........................
D ouble-vessel.......................
Single-vessel.........................
3 ( 1) 
120 (67) 
41 (23) 
16 ( 9)
2 (11) 
14 (78) 
2 (11)
T o ta l ....................................... 180 18
disease. Left ventricular function was asses­
sed by LVEDP and ventriculography in the 
right anterior oblique position. The left ven­
tricle was divided into four segments show­
ing dysfunction in the form of hypokinesia, 
akinesia or dyskinesia. The left ventricular 
classification was not significantly different 
(2.7 v. 2.2).
Intraoperative Status
In Table III the factors involved in assess­
ing cardiopulmonary bypass are shown. The 
duration of cardiac anoxia was 28.6 min­
utes in group 1 and 27.7 minutes in group 2. 
Performance of the pump was analyzed in 
terms of perfusion pressure and perfusion 
time; these were similar in both groups. The 
perfusion was gauged by urinary output, in 
which the differences were insignificant, and 
by the incidence of acidosis. In our series no 
patient required treatment for acidosis dur­
ing or after use of the pump. The plasma 
hemoglobin value was interpreted as a re­
flection of the pump’s ability to hemolyze; 
again similar values were found in both 
groups.
In both groups patients received an aver­
age of 3.3 grafts. Of considerable interest, 
however, are the patients who underwent en­
darterectomy; usually this involved the right 
coronary artery. Of our 198 patients, 50 
underwent endarterectomy and 9 of these 
sustained a PMI —  an incidence of 18% v. 
9% in the total study population. Endarte­
rectomies were performed in 50% of the 
group 2 patients and 22% of the group 1 
patients; this difference was statistically 
significant (P <  0.025, =  5.06).
Another facet of the intraoperative data 
examined was that of blood flow through 
the graft (Fig. 1); the mean flow in both 
populations was comparable. In addition, 
the percentage of grafts with flows less than 
40 ml/min was similar. In the case of the 
posterolateral artery, in which the flow was 
significantly different, the bias favoured the 
infarct group in which no graft had a flow 
less than 40 ml/min. Low graft flow ( <  40 
ml/min) correlated with the area of infarc­
tion in only 5 of the 18 patients.
Postoperative Status
The last set of data to be analyzed was the 
postoperative data including bleeding, ex­
ploratory thoracotomy, arrhythmias and 
mortality (Table IV). The average volume of 
postoperative bleeding (group 1, 0.96 /; 
group 2, 0.84 /) and the incidence of ex­
ploratory thoracotomy were similar in groups
Fig. 1.—Intraoperative data  indicating blood flow 
per graft (m l/m in ) for various vessels. Mean blood 
flows with standard deviation are shown. Percent­
age of grafts with flows less than 40 m l/m in  is 
indicated. RT =  right coronary; LAD =  left an ­
terior descending; M-C =  main coronary; P-L =  
posterolateral; D IAG . =  diagonal.
TABLE III.— Intraoperative D ata on C ardiopulmonary Bypass*
Parameter
Group 1 
(n = 180)
Group 2
(n =  18)
Interval of cardiac anoxia (min)
Perfusion pressure (mm H g )..................
Perfusion time (m in)................................
Urine ou tpu t (/)■_■..................................
Plasm a hemoglobin (g /d l) ......................
28.6 ±  10.0 
65.1 ±  9.0 
61.6 ±  25.4 
0.9 ±  0.5 
47.3 ±  49.8
27.7 ±  13.9
63.5 ±  9.3
66.5 ±  25.6 
1.1 ±  0.6
53.2 ±  36.8
*A11 data  are expressed as mean ±  SD.
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TABLE IV.—Postoperative Data
Group 1 {n = 180) Group 2 (n = 18)
Statistical
significanceComplications and procedures Number (and %) Number (and %)
Exploratory thoracotomy..........
Arrhythmias
9 ( 5) 0 (0) —
Supraventricular..................... 120 (66) 14 (77) _
Ventricular............................... 33 (18) 9 (50) / P  <  0.005
Hospital death ............................. 3 (1.7) 2 (11)
\ X 2 = 8.02
1 and 2, as was the occurrence of supraven­
tricular arrhythmias. Ventricular arrhyth­
mias occurred in a higher proportion of pa­
tients in group 1 than in group 2. The hos­
pital mortality was 1.7% (three patients) in 
group 1 and 11 % (two patients) in group 2.
Discussion
The PMI of 9% places our study in ap­
proximately the mid-range of reported inci­
dence of myocardial infarction. 1' :{- 8-13 
However, our study conflicts with data from 
other centres in many important aspects. 
First, it has been suggested that preoperative 
functional classification has a role to play 
in PMI.1' 3 In our study we have shown that, 
except for patients with a history of preoper­
ative myocardial infarction, clinical assess­
ment and NYHA classification is of no pre­
dictive value in establishing which patients 
are likely to suffer a myocardial infarction. 
In addition, our data show that unstable an­
gina has no role in predisposing patients to 
PMI. Four patients were operated on be­
cause of an acute unstable infarction and 
two of them showed evidence of an extension 
of their infarction.
Our study also showed that preoperative 
angiographic data are not helpful in predict­
ing myocardial infarction, except in disease 
of the left main coronary artery in which PMI 
occurred in two patients. These findings 
agree with those of Brewer, Bilbro and Bar­
tel1 who, on comparing infarct and nonin­
farct groups, found no significant difference 
in risk factors, in hemodynamic data, or in 
the number of diseased vessels. There is dis­
agreement in the literature, however; Rose 
and colleagues0 and Flemma and asso­
ciates3 found that coronary artery disease 
was more severe in patients who suffered an 
infarct than in those who did not. Flemma3 
also noted a greater number of patients with
poor left ventricular function in those with 
PMI.
In the past, it was postulated that the in­
cidence of PMI may be attributable to car­
diopulmonary bypass alone. In one study of 
noncoronary artery heart surgery there was 
a 7% incidence of acute myocardial infarc­
tion.11 However, in our study, after subject­
ing the factors involved in cardiopulmonary 
bypass to thorough analysis, including per­
fusion pressure and perfusion time, we were 
unable to demonstrate any significant dif­
ference between the infarct and the nonin­
farct groups. One difference between the 
study of Hultgren and associates11 and our 
own is the use of total body hypothermia 
to 30°C as part of their cardiopulmonary 
bypass technique; our patients were normo- 
thermic. Rose and colleagues0 used hypo­
thermia; they found no correlation in the 
incidence of infarction with hypothermia or 
the use of cross-clamping of the aorta during 
surgery. Flemma and associates3 had the re­
verse experience. In our experience, the 
number of grafts has not influenced the in­
cidence of PMI; these results agree with 
those of others.1' :i' 5
Of special interest in our intraoperative 
data is the role of endarterectomy. Our stu­
dy seems to indicate that endarterectomy is 
of some predictive value; an endarterectomy 
doubles the patient’s chance of a PMI. At 
times, however, endarterectomy provides 
the only means of extending the operability 
of a diffusely involved right coronary artery 
and such salvage may well be worth the 
risk.13' 16
Our postoperative data on the increased 
incidence of ventricular arrhythmias and 
mortality rate agree with data from other 
centres.1 2 8 Ventricular arrhythmia has 
little predictive value; this complication is 
most likely secondary to the infarction ra­
ther than the primary event.
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The mortality in the infarct group was 
related to the condition of the myocardium. 
One patient sustained a cardiac arrest follow­
ing the induction of anesthesia. He was re­
suscitated, but at operation and postoper- 
atively there was evidence of a massive myo­
cardial infarction. In another patient, who 
preoperatively had unstable angina, ventri­
cular tachycardia and fibrillation developed 
48 hours postoperatively. At autopsy both 
grafts were thrombosed even though good 
graft flow rates were obtained at operation.
Conclusion
Patients with postoperative myocardial in­
farction after CAB surgery have a higher in­
cidence of ventricular arrhythmias than 
those with no infarction. Among factors con­
sidered preoperatively, intraoperatively and 
postoperatively, only endarterectomy ap­
pears to contribute significantly to the inci­
dence of PMI.
We are indebted to Drs. G. White and G. Taich- 
man and to Mrs. M. Rosenbloom for their valu­
able assistance in the preparation of the statis­
tical analysis.
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TRAUMATIC RUPTURE OF THE 
AORTA
Aortographic search jor ruptured thoracic aor­
ta (R T A ) should be done only in those trauma 
patients with radiographic evidence o j a widen­
ed mediastinum. Turney and colleagues (J Tho- 
rac Cardiovasc Surg 72: 727, 1976) reviewed 
the combined experience o f two medical cen­
tres with R T A ; their study was based on a 
5-year experience with 31 cases.
Twenty-five o f the 31 patients (81% ) sur­
vived. The mean age was 26 years (range, 15 
to 67); most were operated on within 18 hours 
after injury. Serious nonthoracic injuries 
were present in every case. Surgical repair was 
done with a left heart bypass in 2 cases (1 
death), a passive aorta-to-aorta shunt in 23 
cases (5 deaths) and without shunt or bypass in 
6 cases (no deaths). In all but one case an end- 
to-end Dacron graft was used in the recon­
struction. Paraplegia developed in 1 patient, 
renal failure in 3 patients (2 deaths), transient 
hypertension in 18 (72% ) o f the survivors and 
palsy of the left recurrent laryngeal (R L ) nerve 
in 8 (32% ) of the survivors. Two deaths could 
be attributed to technical problems with the 
shunt; two to intrapleural exsanguination. Com ­
plications and blood loss were lowest in those 
with no shunt; where possible this is the proce­
dure of choice.
The mediastinum was clearly widened on 
the anteroposterior chest radiographs in most 
cases and definition of the aortic knob was 
blurred in all. Major associated thoracic injury
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was present in all cases. Hypotension due to 
bleeding was present on admission in eight 
cases; in all of these, transfusion and general 
supportive measures permitted aortographic 
studies before thoracotomy. Six patients 
with evidence o f intraperitoneal bleeding 
underwent laparotomy first. These patients 
were all found to have, among other injuries, 
a ruptured spleen; thoracotomy followed lapa­
rotomy and five o f the six survived. Four others
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with questionable intra-abdominal bleeding had 
a laparotomy after the thoracotomy; none of 
these had a ruptured spleen and all survived. In 
no case was the vagus or R L  nerve severed by 
the surgeon, although much manipulation of 
the R L nerve was often required.
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EXPERIENCE WITH REOPERATION FOLLOWING CORONARY 
BYPASS GRAFTING*
W. J. KEON, MD, FRCSfC], P. BEDARD, MD, FRCS[C], Y. AKYUREKLI, MD, FRCS[C]
and M. BRAIS, MD, FRCSfC]
Thirty-four of 1152 patients who had undergone 
aortocoronary bypass grafting underwent re­
operation. There were no early or late deaths 
among these 34 patients. The average time be­
tween operations was 14 months. At the initial 
operation, 88 grafts and 10 internal mammary 
implants were placed; at reoperation, 56 grafts 
and 8 internal mammary implants were placed 
and a left ventricular aneurysm was plicated. 
Twenty patients underwent reoperation for graft 
stenosis or occlusion, five because of progres­
sion of coronary artery disease, seven because 
of combined progression of disease and graft oc­
clusion and two to correct technical errors. Im­
provement in the class of angina was 1.1 classes 
at an average follow-up of 9 months. The authors 
believe that reoperation for coronary bypass 
grafting can be performed safely with symptoma­
tic improvement for the patient.
Trente-quatre patients sur 1152 qui ont repu un 
pontage aortocoronarien, ont subit une nouvelle 
intervention. II n'y a eu aucun deces precoce ou 
retarde chez ces 34 patients. L'intervalle moyen 
entre les operations a ete de 14 mois. A la pre­
miere operation, on avait realise 88 pontages et 
place 10 greffons mammaires internes; lors de 
la seconde intervention, 56 pontages et 8 gref­
fons mammaires internes ont ete mis en place, 
et un anevrisme ventriculaire gauche a ete re­
pare. Vingt patients ont ete reoperes a cause de 
I'occlusion ou de la stenose d'un greffon, cinq 
a cause de 1'evolution de la maladie coronarien- 
ne, sept a cause, a la fois, de 1'evolution de la 
maladie et de I'occlusion du greffon et deux pour 
corriger des erreurs techniques. Apres une pe- 
riode moyenne de post-observation de 9 mois, on 
a observe une amelioration de 1.1 classe dans la 
classification de I'angine. Les auteurs croient 
qu'une deuxieme operation de pontage corona- 
rien peut etre realisee avec securite et entrainer 
une amelioration des symptomes chez le patient.
*From the University of Ottawa cardiac unit, 
Ottawa, Ont.
Presented at the annual meeting of the Canadian 
Cardiovascular Society, Edmonton, Alta., Oct. 18- 
23, 1976.
Reprint requests to: Dr. W. J. Keon, University 
of Ottawa cardiac unit, Ottawa Civic Hospital, 
1053 Carling Ave., Ottawa, Ont. K1Y 4E9.
Sa p h e n o u s  vein bypass grafting was first 
performed nearly 10 years ago. In the inter­
vening years it has become the most widely 
used myocardial revascularization procedure. 
It has been termed a successful procedure by 
many on the basis of its usefulness in the 
relief of angina. Complete absence of angina 
has been reported in 79 and 82% of pa­
tients operated upon.1 - Reported failure of 
aortocoronary bypass grafting requiring re­
operation has been rare. In 1972 Adam and 
colleagues:! reported on 19 patients requiring 
reoperation; 17 survived. In the same year 
Johnson and associates4 reviewed 39 cases; 
most of their patients had had mammary im­
plants previously. In this group there were 
four deaths at the time of reoperation and 
three late deaths. Skow and associates3 re­
ported 14 reoperations; 6 followed a pre­
vious vein graft bypass. There was one late 
death. Recently, the Stanford Medical Cen­
ter reviewed 21 reoperations in which 13 
patients obtained relief or improvement of 
angina and 1 patient died late.6
We have studied 34 patients who under­
went a second coronary artery bypass graft 
operation in our unit. There were no early 
or late deaths. The indications for operation, 
the success rate in the relief of angina and 
the technical problems of surgery are dis­
cussed.
C l in ic a l  M a t e r ia l , M eth o d s  a n d
R e s u l t s
Thirty-four men underwent a second co­
ronary artery bypass graft operation an aver­
age of 14 months after the first. In all, the 
first operation consisted of bypass grafting 
and was performed by the same surgeon who 
performed the second. The patients’ average 
age was 46 years. At the first operation, nor- 
mothermic high-flow perfusion was used; 
four patients did not require perfusion at the 
time of the second operation.
Two of the 34 patients had one diseased 
vessel prior to the initial operation, 14 had 
two and 18 three diseased vessels. Fourteen 
patients had normal ventricular function at
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the first operation, 2 had class I, 15 had 
class II and 2 had class III function (Amer­
ican Heart Association classification). None 
of the patients had congestive heart failure 
nor did it occur in the interval between first 
and second operation. Before the initial oper­
ation, 3 patients were asymptomatic, 9 had 
class II angina, 10 had class III, and 12 had 
class IV (New York Heart Association 
[NYHA] classification) (Table I).
First Operation
Eighty-eight coronary artery bypass grafts 
and 10 internal mammary artery implants 
were placed (Table II). Seven were single 
grafts, 10 were double, 9 triple, 6 quadruple, 
and 2 quintuple grafts. The average graft 
flow was 62.9 ml/min (range 20-200 ml/ 
min).
Interval Between Operations
Angiography that led to a second opera­
tion was performed in 22 patients because of 
angina; in 12 it was part of a routine follow­
up. Twenty patients underwent reoperation 
for occluded or severely stenosed grafts, five 
for progression of coronary disease, seven 
for combined graft occlusion and progres­
sion of disease, and two for a technical error
TABLE I.—Severity of Angina (NYHA 
Classification)
Class
Time I I I I I I IV
Before first operation......... . 3 9 10 12
Before second operation. . 9 7 10 8
After second operation. . . . . . 25 4 4 1
TABLE II.—Procedures
Operation
Procedure First Second
Bypass graft.............................. 88 56
Mammary implant................... 10 8
Plication of left ventricular 
aneurysm................................ 0 1
TABLE III.—Reason for Reoperation
Reason
No. of 
patients
Grafts occluded or severely stenosed 20
Progression of disease........................ 5
Occlusion and progression of disease 7
Technical error.................................... 2
made at the first operation (Table III, Figs. 1 
to 4). In one case, the distal anastomosis of 
a circumflex graft was inadvertently made 
above the area of stenosis; in another patient, 
the anatomy was mistaken, and two diagonal 
grafts were performed instead of two margi­
nal grafts. It was found that 45 of the 88 
grafts originally placed in these 34 patients 
had occluded.
Prior to the second operation, nine pa­
tients had no angina. These patients were 
demonstrated at routine follow-up angio­
graphy to have defective operations leaving 
them at risk for serious infarction and death. 
Seven had class II, 10 class III, and 8 class 
IV angina (Table I). In patients who were 
symptomatic, angina had returned an aver­
age of 8V2 months after the first operation. 
Three patients had suffered myocardial in­
farction (one had had two) prior to the sec­
ond operation. For five patients, ventricular 
function was considered to be one class 
worse, while for one it was one class better, 
before reoperation.
Second Operation
The second operation was performed an 
average of 14 months after the first. In pa­
tients undergoing reoperation for a technical 
error, the average time interval was only 1 
month, for patients with occluded grafts it 
was 8.7 months, for those with progression 
of their disease it was 24.6 months and for 
those with a progression of their disease and 
graft occlusion it was 27.2 months.
In one operation, no new revascularization
Fig. 1.—Angiogram showing progressive occlu­
sion of a bypass graft, early (A) and late (B).
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was performed. This patient had a localized 
occlusion at the distal anastomosis through 
which a probe was passed easily, restoring 
good graft flow (75 ml/min). In another man 
with anterior descending graft occlusion, the 
saphenous vein was found to be severely 
diseased and a mammary artery to anterior 
descending artery anastomosis was per­
formed. In four patients, a new graft was not 
placed but instead the previous graft, now 
occluded, was resected with a new piece of 
vein bypassing the stenosed section. In an­
other case an arteriotomy was performed 
followed by a vein angioplasty. Ten of 45
B
occluded grafts were excised during opera­
tion while the remainder were left in place. 
No grafts were replaced in exactly the same 
position; most were anastomosed a few milli­
metres distal to the previous anastomosis. 
One patient required intra-aortic balloon 
pumping for 24 hours after operation.
During the second operation, 56 grafts 
were inserted and 8 internal mammary im­
plants were placed. In one patient a left 
ventricular aneurysm was plicated (Table 
II). The average graft flow was 56.1 ml/min. 
The graft flow was highest (72.1 ml/min) 
in patients who had combined occlusion and 
disease and lowest in those who had a tech­
nical error (30 ml/min). The flow for those 
who had progression of disease alone was 
53.6 ml/min and in patients with occluded 
grafts it was 50.1 ml/min.
Follow-Up
Follow-up information on all patients was 
obtained at a mean time of 9 months after 
operation. Twenty-five patients had no 
symptoms of angina, 4 had class II, 4 class 
III, and 1 remained in class IV (Table I). 
Since, prior to the second operation, none 
were worse, five patients had therefore im­
proved by three classes and seven by two 
classes. Sixteen patients who had received 
19 grafts at reoperation underwent follow-up
Fig. 2.—Angiogram showing progression of coronary disease since first operation. (A) Preoperative 
angiogram, (B) 3 weeks after operation and (C) 23 months after operation.
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angiography; 4 of the grafts were occluded. 
Stress tests performed on these 16 patients 
were positive for myocardial ischemia in 
three instances.
D iscussion
In our clinic, either operative failure or 
progression of disease as evidenced by angio­
graphic assessment (at routine follow-up 
examination or for severe angina) is an indi­
cation for reoperation. Reoperation is recom­
mended when surgically correctable prob­
lems such as graft occlusion or progression 
of disease are demonstrated.
Our findings concerning symptomatic im­
provement differ from those of Winkle and 
associates.0 Winkle’s group could not de­
monstrate much improvement in angina fol­
lowing reoperation; this was particularly ap­
parent in patients with occluded grafts.0 We 
found that after reoperation patients im­
proved an average of 0.41 classes in the in­
terval between the first and second opera­
tions and had improved 1.1 classes between 
the time of reoperation and follow-up. The 
greatest improvement was in patients with 
progression of disease who improved 2.0 
classes, while those with graft occlusion im­
proved 1.0 class. There was a lesser degree 
of improvement in the other groups — 0.7
Fig. 3.—Angiogram showing combined graft oc­
clusion (A) and progression of coronary artery 
disease (B).
classes in patients with graft occlusion and 
progression of disease and 0.5 in those in 
whom there was a technical error at the ini­
tial operation.
We agree with those authors3-6 who be­
lieve that there are many more technical 
problems associated with reoperation. How­
ever, we do not find the difficulties insur­
mountable and we have not had the severe 
problems that Johnson and his colleagues4 
encountered when two of their patients died 
at operation. In one of our patients, a func­
tioning graft was divided when the chest was 
opened, but it was reanastomosed and the 
operation successfully completed. Adam and 
colleagues8 found that the time spent on by­
pass during the second operation was longer 
than at the first; this differs from our experi­
ence. Perfusion time averaged in our series 
68.66 minutes originally and 61.56 minutes 
at reoperation (this excludes the four patients 
who did not require cardiopulmonary bypass 
at reoperation).
In 27 of our 34 patients grafts became 
occluded after the initial operation; 45 of 
the 88 originally placed grafts became oc-
Fig. 4.—Angiogram of patient in whom tech­
nical error was made at first operation. Graft 
placed proximal to area of stenosis marked by 
arrow.
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eluded. This is a much lower percentage 
than that reported by Adam and colleagues 
and Winkle and associates.'1 This may be 
the result of our attempt to place a graft 
even in technically difficult cases. In addi­
tion we do not consider an operation com­
plete unless moderately as well as seriously 
stenosed vessels have been bypassed. One 
half of patients in our series had triple, 
quadruple, or quintuple grafts. It appears 
that when graft occlusion occurs it does so 
just after operation since the interval be­
tween operations for the patients with oc­
cluded grafts was only 8.7 months. A sur­
prising finding was that the blood flow 
through those grafts that were found on 
follow-up angiography to be occluded 
averaged 63 ml/min at first operation 
(range, 30 to 150 ml/min). We believe 
therefore that low flows at operation are not 
necessarily indicative of future graft occlu­
sion.
Thirty-five percent (12 of 34) of patients 
undergoing reoperation received their first 
operation on an emergency basis. Nine pa­
tients had preinfarction angina and three had 
acute unstable myocardial infarction. Two 
patients were classified as being emergencies 
at second operation; both had preinfarction 
angina. Emergency operations are obviously 
performed under greater pressure than elec­
tive operations; in some cases the only ob­
jective at the time of the emergency surgery 
is to keep the patient alive, but where pos­
sible complete revascularization should be 
attempted.
Of our 1186 patients 319 received routine 
follow-up angiography at the National De­
fence Medical Centre in Ottawa. Routine 
angiography appears to be valuable in deter­
mining which patients require reoperation; 
the risk of late death is thereby lowered. 
Those who underwent routine follow-up 
angiography had a 5 % (16 of 319) reoper­
ation rate and 0.9% (3 of 319) late mortality 
rate compared with 2% (18 of 867) reoper­
ation and 7.7% (67 of 867) late mortality 
rate in those who did not receive routine 
follow-up angiography.
The major dilemma with routine follow-up
angiography is that some asymptomatic pa­
tients will have evidence of a defective oper­
ation; this leaves them at serious risk for in­
farction and death. We have reoperated on 
these patients in an attempt to diminish 
these risks. We also believe that an adequate 
assessment of the effect of this operation’s 
late mortality cannot be made unless the 
operation is satisfactory from a technical 
point of view. The criteria necessary to de­
fine a satisfactory technical operation for 
complete revascularization will require fur­
ther study.
Conclusion
In patients with coronary artery disease, 
reduction in symptoms can be obtained by 
reoperation. Although reoperation is tech­
nically more difficult than the initial opera­
tion it can be performed successfully without 
undue risk. Routine follow-up angiography 
is valuable in assessing the results of sur­
gery and leads to early diagnosis of inade­
quacies resulting from the first operation. A 
second operation is not unduly delayed and 
late mortality decreases. Patients who have 
angiographic evidence of graft malfunction 
or progression of disease deserve a second 
operation.
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ACTINOMYCOSIS OF THE GALLBLADDER*
THOMAS MARRIE, MD, H. GRANT STIVER, MD, FRCP[C], ANDRE MOLGAT, MD, FRCS[C], ROBERT G. STARK, MD, MRCPath, FRCP[C] and DOUGLAS NORRIS, MSc
Actinomycosis of the gallbladder is rare, and 
the pathogenesis of the infection is poorly un­
derstood. The authors report the case of a 77- 
year-old man admitted to hospital because of 
abdominal pain. Clinical and laboratory findings 
suggested the diagnosis of cholecystitis and cho­
lelithiasis. At cholecystectomy the gallbladder 
was inflamed and contained many calculi. Gram 
staining of material from the mucosa of the 
gallbladder demonstrated gram-positive pleomor­
phic filaments, and Actinomyces israelii grew in 
pure culture, thus confirming the diagnosis of ac­
tinomycosis of the gallbladder. The pathogenesis 
of the condition is also discussed.
L'actinomycose de la vesicule biliaire est une 
infection rare dont la pathogenese est mal con- 
nue. Les auteurs signalent le cas d’un homme de 
77 ans, hospitalise pour douleurs abdominales. 
Les examens cliniques et de laboratoires indi- 
quaient un diagnostic de cholecystite et de cho- 
lelithiase. Au moment de la cholecystectomie, la 
vesicule etait enflammee et contenait plusieurs 
calculs. La coloration gram des prelevements de 
la muqueuse de la vesicule a revele des fila­
ments pleomorphes gram positif, et de I'A ctino­
myces is rae lii a pousse en culture pure, con- 
firmant ainsi le diagnostic d'actinomycose de la 
vesicule biliaire. La pathogenese de cette affec­
tion est aussi discutee.
*From the departments of medicine, surgery and pathology, St. Boniface General Hospital, Winni­
peg, Man.
Reprint requests to: Dr. Thomas Marrie, Depart­ment of medical microbiology, Health Sciences Centre, 700 William Ave., Winnipeg, Man. R3E 
0Z3.
A b d o m in a l  actinomycosis, caused by infec­
tion with Actinomyces israelii, usually re­
sults from damage to the gastrointestinal 
mucosa and often rupture of the gastrointes­
tinal tract. Secondary spread within the ab­
domen is usually to the abdominal wall, 
retroperitoneum, subphrenic space and oc­
casionally the liver,1 but actinomycosis of 
the gallbladder is extremely rare;- Davies 
and Keddie:i reported a probable case of 
actinomycosis of the gallbladder and were 
able to find only two other established cases 
described in the literature. We report such 
a case to draw attention to this rare condi­
tion and to discuss its pathogenesis, which 
is poorly understood.
C ase  R e p o r t
A 77-year-old man with an unremarkable 
medical history was admitted to hospital com­plaining of severe epigastric pain associated with nausea and vomiting. There were no iden­tifiable precipitating factors. He had experi­enced similar bouts of pain in the past but could not remember when such an episode had 
last occurred.On physical examination he appeared to be in moderate distress; the epigastrium and right upper quadrant were tender on palpation and 
his oral temperature was 37.5°C. Nasogastric 
suction and intravenous therapy were instituted.Initial laboratory data included a leukocyte count of 12.6 x 107/ and a serum amylase concentration of 2100 Somogyi units/dl. The results of other laboratory investigations over 
the next few days are shown in Table I. Intra­venous cholangiography was carried out 10 days after admission. Lucencies in the com-
TABLE I.—Laboratory Investigations
Serum concentration (normal range)
Amylase Alkaline
( 50-150 Somogyi phosphataseDay units/dl) (30-125 IU /l)
1 21002 . 600 520
3 . . . .  . .'......... -  2885 50 2717 ...........  — 182
i o : . -  172
GlutamicTotal Lactic oxaloaceticbilirubin dehydrogenase transaminase(0.2-1.0 mg/dl)  ( 100-125 IU /l)  (14-47 IU /l)
_ _ _
0.9 238 4051.2 125 810.6 127 350.5 212 210.3 137 37
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mon bile duct were interpreted as calculi. At 
cholecystectomy the gallbladder was found 
to be grossly inflamed, and to contain con­
taining many large calculi; a large calculus 
was found in the common bile duct. Postoper- 
atively penicillin G (20 million units daily) 
was given intravenously for 6 weeks, followed 
by tetracycline (2 g daily) orally for 4 months.
Pathology
The gallbladder (length, 8 cm; diameter, 3 
cm) contained many multifaceted calculi and 
areas of hemorrhagic mucosa. Microscopic 
examination disclosed areas of mucosal loss 
with replacement by granulation tissue. Within 
the wall there were aggregations of lympho­
cytes and plasma cells more numerous than is 
usual in chronic cholecystitis due solely to 
calculi; in areas of the mucosa, foci of typical 
actinomycotic granules were present (Fig. 1).
Microbiology
Swabs taken from the gallbladder mucosa at 
operation were inoculated into thioglycolate 
broth and cooked meat media, and incubated 
at 37°C. In 7 days colonies that varied in size 
from pinpoint to large lobulated forms were 
seen. These grew to within 2 cm of the surface 
of the broth. Microscopic examination revealed 
gram-positive pleomorphic filaments with 
and without branching (Fig. 2). Biochemically 
the organism was catalasenegative and pro­
duced acid but no gas from glucose, xylose, 
mannose and raffinose; there was no reaction 
to mannitol, no liquefaction of gelatin and no 
reduction of nitrate. These biochemical char­
acteristics identified it as A. israelii.4 No Acti- 
nobacillus actinomycetemcomitans was re­
covered.
D iscussion
A. israelii, the causative agent of actino­
mycosis, is gram positive, nonsporulating, 
anaerobic or microaerophilic and is fre­
quently found in the human mouth and in 
gastric aspirates. "’ The presence of hyphae 
with true branching suggests that the organ­
ism is a fungus, but the lack of sterols in the 
cell wall, the sensitivity to antibacterial anti­
biotics and its anaerobic requirements are 
bacterial properties.6
Clinically, actinomycosis involves three 
main anatomical regions. Cope’s classic 
monograph7 reported cervicofacial lesions 
in 63% of 1330 patients, thoracic disease 
in 15% and abdominal involvement in 22%. 
Weese and Smith8 in a review of 57 cases 
of actinomycosis noted a similar distribution 
among these three anatomical regions.
In abdominal actinomycosis spread of the 
infection is usually contiguous rather than 
by the lymphatic or hematogenous route, but 
metastatic spread may occur.9 The usual 
sites of secondary spread within the abdo­
men are to the abdominal wall with the 
formation of multiple draining sinuses, to the 
retroperitoneal region, the subphrenic space 
and occasionally to the liver.- The liver is 
the most common solid abdominal site of 
actinomycosis and seeding of the liver in 
some instances may occur through the portal 
vein;19 gallbladder involvement is rare. Ac­
cording to Mayo-Robson11 gallbladder in­
fection occurs by retrograde spread of Acti­
nomyces sp. up the bile duct from the duo­
denum, but, if so, more cases of actinomy-
Fig. 1.—Mucosal involvement of gallbladder by 
actinomycotic granule (Gram’s stain, reduced bv 
49% from x 25).
Fig. 2.—Material from swab from gallbladder 
mucosa showing gram-positive branching fila­
ments (Gram’s stain, reduced by 44% from x 
1000).
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cosis of the gallbladder should occur. In our 
patient the diagnosis was made fortuitously 
when gram staining of a swab of the mucosal 
surface of the gallbladder revealed the typi­
cal actinomycotic organisms; no features in 
the history or intraoperative findings sug­
gested the diagnosis. The presence of actino­
mycotic granules in the mucosa indicated 
invasive disease and not colonization. Inva­
sion of the gallbladder wall may have fol­
lowed mucosal damage by the cholecystitis.
All strains of A. israelii isolated at the 
Mayo Clinic have been inhibited by penicil­
lin G at 0.1 jig/m l.9 The recommended 
dosage of penicillin for the treatment of ac­
tinomycosis varies from 1 million units dai­
ly9 to “massive long-term administration” .1 
The avascularity and induration that result 
following infection with this organism em­
phasize the need for lengthy high-dosage 
antibiotic administration. Treatment with 
penicillin G parenterally followed by tetra­
cycline (500 mg qid) for 8 to 12 weeks 
should be effective in most cases.9 In our 
patient excision of the gallbladder may have 
been sufficient; however, because of the 
possibility of spread to the liver or to the 
mesentery a 6-week course of penicillin in­
travenously followed by 4 months of tetra­
cycline orally was given. Other organisms, 
especially A. actinomycetemcomitans, are 
frequently isolated together with A. israe­
lii.1'2 The need for treatment directed to 
these other bacteria is controversial. Gram­
negative organisms (including Pseudomonas 
sp., Proteus sp. and Escherichia coli) that 
are resistant to penicillin in vitro, tend to be 
eradicated in vivo with that antibiotic alone, 
as emphasized by clinical cures in patients 
treated with penicillin alone.8
As illustrated by this case, actinomycosis
of the gallbladder may not be recognized 
clinically, especially if mucosal injury by 
cholelithiasis is necessary for invasion by 
this saprophytic organism. However, the 
distinctive histology readily suggests the 
diagnosis. Treatment should consist of pa­
renteral administration of penicillin followed 
by tetracycline orally.
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ACTINOMYCOSIS OF THE COLON*
A. W. JAMES, MD, FRCP[C] and A. H. PHELPS, MD, FRCS[C], FACS
A 44-year-old woman with severe pain in the 
right upper quadrant, simulating acute cholecys­
titis, was found to have a large tumour in the 
transverse colon. Cultures from the mass grew 
Actinomyces israelii. Actinomycosis may often 
be missed; involvement of the large bowel is 
not confined to the appendiceal and cecal areas 
and may simulate other intra-abdominal condi­
tions.
line importante tumeur du colon transverse a ete 
retrouvee chez une femme de 44 ans se plaignant 
d’une douleur intense dans le quadrant supe- 
rieur droit, ressemblant a une attaque de chole- 
cystite aigue. La culture de cette masse tumo- 
rale a mis en evidence de I'Actinomyces israelii. 
Le diagnostic d’actinomycose peut souvent etre 
manque; I'atteinte du gros intestin ne se limite 
pas aux regions de I'appendice et du caecum et 
peut ressembler a d'autres affections intra-ab- 
dominales.
Abdominal actinomycosis, most frequently 
found in the liver and ileocecal region, is 
often mistaken for appendicitis, carcinoma 
of the cecum, tuberculosis or amebiasis. Pri­
mary infection elsewhere in the gastrointes­
tinal tract is rare. Two cases of primary ac­
tinomycotic infection of the colon and rec­
tum were reported by Udagawa, Portin and 
Bernhoft in 1974;1 in one, the descending 
colon was affected with retroperitoneal ex­
tension resembling tuberculosis of the spine, 
diverticular abscess or primary retroperito­
neal malignant neoplasm. We report a case 
because it simulated acute cholecystitis 
though it was the transverse colon that was 
affected.
Case R eport
A 44-year-old Caucasian woman was ad­
mitted for investigation of severe abdominal 
pain in the right upper quadrant that had 
started suddenly the previous night. The pain 
was persistent, sharp and localized; it did not 
radiate to the shoulder or back or change on 
respiration. There was no nausea or vomiting. 
The patient denied a history of food intoler-
*From the departments of pathology and surgery, 
Chilliwack General Hospital, Chilliwack, BC.
Reprint requests to: Dr. A. W. James, Chilli­
wack General Hospital, Chilliwack, BC B2P 1P7.
ance. Her past medical history was unremark­
able.
Physical examination showed a slight malar 
flush; her temperature was 37°C; pulse rate, 
72 beats/min; blood pressure, 120/80 mm Hg; 
and weight, 67.5 kg. Heart sounds and electro­
cardiogram were normal. She was not jaun­
diced. There was a right upper quadrant mass 
consistent with large tender gallbladder and 
guarding. Oral cholecystography showed only 
faint visualization of the gallbladder. Labora­
tory investigations were unremarkable (hemo­
globin concentration, 13g/dl; hematocrit, 
40%; leukocyte count, 11.5X109//).
At laparotomy a large mass was found in the 
right transverse colon; it simulated a perfor­
ated carcinoma. There was no other abdominal 
abnormality. A colostomy and Mikulicz re­
section were carried out; the length of the re­
sected segment of bowel was 16 cm and the 
large mass on the serosal surface measured 10 
x 7 cm. The mucosa of the bowel appeared 
normal'(Figs. 1 and 2). The tumour was cov-
Fig. 1.—Resected specimen of transverse colon 
showing serosal mass.
Fig. 2.—Resected specimen of transverse colon 
showing apparently normal mucosa.
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ered with a creamy purulent exudate and on 
section showed a large cavity filled with green-
Fig. 3.—Histologic section of tumour: no evidence 
of trauma or disease (hematoxylin and eosin re­
duced by 33% from x 80).
Fig. 4. —Section of tumour showing sulfur gra­
nule and abscess (hematoxylin and eosin, reduced 
by 33% from x 80).
Fig. 5.—Higher magnification of Fig. 4 show­
ing branching mycelial filaments and typical colony 
of actinomyces surrounded by leukocytes and 
bacteria (hematoxylin and eosin, reduced by 33% 
from x 320).
ish pus and granular material. Histologic sec­
tions revealed the typical sulfur granules of 
actinomycosis, reactive and purulent granula­
tion and microabscesses (Figs. 3 to 5). The 
bacteriologic cultures taken from the mass 
grew, under anaerobic conditions, gram-posi­
tive nonsporulating organisms with sulfur gra­
nules, identified and confirmed by the refer­
ence laboratory of the British Columbia Health 
Services as Actinomyces israelii. The patient 
was treated with ampicillin, did well and was 
discharged 12 days after operation. The colo­
stomy was closed 1 month later without inci­
dent.
Co m m e n t
A. israelii is a common saphrophyte in 
the human gastrointestinal tract. The mech­
anism causing its conversion to a pathogen 
is not understood.2' 3 It appears incapable 
of penetrating the normal mucosa. Infec­
tion usually follows a break in the mu­
cosal barrier resulting from disease or trau­
ma. In the present case there was no evidence 
of pre-existing disease, trauma, infection, or 
a gastrointestinal lesion. Gram-positive 
branching rods morphologically similar to 
Actinomyces sp. were cultivated from the 
tonsillar crypts of the patient following lapa­
rotomy.
The diagnosis of actinomycosis may be 
difficult both clinically and at laparotomy, 
and clinical awareness of the possibility of 
the condition is necessary so that appropriate 
cultures can be mounted under anaerobic or 
microaerophilic conditions. The present case 
demonstrates that actinomycosis may often 
be missed in humans. The serologic diag­
nosis of actinomycosis using the method of 
crossed immunoelectrophoresis, as proposed 
by Holmberg, Nord and Wadstrom,4 would 
be a useful adjunct in the diagnosis.
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GIANT OVARIAN CYST IN A DWARF*
STEFAN SEMCHYSHYN, MD, RONALD C. STRICKLER, MD, FRCS[C] 
and ALAN H. GERULATH, MD, MS, FRCS[C]
The authors describe a case of giant mucinous 
cystadenoma in a dwarf. The cystadenoma 
weighed 32 kg, almost half the patient’s normal 
weight. Such tumours are rare and are some­
times mistaken for ascites. They are usually 
benign, but care should be taken to remove them 
intact since malignant degeneration of mucinous 
cysts occurs in 5 to 15% of cases. Understand­
ing of the possible complications allows for a 
favourable prognosis.
Les auteurs decrivent un cas de cystadenome 
mucineux geant chez une naine. Le cystadenome 
pesait 32 kg, soit presque la moitie du poids nor­
mal de la patiente. De telles tumeurs sont rares 
et elles sont parfois confondues avec une ascite. 
Elies sont habituellement benignes, mais on doit 
prendre soin de les enlever intactes puisqu'une 
degenerescence maligne des kystes mucineux 
survient dans 5 a 15% des cas. Une connais- 
sance des complications possibles permet d'en- 
visager un pronostic favorable.
G iant ovarian tumours are now rarely en­
countered because ovarian masses are de­
tected and removed before they can attain 
mammoth proportions. Kehrer,1 in a report 
of 100 cases from 1873 to 1928, defined two 
criteria for the diagnosis of giant ovarian 
cysts: the tumour mass weighs at least 25 
kg and the total body weight of the patient 
following extirpation approximates the 
weight of the cyst. The largest tumour was 
described by Spohn and weighed 147.6 kg.2 
Reports of these neoplasms have decreased 
notably in the last 5 decades; from 1928 to 
1975 only 26 cases were documented.1- :!'s 
This report describes a case of giant muci­
nous cystadenoma in a dwarf.
C ase R eport
Clinical Course
A 66-year-old Canadian-born Caucasian 
woman had experienced gradually increasing 
abdominal girth for 4 years. Over the 3 months
*From the department of obstetrics and gyneco­
logy, St. Michael’s Hospital, University of To­
ronto, Toronto, Ont.
Reprint requests to: Dr. Alan H. Gerulath, De­
partment of obstetrics and gynecology, St. Michael’s 
Hospital, 30 Bond St., Toronto, Ont. M5B 1W8.
before admission, she noted increasing dyspnea 
on exertion and on lying flat, fatigue, diffi­
culty in walking and increasing edema of both 
legs. She was otherwise asymptomatic. She 
lived alone and was self-supporting.
She always had been of small stature (height, 
121 cm; weight, 67 kg) and had no body or 
head hair. Her parents and siblings were of 
normal size and had normal hair distribution. 
As a child she had had rickets, but had enjoyed 
good health since. Menarche occurred at the 
age of 14 years and menopause at the age of 
43 years.
On admission (Fig. 1) the diaphragm was 
noted to be elevated; air entry to both lungs 
was reduced, but she was not short of breath 
when sitting at rest. Blood pressure was 140/ 
70 mm Hg in the upright and supine positions. 
The veins of the anterior abdominal wall were 
dilated; the abdomen was massively distended, 
symmetrical and tense. A fluid thrill was pre­
sent; shifting dullness was not demonstrable. 
Both legs were edematous up to the groin.
Fig. 1.—Patient on admission showing massive 
symmetrical abdominal distension, dilated super­
ficial veins in anterior abdominal wall, dwarfed 
stature and alopecia.
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The patient’s hematologic values, urinalysis, 
biochemistry values (liver function tests, elec­
trolytes, creatinine), blood gases and electro­
cardiogram were normal. Chest radiography 
confirmed the diaphragmatic elevation and 
consequent reduction of lung fields; intraven­
ous pyelography suggested an abdominal tu­
mour, partially compressing both ureters.
At laparotomy, a smooth, thick-walled cyst, 
which arose from the right ovary, filled the 
peritoneal cavity. Adhesions between the mass 
and the anterior and posterior parietal perito­
neum, omentum and bowel were divided by 
blunt and sharp dissection leaving raw surfaces 
that could not be covered. After insertion of 
a trocar, 14 / of fluid was slowly drained from 
the mass to permit delivery from the abdomen. 
The ovarian cyst was then removed intact fol­
lowing closure of the drainage opening with a 
purse-string suture. The small uterus and atro­
phic left ovary were removed without diffi­
culty.
Ascites and dependent edema developed 
over the first 3 postoperative days. The se­
rum protein concentration, which was 5.5 
g/dl (albumin:globulin ratio, 3.8:2.8) preoper- 
atively, decreased to 3.7 g/dl (A:G ratio, 
2.7:2.0) by the 3rd day. During the same in­
terval, the hemoglobin concentration decreased 
to 9.1 g/dl from 11.4 g/dl. For 2 days she was 
transfused with albumin (100 g), two units of 
whole blood and two units of packed cells. 
The ascites and edema rapidly cleared and on 
the 7th day the serum protein concentration 
was 6.5 g/dl (A:G ratio, 3.7:2.8) and the he­
moglobin value, 10.6 g/dl. Her postoperative 
course was otherwise uneventful. She was dis­
charged on the 9th day and was well when 
last seen, 6 weeks after the operation.
Anesthesia
Premedication of atropine was given 1 hour 
before operation. Following 5 minutes of oxy­
genation, a “crash induction” was undertaken 
with thiopentone and succinylcholine. As the 
abdominal mass interfered with the handle of 
the laryngoscope, intubation could be accom­
plished only with the head turned 60° to the 
side. Anesthesia was maintained with nitrous 
oxide, oxygen 4.2 //min. and halothane 0.5%. 
Using manual ventilation a pressure of 48 cm 
H20  was required to obtain a tidal volume of 
500 ml. After removal of the abdominal tu­
mour, 12 cm HsO airway pressure created the 
same tidal volume. During drainage of the 
cyst, metaraminol bitartrate (Aramine, 1 mg 
intravenously) was given to prevent hypoten­
sion. Total fluid replacement during the 2-hour
operation was 1000 ml Ringer’s lactate solu­
tion. During the first 24 hours after operation, 
the blood gases and biochemical values re­
mained in the normal range and there was no 
hypotension.
Pathology
The smooth, thick-walled, partially deflated 
cystic mass weighed 18 kg; it was multilocular 
with solid plaque-like areas on the inner sur­
face. Microscopic examination confirmed the 
diagnosis of a mucinous cystadenoma. Focal 
areas of Brenner tumour were found in the 
cyst wall.
D iscussion
The giant cystadenoma weighed approxi­
mately 32 kg (weight of fluid plus pathology 
specimen) and accounted for 48% of this 
woman’s preoperative weight. The huge size 
of the tumour could be attributed to patient 
neglect as the tumour was benign and the 
history of increasing abdominal girth span­
ned 4 years. The presentation in a dwarfed 
woman made the appearance more dramatic, 
but is probably only circumstantial.
Most, but not all, giant ovarian tumours 
are benign. The ovarian cyst is commonly 
mistaken for ascites; resultant paracentesis 
may delay treatment. In malignant ovarian 
cysts, paracentesis may result in the spillage 
of neoplastic cells into the peritoneal cavity. 
This case underlines the necessity for care­
ful investigation. The initial impression was 
that the patient had an advanced malignant 
condition; simple palliative measures would 
have been unfortunate.
Histologically, most giant tumours are 
mucinous cystadenomas in adults and be­
nign cystic teratomas in young women. ’1 The 
association of the mucinous and Brenner 
elements in the tumour of our patient is not 
unexpected, since both elements arise from 
the same stem cell.- Every effort should be 
made to remove cystadenomas intact. Ma­
lignant degeneration of benign mucinous 
cysts has been found in 5 to 15% of cases.- 
This possibility and the danger of pseudo­
myxoma peritonei should make the physi­
cian especially careful to remove cysts intact 
without spilling the contents.
Visceral and peritoneal adhesions from 
these cysts have been described in the ma­
jority of patients; we were able to free these
March 1977 THE CANADIAN JOURNAL OF SURGERY 155
with varying degrees of difficulty. Although 
not a problem in our patient, partial resec­
tion of the cyst wall and, rarely, marsupial­
ization of the cyst to the abdominal wall 
were required in other cases in which there 
were dense adhesions.The pathogenesis of 
the adhesions is unclear; however, they could 
result from a foreign-body giant-cell reaction 
due to a leakage of fluid, or from subclin- 
ical trauma to the cyst wall, such as friction 
during respiration with resulting hemorrhage 
and necrosis.
The raw peritoneal surface that remained 
after the adhesions were resected led to 
the loss of blood and protein-rich fluid into 
the peritoneal cavity. The resulting fall in 
intravascular osmotic pressure further con­
tributed to the ascites and dependent edema. 
Paracentesis would only aggravate this loss 
of serum protein. The administration of in­
travenous albumin and whole blood can be 
curative as it was in our case.
The edema of the lower limbs and the di­
lated superficial veins over the abdomen are 
evidence of inferior vena caval compression. 
The patient did not demonstrate supine hy­
potension, which may occur with large pelvic 
tumours and during late pregnancy. When 
present, supine hypotension is relieved by 
turning the patient into the lateral recum­
bent position. In our patient, the long history 
may have permitted formation of an ade­
quate collateral venous return; postoper- 
atively she did not suffer from chronic su­
pine hypotension. This complication may 
occur and is presumed to result from ex­
tensive pooling of blood in the expanded 
venous space.
The difficulty we experienced in intubat­
ing our patient was unique but was easily 
overcome by a change in her head position. 
In the anesthetic management of patients 
with giant abdominal tumours adequate ven­
tilation pressures must be established to 
overcome the compression effect on the 
diaphragm and to allow for correction of 
any blood-gas or acid-base imbalance. Dur­
ing drainage of large masses containing pro­
tein-rich fluid, hypotension may occur; the 
prophylactic vasopressor given to this patient 
masked or prevented this effect. After sur­
gery, the relief of vena caval compression 
may result in hypertension due to the sud­
den improvement in venous return as hap­
pened in our patient. Fluid administration 
initiated before operation may over-expand 
the vascular volume and also contribute to 
postoperative hypertension.6 Our patient had 
no problems with blood pressure.
In Canada, where medical care is easily 
accessible and surgical intervention for ova­
rian masses is prompt, giant ovarian tumours 
should be almost unknown. When such 
cases are seen it is important to recognize 
the benign nature of the lesion, to try and 
remove the lesion intact and to understand 
the potential complications so that they may 
be prevented.
We thank Dr. W. Noble, department of anesthe­
siology, for advice in the preparation of this 
manuscript and Mrs. S. Sumar for secretarial 
assistance.
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METHYSERGIDE THERAPY CAUSING VASCULAR INSUFFICIENCY
OF THE UPPER LIMB*
F. M. AMELI, MB, ChB, FRCS(Edin), FRCS[C], M. NATHANSON, MD, FRCP[C]
and I. ELKAN, MD, FRCP[C]
A 41-year-old woman, who was receiving methy- 
sergide maleate for the treatment of severe 
headaches, had occlusion of the left brachial 
artery, confirmed by arteriography. The occlu­
sion was believed to result from the use of me- 
thysergide and the drug was therefore with­
drawn. Within 4 days the distal pulses were nor­
mal, as confirmed by arteriography, and she was 
asymptomatic.
Une femme de 41 ans ayant regu du maleate de 
methysergide pour le traitement de cephalees 
intense, a souffert d'une occlusion de I'artere 
brachiale gauche, confirmee a I'arteriographie. 
On a cru que I'occlusion pouvait avoir ete cau- 
see par le methysergide, et on en cessa done 
I'administration. En quatre jours les pouls des 
extremites sont devenus normaux, tel que con­
tinue a I’arteriographie, et il y a eu disparition 
des symptomes.
M ethysergide (1, methyl-d-lysergic acid 
butanolamide; Sansert) therapy commonly 
causes mild transient side effects, such as 
diarrhea, nausea and vomiting. Certain cen­
tral nervous system symptoms such as drow­
siness, nervousness, insomnia, euphoria, ex­
citement and confusion may also occur. We 
present the unusual case of a woman who 
suffered transient brachial artery occlusion 
after receiving methysergide for the treat­
ment of vascular headaches.
Case R eport
A 41-year-old white woman was admitted to 
hospital from the outpatient department com­
plaining of numbness in the left hand. She 
had been admitted 2 years before with acute 
pyelonephritis and nephropathy following in­
gestion of analgesic drugs over a period of 10 
years. After discharge, as had been her cus­
tom, she continued to take propoxyphene hy­
drochloride (Darvon) and to smoke two pack-
*From the departments of surgery, medicine and 
radiology, Toronto East General and Orthopaedic 
Hospital and the University of Toronto, Toronto, 
Ont.
Reprint requests to: Dr. F. M. Ameli, Ste. 9, 
900 Coxwell Ave., Toronto, Ont. M4C 3G2.
ages of cigarettes daily. Two months before 
coming to the outpatient department methy­
sergide bimaleate (2 mg tablets) was pre­
scribed by her family physician for treatment 
of continuing severe headaches; she took two 
to three tablets daily.
On admission to hospital her blood pressure 
was 130/70 mm Hg in the right arm; no blood 
pressure was obtainable in the left arm. The 
left hand was cold and pale and no radial or 
ulnar pulses were palpable. The remainder of 
the physical examination was unremarkable.
Results of the laboratory investigation were 
as follows: hemoglobin value, 13.3 g/dl; ery­
throcyte sedimentation rate, 5 mm/h; serum 
creatinine value, 2.2 mg/dl; blood urea nitro­
gen concentration, 12 mg/dl; serum choleste­
rol concentration, 228 mg/dl and serum tri­
glyceride concentration, 96 mg/dl. Coagula­
tion studies were normal.
An arteriogram showed occlusion of the 
left brachial artery just beyond its origin (Fig. 
1). There was delayed filling of the radial and
Fig. 1.—Occlusion of left brachial artery.
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ulnar vessels in the forearm (Fig. 2). These 
vessels were in a state of severe spasm.
After review of the radiographs and discus­
sion of the patient’s previous drug therapy, it 
was concluded that the vascular occlusion could 
have resulted from the use of methysergidc. 
Accordingly the drug was withdrawn. Within 
4 days the distal pulses returned to normal and 
the patient became asymptomatic. Codeine was
Fig- 2.—Delayed filling of left brachial radial 
and ulnar arteries.
prescribed after her discharge and she was ad­
vised to stop smoking. Repeat arteriography 
1 month later showed the vessels in the left arm 
to be normal (Fig. 3). The patient has remained 
asymptomatic.
D iscussion
Methysergide is a congener of lysergic 
acid diethylamide (LSD). It is an ergot 
^derivative but has only slight vasocon­
strictor and oxytoxic activity. It has been
Fig. 3.—Normal brachial artery after withdrawal 
of methysergide.
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found valuable in the prophylactic treatment 
of migraine and other vascular headaches, 
but is not effective when given during acute 
attacks. Since the pathophysiology of mi­
graine is not fully known, it is not certain 
whether the prophylactic benefit of methy- 
sergide is the result of central or peripheral 
activity; in addition it is still unclear why me- 
thysergide is effective in migraine prophy­
laxis.
Methysergide commonly causes mild tran­
sient side effects involving the gastrointes­
tinal tract; occasionally there may be side 
effects on the central nervous system. A rare 
but potentially serious complication of its 
prolonged use is inflammatory fibrosis caus­
ing retroperitoneal, pleuropulmonary or co­
ronary and endocardial fibrosis.1 This fibro­
sis usually regresses after withdrawal of the 
drug, but occasionally surgical intervention 
is necessary. Persistent cardiac valvular dam­
age has been reported.2 Methysergide has 
been implicated in the exacerbation of an­
gina pectoris and in the pathogenesis of vas­
cular occlusion at a variety of sites, includ­
ing the lower limbs,3 the coronary arteries,4 
the superior mesenteric artery5 and the aor- 
ta.''1 Occlusion of blood supply in the upper 
limb has been mentioned in the literature7 
but not confirmed by arteriography.
We thank the department of photography at 
the Toronto East General and Orthopaedic Hospi­
tal for the preparation of the illustrations.
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CHRONIC SUBPHRENIC ABSCESS: THE MISSED DIAGNOSIS*
G. A. C. MILNE, MD, FRCS[C] and I. W. GEERE, MB, ChB, FRCP[C]
This report of a case of chronic subphrenic 
abscess, with a brief review and recommenda­
tions for diagnosis and prevention, draws atten­
tion to this clinical entity as a potential cause of 
chronic ill health. The clinical presentation and 
laboratory findings in this case were unremark­
able. It is clear that the condition can be easily 
missed and the patient may be exposed unneces­
sarily to prolonged illness and to inappropriate 
investigation and therapy.
Ce rapport d'un cas d'abces chronique de la re­
gion sous-diaphragmatique, accompagne d’une 
breve revue et de recommendations sur son 
diagnostic et sa prevention, vise a attirer I'atten- 
tion sur cette entite clinique comme cause pos­
sible d’un etat maladif chronique. Le tableau 
clinique et les resultats d’analyses de labora- 
toire n'offraient rien de particulier. II est evident 
que cette affection peut facilement ne pas etre 
decelee et le patient peut alors etre inutilement 
expose a une maladie prolongee, et a des exa- 
mens et traitements inadequats.
A lthough  reports of a delayed manifesta­
tion of subphrenic abscess have appeared in 
the literature,1-4 their apparent scarcity sug­
gests either that the condition is rare or that 
it goes unrecognized and contributes to the 
pool of patients with chronic ill health. These 
considerations have prompted us to report 
a case of subphrenic abscess in a 20-year- 
old woman who presented with a 6-week 
history of chest pain, fever and weight loss 
6 months after appendectomy.
Case R epo rt
A 20-year-old Caucasian woman (weight, 
51.6 kg) had a 6-week history of chest pain, 
fever, chills and weight loss (2.25 to 2.7 kg). 
The pain, described as dull, dragging, or pull­
ing, was present in the right upper chest and 
the right posterolateral aspect of the neck; the 
patient attributed the neck pain to muscle 
strain caused by curling. During the previous 
6 weeks the pain had moved to the right lower 
chest and was worse on deep breathing. Two 
weeks before admission, she had sought med­
ical advice elsewhere and, after results of a 
chest radiograph were negative, was treated
*From the departments of surgery and pathology, 
University of Saskatchewan, Plains Health Centre, 
Regina, Sask.
Reprint requests to: Dr. I. W. Geere, Department 
of pathology, Plains Health Centre, 4500 Wascana 
Parkway, Regina, Sask. S4S 5W9.
for pulmonary embolism, but her condition did 
not improve.
On physical examination the patient ap­
peared slightly pale and anxious, but not great­
ly distressed. The temperature was 37.9°C; for 
the next 7 days before effective antibiotic the­
rapy was introduced it varied between 37 and 
39°C. The patient, a nonsmoker, had a slight, 
nonproductive cough, which had been present 
for 2 weeks. The only notable physical finding 
was diminished air entry in the right lower 
chest. A chest radiograph showed moderate 
elevation of the right hemidiaphragm and a 
small effusion in the right costophrenic angle. 
The lung parenchyma was normal. A lung 
scan at the time of admission and a liver scan 
7 days later were normal. Laboratory findings 
showed slight normocytic, normochromic ane­
mia (hemoglobin concentration, 10.9 g/dl); the 
total leukocyte count was 10.7x10V/ t64% 
polymorphs, 25% lymphocytes); the erythro­
cyte sedimentation rate was 71 mm/h (Wester- 
gren); the alkaline phosphatase concentration 
was increased slightly (109 TU/l) as was the se­
rum glutamic oxaloacetic transaminase (51 
IU//). Other concentrations of serum electro­
lytes were normal.
Aspiration of the effusion produced 4 ml 
of heavily blood-stained pus, which on gram 
staining showed two morphotypes of gram­
negative bacteria. Cultures of the material 
grew Escherichia coli and Bacteroides jragilis. 
This unusual finding in an otherwise active and 
healthy young woman prompted a review of 
the patient’s medical history, with the emphasis 
on possible intra-abdominal sepsis. We learned 
that the patient had undergone appendectomy 
6 months before for a ruptured appendix; this 
was followed by an episode of pneumonia that 
had resolved satisfactorily with antibiotic the­
rapy. Since then the patient had been normally 
active, but had experienced fatigue more 
readily.
Antibiotic therapy, which was originally ce­
phalexin (500 mg, bid, orally), was changed to 
gentamicin (60 mg, lid, IV) and clindamycin 
(600 mg, qid, IV); after 48 hours the patient’s 
fever resolved. After 4 days clindamycin was 
replaced by chloramphenicol (500 mg, qid, IV) 
because of the onset of diarrhea.
A liver scan and later a liver-lung scan were 
done, because an intra-abdominal abscess — 
more specifically a subphrenic collection of 
pus — was suspected. These studies disclosed 
a defect in the posterior aspect of the right lobe 
of the liver; the findings were consistent with
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the presence of a collection of pus. Subsequent 
surgical exploration by the Ochsner approach 
revealed a posterior subphrenic abscess con­
taining approximately 60 ml of pus. The abscess 
was drained. From the pus E. coli and B. fra- 
gilis were cultured. These organisms were 
found to be identical biochemically to the or­
ganisms originally isolated from the thorax. 
The patient’s subsequent course was satisfac­
tory.
Discussion
In standard texts of surgery too little em­
phasis is placed upon the recognition of 
subphrenic abscess. Delay in the manifesta­
tion of this condition caused Harley1 to 
classify the condition as chronic subphrenic 
abscess; he defined it as an abscess “which 
has been present for six or more months 
from the time of the causal condition”. Har­
ley described two patients in whom a sub­
phrenic abscess had been present for 10 
years.
As in our patient, the initial symptoms 
are usually vague —  chest pains, upper ab­
dominal discomfort, occasional fever and 
fatigue. Our patient’s only complaint until 
a month before definitive diagnosis was that 
she lacked energy. She subsequently experi­
enced neck and chest pain. Vague com­
plaints can lead to extensive unproductive 
investigation and at best palliative treat­
ment. At worst it can lead to repeated 
courses of inappropriate antibiotic therapy 
that may perpetuate the chronicity of the 
condition. Our patient was initially treated 
for pulmonary embolism.
Features in the diagnosis that are suspici­
ous of an infection are generally nonspecific 
— low hemoglobin, elevated leukocyte count 
and erythrocyte sedimentation rate, and low 
grade, intermittent, fever. In the present case 
these features were present; in addition, re­
sults of liver function tests were mildly ab­
normal. This focused our attention on the 
possibility of a subdiaphragmatic process. 
The radiograph of the chest showed a slight 
effusion and elevation of the diaphragm 
added further support to a subdiaphragmatic 
cause. When the effusion was found to be 
purulent and to contain organisms more 
commonly associated with intra-abdominal 
sepsis, further investigations were carried 
out to discover a possible focus of sub­
diaphragmatic sepsis.
Gold and Johnson5 have stated that 
“combined lung-liver scintillation imaging 
is a sensitive and accurate indicator of 
abscesses and other abnormal collections in 
the right subphrenic space”. This was cer­
tainly so in our case, where the results of the 
scan led to exploratory surgery.
Physical findings may be rare in cases of 
subphrenic abscess. There may be little ab­
normality in the chest unless the reactivation 
of the abscess produces a transdiaphragmatic 
inflammatory response. Such a response 
must be (as in our case) of sufficient magni­
tude to produce empyema or pneumonia. 
The absence of an upper quadrant mass in 
chronic cases is referred to by Harrison;3 
whether chronic or acute, the position of the 
abscess will determine the presence or ab­
sence of intrathoracic involvement.
A review of the patient’s surgical and ob­
stetric history is valuable and special con­
sideration should be given to a history of 
previous abdominal surgery. On the other 
hand, 15% of subphrenic abscesses are re­
ported to be without apparent antecedent 
cause.6
The antimicrobial treatment of peritonitis, 
whatever the cause, requires careful con­
sideration. It is argued by some that the ini­
tial therapy can arrest infection at the stage 
of “cellulitis”.2 Aminoglycosides alone in 
such cases can reduce early mortality but 
result in the production of intra-abdominal 
abscesses containing viable organisms.*7 This 
is due in part to the polymicrobic nature of 
peritonitis and the resistance of many anae­
robic organisms to the aminoglycoside anti­
biotics. Successful antibiotic treatment of 
peritonitis must include a drug active against 
the anaerobic organisms that predominate 
in such cases. Currently, either chloramphe­
nicol or clindamycin, usually combined with 
an aminoglycoside are the drugs of choice 
for systemic therapy. Nelson, Kuzman and 
Cohn,8 make a strong case for intraperi- 
toneal lavage with kanamycin after intra­
operative soiling of the peritoneum.
Conclusions
The case presented draws attention to a 
condition with considerable potential for 
chronicity. The nonspecific complaints and 
the unremarkable results of the laboratory 
investigations should encourage the con-
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sideration of chronic subphrenic abscess in 
any differential diagnosis. It is likely that 
repeated doses of relatively ineffective anti­
biotics may perpetuate the condition.
The following points should receive con­
sideration for the prevention and diagnosis 
of chronic subphrenic abscess.
1. Adequate antimicrobial therapy should 
be instituted following surgical or traumatic 
contamination of the peritoneal cavity. Sys­
temic antimicrobial therapy for a period of at 
least 10 days with an aminoglycoside in com­
bination with either clindamycin or chloram­
phenicol is recommended. In addition peri­
toneal lavage with normal saline followed by 
kanamycin solution may be used.
2. Following discharge from hospital, 
such a patient should be reviewed for a pro­
longed period of time; chronic subphrenic 
abscess may develop years after surgery.
3. Special consideration should be given 
to the patient with nonspecific complaints, 
such as fatigue and occasional fever, whose 
laboratory findings include slight leukocyto­
sis and slightly elevated serum alkaline phos­
phatase and aminotransferase enzyme con­
centrations. These findings should arouse 
strong suspicion of a chronic subdiaphrag- 
matic abscess and prompt a careful review
of the past surgical and obstetric history. The 
patient should be investigated with a com­
bined liver-lung scan, a radiograph of the 
chest and a gastrointestinal series; visceral 
displacement due to a mass should be speci­
fically looked for on the gastrointestinal ra­
diograph.
Definitive treatment of the abscess is sur­
gical with antibiotics playing an adjunctive 
role.
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SUBCAPITAL FRACTURE OF THE HIP: A RARE COMPLICATION OF 
INTERTROCHANTERIC FRACTURE OF THE FEMUR*
GORDON A. HUNTER, MB, FRCS, FRCSfC] and ARUN MEHTA, MB, FRCS(Edin)
Three cases of subcapital fracture of the hip that 
occurred after an intertrochanteric fracture of 
the femur had been nailed have been described 
in the literature. The tip of the nail failed to pene­
trate the femoral head and a stress fracture oc­
curred in two at the tip of the nail and in the 
other at the tip of a blade plate. This paper re­
ports three further cases of this recently recog­
nized and rare complication of intertrochanteric 
fractures. It is emphasized that the condition 
must be recognized and treated without delay.
La litterature decrit trois cas de fracture de la 
tete de la hanche qui sont survenus apres qu'une 
fracture inter-trochanterienne du femur eut ete
*From the division of orthopedics, St. Michael’s 
Hospital, and the University of Toronto, Toronto, 
Ont.
Reprint requests to: Dr. G. A. Hunter, Ste. 202, 
55 Queen St. E., Toronto, Ont. M5C 1R5.
reparee avec un clou —  le bout du clou ne reus- 
sissant pas a penetrer la tete femorale et une 
fracture par stress se produisant, dans deux cas, 
au bout du clou, et, dans le troisieme, au bout 
d'une plaque. Cette publication signale trois au- 
tres cas de cette complication rare des frac­
tures inter-trochanteriennes qui n'a ete reconnue 
que recemment. On souligne I’importance de sa- 
voir reconnaitre cet etat et de le traiter sans 
delai.
We report herein three cases of subcapital 
fracture of the hip that occurred after an in­
tertrochanteric fracture of the femur had 
been nailed. Only three other cases have been 
reported in the literature: Tronzo1 described 
two cases in which fracture occurred at the 
tip of the nail in the subcapital region of the 
neck and Cameron and associates2 reported
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Fig. lb
Fig. 1.—Case 1. (a) Internal fixation with Rich­
ards screw and plate of trochanteric fracture in 60- 
year-old man. (b) Subcapital fracture 9 months 
after internal fixation of trochanteric fracture.
one in which fracture occurred at the tip of 
a blade plate. Our three cases are docu­
mented so that others will be made aware of 
this rare complication. In addition we sug­
gest possible etiologic causes and define ways 
of preventing such a complication.
C ase R eports
Case I .—Three years after a right upper 
lobectomy for squamous cell carcinoma of the 
lung a 60-year-old man was admitted with a 
trochanteric fracture of the left hip. The frac­
ture was reduced and internally fixed with a 
Richards screw and plate (Fig. la). Because of 
the patient’s history of neoplastic disease a 
biopsy of the trochanteric region was taken, 
but the specimen was free of neoplastic de­
posits.
The patient was readmitted 9 months later 
with pain in the left hip. Radiographs suggested 
a subcapital fracture of the left femur (Fig. 
lb). Nine days later a total hip replacement was 
performed. Two weeks after replacement sur­
gery a hematoma developed; it was evacuated 
and the wound debrided. Cultures of the wound 
grew Pseudomonas sp. The patient was treated 
with appropriate antibiotics. Wound drainage 
ceased after 3 weeks but a deep infection was 
suspected. At the time of writing the patient 
has a dry wound; he can walk with one cane 
and has an adequate range of hip movement. 
His progress is being monitored carefully be­
cause we suspect he may require excision 
arthroplasty.
Case 2.—A 79-year-old woman was ad­
mitted with an intertrochanteric fracture of 
the left hip (Fig. 2a). This was treated by a 
medial displacement osteotomy. Fixation was 
achieved with a Thornton nail plate (Fig. 2b); 
however, a revision was necessary 3 weeks la­
ter at which time the fracture was immobilized 
with a Richards screw and plate (Fig. 2c).
Almost 9 months later the patient com­
plained of pain in the left hip. Radiographs 
demonstrated a subcapital fracture. The patient 
was confined to bed or chair, she had fecal and 
urinary incontinence and was suffering from 
senile dementia. Therefore we decided that no 
further procedure was necessary or advisable.
Three years later the patient was still alive 
but was unable to walk.
Case 3.—A 71-year-old woman was admitted 
with an intertrochanteric fracture of the right 
hip (Fig. 3a). The fracture was reduced and 
internally fixed with a Richards screw and 
plate (Fig. 3b). Approximately 8 months later 
the patient was readmitted complaining of hip
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pain. The Richards screw and plate were re­
moved, but the pain persisted. Tomography 1 
year after the original operation demonstrated 
a subcapital fracture o f the femoral head 
(Fig. 3c). The femoral head was excised and 
replaced with a cemented Thompson prosthesis. 
The patient recovered quickly and is doing 
well.
Discussion
In each of the two cases described by Tron- 
zo1 of subcapital fracture following repair 
of an intertrochanteric fracture, the tip of 
the nail failed to pass into the femoral head. 
Under these circumstances Tronzo believed 
that the area just below the femoral head 
is exposed to an unusual weakening process 
resulting in a stress fracture at the tip of the 
nail. In one case the fracture was treated 
with an endoprosthesis and in the other the 
fracture healed after fixation with a com­
pression screw.1
Cameron and colleagues2 did not con­
sider this a fatigue or stress fracture in the 
usual sense. They believed that in their case 
fracture occurred at a point of stress con­
centration and the forces of the femoral head 
were transmitted into the stiff metal nail and
Fig. 2b Fig. 2c
Fig. 2.—Case 2. (a) Intertrochanteric fracture of left hip in 79-year-old woman, (b) Intertrochan­
teric fracture after fixation with Thornton nail plate, (c) Revision of original surgery with Rich­
ards screw and plate.
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then down the shaft. They called this a 
“stress-riser” fracture or a “Young’s modu­
lus” fracture. It is similar to fractures that 
occur at the level of the last screw in a bone 
plate. In view of the “stress-riser” effect, 
they concluded that the internal fixation de­
vice should be close to the subchondral bone 
in the femoral head and that the device 
should be removed as soon as possible. In 
their patient the femoral head had evidently 
lost its blood supply at the time of the sub­
capital fracture. Therefore, they recom­
mended that the fracture should be treated 
by joint replacement —  either unipolar with 
a long-stem Thompson or Moore prosthesis 
(as was done in our third patient) or with a 
bipolar replacement. A long-stem femoral 
component is recommended because the 
screw holes in the femoral shaft left by re­
moval of the blade plate act as “stress-risers”. 
If the stem of the prosthesis passes distal to 
these screw holes this “stress-riser” effect is 
largely nullified.
Etiology
The etiology of such fractures is specula­
tive, but may be due to one or more of the 
following:
1. A stress fracture, as suggested by 
Tronzo.1
2. A “stress-riser” fracture, as suggested 
by Cameron and colleagues.2
3. A previously unrecognized subcapital 
fracture associated with an intertrochanteric 
fracture.
4. The presence of soft bone (e.g., osteo­
porosis or neoplastic deposits within the neck 
of the femur may render the bone more 
liable to fracture following introduction of 
the internal fixation device and may even, 
on rare occasions, be caused by the intro­
duction of the device).
Prevention
In order to prevent this rare complication 
of intertrochanteric fracture of the hip the 
following factors should be stressed.
Fig. 3c
Fig. 3.—Case 3. (a) Intertrochanteric fracture of right hip in 71-year-old woman, (b) Repair of 
intertrochanteric fracture with Richards screw and plate, (c) Subcapital fracture following removal of 
internal fixation device.
I
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1. The femoral nail or screw should be in­
serted close to the subchondral layer of the 
femoral head.
2. The internal fixation device should be 
removed as soon as fracture healing is sound.
3. An attempt should be made to stabilize 
an unstable fracture in order to secure frac­
ture healing by means of displacement osteo­
tomies, the use of bone graft or even bone 
cement.
4. Following removal of the internal 
fixation device it may be advisable to insert 
bone graft chips into the femoral neck and 
head.
A ddendum
After this paper was accepted for publica­
tion, we noted a report by D. M. Baker,:f who 
described three patients in whom a femoral 
neck fracture developed at least 1 year after a 
healed intertrochanteric fracture of the femur. 
Each patient appeared to have had a second 
fall. The prognosis for this second injury was 
poor — one patient had nonunion of the fe­
moral neck fracture and the other two required 
a Girdlestone procedure.
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RADIOLUCENT URINARY CALCULUS IN A TRANSPLANT PATIENT: 
AN UNSUSPECTED CAUSE OF URETEROPELVIC OBSTRUCTION*
MARTIN G. McLOUGHLIN, MD
The occurrence of nephrolithiasis and nephro- 
calcinosis in the patient who has undergone a 
renal transplant is rare and is usually related to 
parathyroid hypersecretion. A case is presented 
in which the patient had a radiolucent stone that 
arose as a result of the use of nonabsorbable 
sutures. It is clear that nonabsorbable sutures 
should be avoided in renal allotransplant reci­
pients.
L'apparstion d'une nephrolithiase et d’une ne- 
phrocalcinose chez le patient qui a subit une 
greffe renale est un evenement rare qui est habi- 
tuellement relie a une hypersecretion de la para- 
thyroide. On presente un cas ou le patient etait 
porteur d'un calcul translucide aux rayons-x dont 
la formation est due a I'emploi de sutures non­
absorbables. II est clair qu'on devrait eviter ('uti­
lisation des sutures non absorbables chez les 
receveurs d'allogreffes renales.
Th e  recipient of renal transplant who has 
a functioning graft has the ability to pro­
duce the active form of vitamin D (1, 25- 
dihydroxycholecalciferol) resulting in a fair­
ly stable state of calcium metabolism. Rare-
*From the department of urology, Brady Urolo­
gical Institute, Johns Hopkins Hospital, Baltimore, 
MD.
Reprint requests to: Dr. M. G. McLoughlin, De­
partment of urology, Johns Hopkins Hospital, Bal­
timore, MD 21205.
ly does hyperparathyroidism result in hyper­
calcemia, hypercalcuria and nephrocalcino- 
sis or urinary calculi. Obstruction of the 
ureteropelvic junction developed at the 
anastomotic site of ureteral pyelostomy in 
our patient 3 years after renal allotrans­
plantation. At operation we found a radio­
lucent stone that contributed to the obstruc­
tion.
Case R eport
Chronic renal failure secondary to chronic 
glomerulonephritis developed in a 56-year-old 
man; a kidney donated by his brother was 
placed in the left renal fossa. Because of a short 
ureter, the preferred ureteral neocystotomy 
could not be done; instead the patient’s ureter 
was anastomosed to the donor pelvis with a 
running 6-0 polypropylene (Prolene) suture. 
Five days after transplantation the patient 
underwent reoperation for a large pyelocuta- 
neous fistula; this was closed with running 6-0 
Prolene suture. Postoperatively he did well 
and was discharged 7 days after the second 
operation.
The patient was admitted to hospital 3 years 
later with hematuria, mild hypertension (dias­
tolic pressure, 100 mm Hg) a serum creati­
nine concentration of 1.5 mg/dl, a serum cal­
cium concentration of 8.7 mg/dl and a uric 
acid concentration of 7.6 m g/dl. A radiograph
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of the abdomen showed no calcification in 
the area of the renal graft or ureter (Fig. 1). 
Intravenous urography showed obstruction at 
the ureteropelvic junction (Fig. 2) and retro­
grade pyelography confirmed the obstruction. 
At operation, the ureter was traced up to the 
ureteropelvic junction, which was encased in 
dense scar tissue; a stone (diameter, 1 cm) was 
found at the ureteropelvic junction attached to
Fig. 2.—Intravenous urogram demonstrating 
obstruction at ureteropelvic junction in renal 
allograft.
the Prolene suture. The stone was removed; 
on analysis it contained oxalate, phosphate and 
a small quantity of calcium. A no. 8 feeding 
tube was placed down the ureter and into the 
patient’s bladder; this was used as an internal 
stent. Any attempt to close the pyelotomy 
would have resulted in stenosis; we were not 
able to mobilize tissues to perform a YV 
plasty. Therefore, an incision was made in the 
kidney capsule and a rotational capsule flap 
was formed, suturing the capsule over the 
pyelotomy with interrupted 4-0 Dexon sutures. 
Postoperatively ileus developed; on the 7th 
day after operation the patient suffered a 
subendocardial myocardial infarction. Fortun­
ately his recovery was uneventful. On the 14th 
postoperative day the internal stent was re­
moved; intravenous pyelography showed no de­
lay in function (Fig. 3). The serum creatinine 
concentration was 1.0 mg/dl. The patient is 
no longer hypertensive and has been dis­
charged from hospital.
D iscussion
Reports in the literature on nephroli­
thiasis and nephrocalcinosis in transplant 
recipients emphasize that most urinary cal­
culi are related to parathyroid abnormali­
ties.-'4 Steroid administration can result in 
increased phosphorus excretion with second­
ary hypercalcemia, and the production by 
the functioning graft of 1, 25-dihydroxy- 
cholecalciferol can increase calcium absorp­
tion from the intestine; however, these
Fig. 3.—Intravenous pyelogram 2 weeks after 
operation demonstrates good function and pat­
ent ureteropelvic junction.

In treating any serious infection involving gram-negative organisms, 
PYOPEN makes a lot of sense.
Because PYOPEN is a penicillin, it provides the traditional margin of 
safety common to all penicillins.
PYOPEN is free from dose-related toxicities, yet it provides bactericidal 
effectiveness against Pseudomonas aeruginosa and other gram-negative 
organisms including Proteus species often resistant to other antibiotics.
If a gram-negative infection is suspected,make sure you request a 
PYOPEN sensitivity test.
CONTRAINDICATIONS: C arbenic illin  shou ld  no t be used in pa tien ts  w ith  a h is to ry  o f pen ic illin  or cepha lospo rin  allergy. C a rben ic illin  is 
hydrolyzed by s taphylococcal beta-lactamase and is, therefore, con tra ind ica ted  in in fections caused by beta-lactam ase-producing 
s taphylococci. PRECAUTIONS: The same as fo r pe n ic illin  G. Resistant o rganism s have arisen during  trea tm en t. Adequate dosage 
should therefore be m ainta ined and in te rm itte n t sens itiv ity  tes ts  carried out. W ith  high doses o f  PYOPEN the  co ncom itan t ad­
m in istra tion  o f sodium  may be hazardous in pa tien ts  w ith  serious cardiac disease. One g o f PYOPEN co n ta in s  6.5 mEq o f sodium  ion. 
Therefore, large doses o f the  drug should be adm in is te red  w ith  cau tion  to  patients w ith  congestive heart fa ilure, severe hypertens ion , or 
edema. ADVERSE REACTIONS: Similar to  those  reported w ith  pe n ic illin  G. A lso reported: pain and rashes at s ite  o f i.m. in je c tio n ; th ro m ­
boph leb itis  a fte r pro longed adm in istra tion; p ru ritus; eos inoph ilia ; nausea; occasional rise in SGOT and a lka line  phosphatase levels; one 
case o f an unexplained d rop  in hem oglobin level; one case o f seizure in a hem ip leg ic  patient on h igh  doses and one case o f increased 
m uscle weakness in a pa tient w ith m yasthenia gravis have been reported. Prolonged b leeding time has been reported in 22 o f a series o f 
30 patients receiving between 500 and 750 m g /k g  d a ily  o f PYOPEN during 14 days (g iv ing  blood levels o f 200-400 ^ g /m l). A ggregation  o f 
p latelets by adenosine diphosphate was decreased in all 30 patients. The defect appeared within 12 hou rs  a fte r s ta rting  therapy and to o k  
from 3 to 7 days to  disappear a fter d isco n tin u in g  the drug. Two women receiving 30 g o f  PYOPEN da ily  deve loped hypokalem ia a fte r 7 
and 9 days respectively. Potassium levels were 2 and 1.5 m E q /l. Oral potassium  ch lo ride  rapidly co rrected  th e  e le c tro ly te  d isorder. 
DOSAGE: Relatively h igh  doses of carben ic illin  are required in the  treatm ent o f severe Pseudomonas in fe c tio n s . ADULTS— Severe and 
overwhelm ing in fec tions  (septicem ia, extensive burns and w ounds, pneum onia, m en ing itis , periton itis): 12 to  30 g da ily  in travenously  or 
by infusion w ith  or w ith o u t 1 g of probenecid o ra lly  3 tim es da ily. In m oderately severe infections: 1 g every 4 hours for 5 to  10 days. 
CHILDREN — Dosage, accord ing to w eight and age and severity o f in fec tion , may vary from  100-300 m g /k g /b o d y  weight. AVAILABILITY: 
V ials con ta in ing : 1 g o r 5 g carbenic illin . C om plete p rescrib ing  in fo rm a tion  and references available on request.
Only regular sensitivity testing will tell 
you how effective PYOPEN can be 
in treating;
Q uality has 
no substitute
A Y E R S T  LAB OR ATOR IES
D iv is io n  o f  A ye rst, M cK e n n a  & H a rr is o n  L im ite d  M o n tre a l, C anada 
Made in Canada by arrangem ent w ith  BEECHAM, INC.
5 2 5 0 /3 /6 /E
176 THE C AN ADIAN JOURNAL OF SURGERY Vol. 20
factors usually do not result in the produc­
tion of hypercalcemia and hypercalcuria. In 
our case the ureteropelvic junction was 
stenotic and a urinary calculus was attached 
to a Prolene suture. The calcium determina­
tions in this patient were within normal 
limits, suggesting that the stone was formed 
as a direct result of the use of Prolene. We 
used Prolene in difficult urologic procedures 
because our experience with absorbable 
sutures had been unsatisfactory and because 
we were able to repair many urologic com­
plications with Prolene.r> Thus, it may be 
that while we resolved one complication, 
we laid the groundwork for secondary com­
plications, because prolonged exposure of 
the nonabsorbable Prolene suture to urine 
resulted in stone formation. For this reason, 
we now use polyglycolic acid sutures in re­
constructive urologic procedures involving 
renal allotransplant recipients. In the present 
case, after opening the stenotic ureteropelvic 
junction and removing the calculus, the large 
defect was reconstructed by use of a renal 
capsular flap; this maneuver provided ade­
quate drainage with a leak-proof closure.
Nonabsorbable suture material utilized in 
reconstructive ureteropelvic surgery may 
provide a nidus for stone formation in the 
immunosuppressed patient. The stone in our 
patient was radiolucent; at operation it was 
found to be the unsuspected cause of an 
obstructive uropathy. It is important that 
this clinical entity be recognized as a possibi­
lity in preoperative planning for the treat­
ment of obstruction at the ureteropelvic 
junction in renal allotransplant recipients.
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CORRESPONDENCE
GASTROINTESTINAL HORMONES
To the editor: The study of gastrointestinal 
hormones is a rapidly advancing field that 
has generated much interest. Because of the 
speed at which advances are being made it 
seems that a number of points outlined in a 
recent review article by S. N. Sullivan on 
gastrointestinal hormones in this journal 
(19:295, July 1976) require clarification.
The Author states that the APUD cells 
found in the pituitary gland, thyroid gland, 
adrenal gland, pancreas, lungs and gastroin­
testinal tract are believed to be of neuroecto­
dermal origin. There is evidence that the C 
cells in the thyroid do migrate from the neu­
ral crest; however, two studies1- - have pro­
vided evidence that the cells of the pancreas 
and gastrointestinal tract do not originate 
from the neural crest. These studies stress 
that the APUD characteristics are not suffi­
cient criteria to substantiate the neural crest 
origin of these cells.
Gastrin is synthesized in antral and duo­
denal G cells. The adult human antral muco­
sa contains 10 times more immunoreactive 
gastrin (IRG) than the duodenal mucosa; the 
adult pancreas contains no IRG. However, 
IRG has been found in the pancreatic glands 
of the human, rat and calf fetus. The pan­
creatic a j  cell does not contain gastrin. The 
pancreatic D cell has been shown to contain 
somatostatin.
Four major components of gastrin have 
been identified in serum and tissue extracts. 
Mini-gastrin, the smallest of these compo­
nents, has recently been found to contain 14 
instead of the originally described 13 amino 
acids; therefore, it is referred to in the 
Walsh nomenclature as G-14. Recent experi­
ments in man have shown that natural hu­
man G-17 has a half life of 6 to 7 minutes 
while natural human G-34 has a half life of 
40 to 45 minutes. With the information 
available, it is difficult to make a case for 
gastrin as a major determinant of normal 
lower esophageal sphincter pressure.
Regarding the Zollinger-Ellison syn­
drome, a recent review article, not cited by 
Sullivan,3 relates clinical aspects with bio­
chemical and morphologic characteristics of 
gastrinoma tissue. Two entries in Sullivan’s 
Table VIII are incorrect: some Zollinger-
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Ellison patients release gastrin after food and 
neither condition affects the pancreatic D 
cells, the somatostatin-producing cells. The 
incidence of hypergastrinemia resulting from 
G-cell hyperplasia is extremely rare. The sur­
gical procedure of choice in the Zollinger- 
Ellison syndrome is total gastrectomy, main­
ly because it has the best prognosis, since all 
gastrinomas seem to express their malignant 
potential through excess acid production.
In the section on enteroglucagon (gluca­
gon-like immunoreactivity [GLI]) Sullivan 
creates the impression that there is only one 
substance. Recently the Novo group4 isolated 
one GLI that contains 100 amino acids. This 
partially characterized GLI protein contains 
the 29-amino-acid glucagon sequence as a 
part of its carboxyl portion. The Novo group 
is precise in pointing out that this is one of 
probably a number of different GLI mole­
cules.
The WDHA or Verner-Morrison syn­
drome is probably a collection of a number 
of different diarrheal states. It has been sug­
gested that hormonal factors are involved in 
the etiology of these syndromes. Claims have 
been made for secretin, gastric inhibitory po­
lypeptide, vasoactive intestinal peptide and 
human pancreatic polypeptide as the etio- 
logic factor. To date, none of these claims 
have been substantiated. A more tenable ap­
proach is that the combined activities of a 
number of hormones cause this syndrome. 
This approach is supported by the relative 
high frequency of multihormonal pancreatic 
endocrine tumours.
A number of the conclusions drawn in the 
review article are premature. A thorough 
examination of the data available about the 
physiologic and pathophysiologic roles of 
different gastrointestinal hormones leads to 
the conclusion that we are only beginning to 
realize the problems involved in the accurate 
estimation and eventual interpretation of re­
sults regarding these different hormones.
N. S. T rack, ph  d
Department of surgery,
McMaster University,
Hamilton, Ont.
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To the editor-. In reply to Dr. Track’s com­
ments: for those who attempt to review a 
topic there is often an unsettling aspect to 
the “information explosion” —  yesterday’s 
fancy may be today’s fact, while today’s fact 
may be tomorrow’s fiction. When I dotted 
the last “i” and crossed the last “t” in my re­
view of gastrointestinal hormones it was as 
accurate as I could make it, but in the last 
analysis it is only my interpretation of the 
data that I had available.
Most of Dr. Track’s comments are valid, 
although 1 know more authoritative voices 
than mine would give him arguments on sev­
eral points. It is obvious that he has digested 
the meat of the matter and I am pleased to 
see that he did not miss the flavour. I can 
only reiterate the final statement in my pa­
per: “Much is still to be discovered.”
5. N. Sullivan, md
Royal Postgraduate Medical School,
University of London,
London, England.
CRITIQUE OF ITEM 350 (SESAP II)
Bradycardia can produce the symptoms ob­
served in Stokes-Adams attacks, in angina 
pectoris, or in association with congestive heart 
failure. Pacemakers have proven effective in 
controlling ventricular bradycardia. The use of 
a pacemaker should be considered for the in­
dividual who develops a complete heart block 
prior to an operation, because intrinsic brady­
cardia can interfere with cardiac response to 
hemodynamic changes imposed by a general 
anesthetic and operative manipulations. Of the 
choices presented, atrial fibrillation is the least 
likely indication for use of a temporary or per­
manent pacemaker. Q
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in Sabiston DC Jr (ed): (Davis-Christopher) 
Textbook of Sugery, ed 10. Philadelphia, WB 
Saunders Co, 1972, pp 2079-2099
when shock
threatens the lung
helps reduce pulmonary 
damage and increase ^  
survival rates.
•  preserves lysosome and cell membranes, thereby preventing the release of destructive 
lysosomal enzymes3
• preserves platelets thereby reducing the risk of intravascular coagulation'
•  preserves leukocyte integrity thereby helping to maintain the pulmonary architecture1
The recovery of patients in shock is often complicated by a pattern of deteriorating pul­
monary function, commonly described as shock lung. This pulmonary insufficiency 
progresses despite restoration of haemodynamic balance and apparent stabilization of 
the acute episode.
Cinder conditions of prolonged shock, lack of oxygen at the cellular level causes 
alterations in the oxygen-carbon dioxide exchange mechanism. These 
changes in cell metabolism lead ultimately to interstitial oedema and peri- 
■  w vascular haemorrhage.1 Polymorphonuclear leukocytes aggregate in
the pulmonary capillaries and obstruct the pulmonary vascular 
bed. As these trapped cells break down, they release lyso- 
somes, tiny subcellular particles containing proteolytic 
enzymes.’ These enzymes attack their host cell and 
go on to damage or destroy other cells.2 The re- 
m suiting tissue damage may not readily repair
itself even if the shock patient survives. 
When administered in conjunction with 
standard therapeutic measures, Solu- 
Medrol exerts a protective effect 
jj*  on the lung and improves the 
patient’s chance of survival.
Prescribing information on page 180
Upjohn
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In the treatment of shock  
and its pulmonary 
complications
Solu-Medrol
soon enough, often enough, 
in pharmacologic doses
Dosage and Administration: In treating severe 
shock, there is a tendency in current medical 
practice to use massive (pharmacologic) doses 
of corticosteroids. (The anti-inflammatory ac­
tivity of 1 mg of Solu-Medrol is equal to 4 mg 
or more of hydrocortisone.)
The suggested dosage of Solu-Medrol for 
severe shock is 30 mg/kg stat and repeated in 
four hours, if necessary.
Therapy is initiated by administering Solu- 
Medrol intravenously over a period of at least 
ten minutes. In general, therapy should be con­
tinued only until the patient's condition has 
stabilized — usually not beyond 48 to 72 hours. 
Solu-Medrol may be given by intravenous in­
jection, by intravenous infusion, or by intra­
muscular injection. The preferred method for 
initial emergency use is intravenous injection.
Cautions: The general precautions and con­
traindications to systemic corticosteroid therapy 
should apply to the use of Solu-Medrol. How­
ever, when used for medical emergencies, or 
in shock-like states, the possible lifesaving ef­
fects must be weighed against the possible 
undesired hormonal effects. In the treatment 
of shock, Solu-Medrol should be adjunctive to 
conventional supportive therapy such as fluid 
replacement, etc. Although adverse effects as­
sociated with high-dose short-term corticoid 
therapy are uncommon, peptic ulceration 
may occur.
Supplied: As Solu-Medrol (methylprednisolone 
sodium succinate) in 40 mg and 125 mg 
Mix-O-Vials; 500 mg and 1 g vials with water 
for injection.
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POSTOPERATIVE CONGENITAL HEART 
DISEASE. Edited by Ammon Rosenthal, 
Edmund H. Sonnenblick and Michael Lesch. 
166 pp. Illust. Grune & Stratton, Inc., New 
York; Longman Canada Limited, Toronto, 
1975. $16.75.
This book is a collection of review articles, 
mainly by clinicians, on the long-term post­
operative course of patients with congenital 
heart disease. The papers included were ori­
ginally published during 1975 in “Progress in 
Cardiovascular Diseases”. Taken as a whole 
this book is a complete discussion of the post­
operative clinical, radiologic and electrocardio­
graphic aspects of the most common congenital 
cardiovascular disorders; postoperative residua, 
sequelae and complications are well presented. 
Modern noninvasive techniques for patient 
assessment, such as vectorcardiography, ultra­
sound, radionuclide angiocardiography and ear 
oximetry are covered. Of particular interest is 
the chapter describing the experience with 
prosthetic valve replacement in children and 
the chapter on postsurgical myocardial per­
formance; we are reminded that despite suc­
cessful correction of the anatomic lesion, the 
pump function of the heart may remain sub­
normal.
This book will be useful to the pediatric 
cardiologist, the cardiovascular surgeon and 
the cardiologist whose practice includes adults 
who, as children, underwent repair of con­
genital heart defects.
O .  H. T e l x e i r a
Section of cardiology,
Children’s Hospital of Eastern Ontario,
Ottawa, Ont.
PROGRESS IN CARDIOLOGY 4. Edited by 
Paul N. Yu and John F. Goodwin, 224 pp. 
Illust. Lea & Febiger, Philadelphia; The 
Macmillan Company of Canada Limited, 
Toronto, 1975. $16.65.
This slim volume is the fourth in an annual 
series; the authors have selected specific topics 
in cardiac function and disease for an in-depth 
analysis and explanation.
Some chapters, such as those dealing with 
mitral valve prolapse, quantitative left ventri­
culography and the preservation of myocardium 
summarize present knowledge on topics of 
current interest. Others, particularly the chap­
ters on the genesis of the heart sounds and the
PRODUCT OF
Upjohn
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ever-present problem of digitalis toxicity pres­
ent new experimental data and hypotheses, 
which supplement and sometimes challenge 
traditional concepts. In addition some chapters 
explore exotic topics such as coronary artery 
disease in children and high-altitude pulmonary 
edema.
One of the best contributions is a thorough 
review of the source, assay methods and 
clinical significance of enzymes implicated in 
myocardial disease; infarct quantification 
through measurement of enzyme release is also 
described.
This book is neither for skimming briefly 
nor for uninterrupted reading; the digestion of 
a single chapter will give the reader a thorough, 
though not always balanced, topic survey and 
the references are up to date and useful.
I think this book would be of interest to 
cardiologists, cardiac surgeons and internists;
B. C. Thorton
Division of cardiology,
Ottawa Civic Hospital,
Ottawa, Ont.
COMPLICATIONS OF UROLOGIC SUR­
GERY. PREVENTION AND MANAGE­
MENT. Edited by Robert U. Smith and 
Donald G. Skinner. 520 pp. Illust. W. B. 
Saunders Company, Philadelphia; W. B. 
Saunders Company Canada Limited. Tor­
onto, 1976. $30.40.
This book is made up of 24 chapters by 26 
authors, and includes discussions on the com­
plications of urologic surgery and urologic 
trauma. The editors should be complimented 
for their choice of authors. The reader will 
sense that the information presented stems 
from personal experience; this is particularly 
valuable in discussing uncommon conditions, 
where special expertise is necessary. The book 
deals largely with the surgical aspects of uro­
logy; however, chapters are included on those 
medical complications especially relevant to 
urologic practice.
Although the prevention and treatment of 
complications are included in most standard 
text books, it is useful to have this information 
thoroughly discussed. Unfortunately, some of 
the authors did not focus on the objectives of 
the book. It is true that the technical details of 
urologic surgery are important in avoiding 
complications but detailed descriptions of 
operative techniques are inappropriate. In a 
book such as this, the reader would have ex­
pected to see the complications clearly listed;
the discussion should concentrate on preven­
tion of complications. Specific points in the 
preoperative assessment and operative tech­
nique should be made; these could have been 
followed up with a description of the methods 
available for dealing with complications. This 
format was followed in many of the chapters 
with great success; unfortunately, in other 
chapters the conditions were discussed as if 
the book was a general text on urology.
The book is recommended to residents in 
training, but practising urologists will also 
profit from it, for the book includes some new 
and useful practical points regarding the man­
agement of uncommon urologic problems.
S. A. Awad
Department of urology,
Queen’s University,
Kingston, Ont.
RECENT ADVANCES IN UROLOGY. No.
2. Edited by W. F. Hendry, 353 pp. Illust.
Churchill Livingstone, Edinburgh; Longman
Canada Limited, Toronto, 1976. $39.50.
All who set out to prepare a book on recent 
advances must choose between detailed dis­
cussions of a few topics or a shorter discussion 
of many; Hendry has chosen the latter. Four­
teen topics are reviewed; these include urinary 
tract infection, renal replacement therapy, ure­
throplasty, and carcinoma of the urothelium, 
prostate and testis.
The bibliography as far as it goes is excel­
lent. Unfortunately most references are to 
works published before 1975 and therefore can 
hardly be considered “recent”; for example, 
the paper on renal replacement therapy, a ra­
pidly advancing field, includes only 3 references 
from 1975; the other 67 references are of an 
earlier vintage.
The contributors to this book include such 
well-known British urologists as Blandy, Tur- 
ner-Warwick and Innes Williams. The editor 
expresses in the preface his hope that “the 
trainee surgeon will find this book useful in 
studying for higher examination” and that “the 
practising surgeon will find something of in­
terest”. I am sure that one could not pass any 
“higher examination” by studying this book 
alone, though it does survey important topics; 
it is brief and easily read and is useful as a 
quick review for the busy practising urologist.
T. Juda 
Ste. 304,
25 Brunswick Ave.,
Toronto, Ont.
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A Review of Anatomical Neurology. Walter 
Robinson Ingram. 428 pp. Illust. University Park 
Press, Baltimore. 1976. $19.50. ISBN 0-8391- 
0961-X.
Bum Therapy and Research. Witold Rudowski, 
Wieslaw Nasilowski, Witold Zietkiewics and 
Konrad Zienkiewics. 332 pp. Illust. The Johns 
Hopkins University Press, Baltimore, 1976. 
Price not stated. ISBN 0-8018-1643-2.
Cahiers d’Enseignement de la S.O.F.C.O.T. 4 Con­
ferences d’Enseignement. Edited by J. Duparc. 
186 pp. Illust. Expansion Scientifique Frangaise, 
Paris, 1976. $24.84 paperbound. ISBN 2-7046- 
0875-X.
Chirurgie 76. Resumes de la Conference, des 
Tables Rondes, des Forums et Communications 
du 78e Congres Frangais de Chirurgie. Edited 
by J .-Cl. Patel. 198 pp. Masson, Paris, 1976. 
$14.08 paperbound. ISBN 2-225-45573-2. 
Endoscopy. Edited by George Berci. 805 pp. Illust. 
Appleton-Century-Crofts, New York, 1976. 
$78.50. ISBN 0-8385-2216-5.
Histopathologie O. R. L. et Cervico-Faciale. Jean 
Leroux-Robert and Jean de Brux. 390 pp. Illust. 
Masson, Paris, 1976. $50.71. ISBN 2-225-45793- 
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N O T IC E
CANADIAN ASSOCIATION 
OF GENERAL SURGEONS/
L’ASSOCIATION CANADIENNE DES 
CHIRURGIENS GENERAUX
The inaugural meeting of the Canadian 
Association of General Surgeons/L’Asso­
ciation Canadienne des Chirurgiens Gene- 
raux will be held at the Royal York Hotel, 
Toronto, on Wednesday, May 11 and 
Thursday, May 12, 1977.
All certificants in general surgery of the 
Royal College of Physicians and Surgeons 
of Canada, or of the Corporation Profes- 
sionelle des Medecins du Quebec, are in­
vited to attend, and to stay for the “Gallie 
Day” surgical program on Friday, May 13, 
sponsored by the University of Toronto.
The program will include symposia and 
panels on peptic ulcer disease, cancer of 
colon and rectum, pancreatitis, intensive 
care, recent advances in continent ileostomy, 
retained common duct stones, hemorrhoids, 
immunotherapy, and evaluation of blood 
flow.
Translation services will be provided.
Registration fee for the meeting is $50. 
Banquet tickets are $15. per person.
For program and registration form, please 
write to: Canadian Association of General 
Surgeons, Room 310, Banting Institute, 100 
College St., Toronto, Ont. M5G 1L5.
